envx-20250928
0001828318
December 28
2025
Q3
false
0.0892160
xbrli:shares
iso4217:USD
iso4217:USD
xbrli:shares
envx:segment
xbrli:pure
utr:sqft
envx:plaintiff
envx:claim
utr:D
envx:award
envx:family_member
0001828318
2024-12-30
2025-09-28
0001828318
2025-11-03
0001828318
2025-09-28
0001828318
2024-12-29
0001828318
2025-06-30
2025-09-28
0001828318
2024-07-01
2024-09-29
0001828318
2024-01-01
2024-09-29
0001828318
envx:A2024RestructuringPlanMember
2024-07-01
2024-09-29
0001828318
envx:A2024RestructuringPlanMember
2024-01-01
2024-09-29
0001828318
us-gaap:CommonStockMember
2024-12-29
0001828318
us-gaap:AdditionalPaidInCapitalMember
2024-12-29
0001828318
us-gaap:TreasuryStockCommonMember
2024-12-29
0001828318
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-12-29
0001828318
us-gaap:RetainedEarningsMember
2024-12-29
0001828318
us-gaap:ParentMember
2024-12-29
0001828318
us-gaap:NoncontrollingInterestMember
2024-12-29
0001828318
us-gaap:RetainedEarningsMember
2024-12-30
2025-03-30
0001828318
us-gaap:ParentMember
2024-12-30
2025-03-30
0001828318
us-gaap:NoncontrollingInterestMember
2024-12-30
2025-03-30
0001828318
2024-12-30
2025-03-30
0001828318
us-gaap:CommonStockMember
2024-12-30
2025-03-30
0001828318
us-gaap:AdditionalPaidInCapitalMember
2024-12-30
2025-03-30
0001828318
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-12-30
2025-03-30
0001828318
us-gaap:CommonStockMember
2025-03-30
0001828318
us-gaap:AdditionalPaidInCapitalMember
2025-03-30
0001828318
us-gaap:TreasuryStockCommonMember
2025-03-30
0001828318
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-03-30
0001828318
us-gaap:RetainedEarningsMember
2025-03-30
0001828318
us-gaap:ParentMember
2025-03-30
0001828318
us-gaap:NoncontrollingInterestMember
2025-03-30
0001828318
2025-03-30
0001828318
us-gaap:RetainedEarningsMember
2025-03-31
2025-06-29
0001828318
us-gaap:ParentMember
2025-03-31
2025-06-29
0001828318
us-gaap:NoncontrollingInterestMember
2025-03-31
2025-06-29
0001828318
2025-03-31
2025-06-29
0001828318
us-gaap:CommonStockMember
2025-03-31
2025-06-29
0001828318
us-gaap:AdditionalPaidInCapitalMember
2025-03-31
2025-06-29
0001828318
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-03-31
2025-06-29
0001828318
us-gaap:CommonStockMember
2025-06-29
0001828318
us-gaap:AdditionalPaidInCapitalMember
2025-06-29
0001828318
us-gaap:TreasuryStockCommonMember
2025-06-29
0001828318
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-06-29
0001828318
us-gaap:RetainedEarningsMember
2025-06-29
0001828318
us-gaap:ParentMember
2025-06-29
0001828318
us-gaap:NoncontrollingInterestMember
2025-06-29
0001828318
2025-06-29
0001828318
us-gaap:RetainedEarningsMember
2025-06-30
2025-09-28
0001828318
us-gaap:ParentMember
2025-06-30
2025-09-28
0001828318
us-gaap:NoncontrollingInterestMember
2025-06-30
2025-09-28
0001828318
us-gaap:CommonStockMember
2025-06-30
2025-09-28
0001828318
us-gaap:AdditionalPaidInCapitalMember
2025-06-30
2025-09-28
0001828318
us-gaap:TreasuryStockCommonMember
2025-06-30
2025-09-28
0001828318
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-06-30
2025-09-28
0001828318
us-gaap:CommonStockMember
2025-09-28
0001828318
us-gaap:AdditionalPaidInCapitalMember
2025-09-28
0001828318
us-gaap:TreasuryStockCommonMember
2025-09-28
0001828318
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-09-28
0001828318
us-gaap:RetainedEarningsMember
2025-09-28
0001828318
us-gaap:ParentMember
2025-09-28
0001828318
us-gaap:NoncontrollingInterestMember
2025-09-28
0001828318
us-gaap:CommonStockMember
2023-12-31
0001828318
us-gaap:AdditionalPaidInCapitalMember
2023-12-31
0001828318
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-12-31
0001828318
us-gaap:RetainedEarningsMember
2023-12-31
0001828318
us-gaap:ParentMember
2023-12-31
0001828318
us-gaap:NoncontrollingInterestMember
2023-12-31
0001828318
2023-12-31
0001828318
us-gaap:RetainedEarningsMember
2024-01-01
2024-03-31
0001828318
us-gaap:ParentMember
2024-01-01
2024-03-31
0001828318
us-gaap:NoncontrollingInterestMember
2024-01-01
2024-03-31
0001828318
2024-01-01
2024-03-31
0001828318
us-gaap:CommonStockMember
2024-01-01
2024-03-31
0001828318
us-gaap:AdditionalPaidInCapitalMember
2024-01-01
2024-03-31
0001828318
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-01-01
2024-03-31
0001828318
us-gaap:CommonStockMember
2024-03-31
0001828318
us-gaap:AdditionalPaidInCapitalMember
2024-03-31
0001828318
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-03-31
0001828318
us-gaap:RetainedEarningsMember
2024-03-31
0001828318
us-gaap:ParentMember
2024-03-31
0001828318
us-gaap:NoncontrollingInterestMember
2024-03-31
0001828318
2024-03-31
0001828318
us-gaap:RetainedEarningsMember
2024-04-01
2024-06-30
0001828318
us-gaap:ParentMember
2024-04-01
2024-06-30
0001828318
us-gaap:NoncontrollingInterestMember
2024-04-01
2024-06-30
0001828318
2024-04-01
2024-06-30
0001828318
us-gaap:CommonStockMember
2024-04-01
2024-06-30
0001828318
us-gaap:AdditionalPaidInCapitalMember
2024-04-01
2024-06-30
0001828318
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-04-01
2024-06-30
0001828318
us-gaap:CommonStockMember
2024-06-30
0001828318
us-gaap:AdditionalPaidInCapitalMember
2024-06-30
0001828318
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-06-30
0001828318
us-gaap:RetainedEarningsMember
2024-06-30
0001828318
us-gaap:ParentMember
2024-06-30
0001828318
us-gaap:NoncontrollingInterestMember
2024-06-30
0001828318
2024-06-30
0001828318
us-gaap:RetainedEarningsMember
2024-07-01
2024-09-29
0001828318
us-gaap:ParentMember
2024-07-01
2024-09-29
0001828318
us-gaap:NoncontrollingInterestMember
2024-07-01
2024-09-29
0001828318
us-gaap:CommonStockMember
2024-07-01
2024-09-29
0001828318
us-gaap:AdditionalPaidInCapitalMember
2024-07-01
2024-09-29
0001828318
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-07-01
2024-09-29
0001828318
us-gaap:CommonStockMember
2024-09-29
0001828318
us-gaap:AdditionalPaidInCapitalMember
2024-09-29
0001828318
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-09-29
0001828318
us-gaap:RetainedEarningsMember
2024-09-29
0001828318
us-gaap:ParentMember
2024-09-29
0001828318
us-gaap:NoncontrollingInterestMember
2024-09-29
0001828318
2024-09-29
0001828318
2025-07-21
2025-07-21
0001828318
envx:A30ConvertibleSeniorNotesMember
us-gaap:ConvertibleDebtMember
2025-09-10
0001828318
us-gaap:ProductMember
2025-06-30
2025-09-28
0001828318
us-gaap:ProductMember
2024-07-01
2024-09-29
0001828318
us-gaap:ProductMember
country:KR
us-gaap:GeographicConcentrationRiskMember
us-gaap:SalesRevenueNetMember
2025-06-30
2025-09-28
0001828318
us-gaap:ProductMember
country:KR
us-gaap:GeographicConcentrationRiskMember
us-gaap:SalesRevenueNetMember
2024-07-01
2024-09-29
0001828318
us-gaap:ProductMember
2024-12-30
2025-09-28
0001828318
us-gaap:ProductMember
2024-01-01
2024-09-29
0001828318
us-gaap:ProductMember
country:KR
us-gaap:GeographicConcentrationRiskMember
us-gaap:SalesRevenueNetMember
2024-12-30
2025-09-28
0001828318
us-gaap:ProductMember
country:KR
us-gaap:GeographicConcentrationRiskMember
us-gaap:SalesRevenueNetMember
2024-01-01
2024-09-29
0001828318
envx:SolarEdgeTechnologiesInc.Member
2025-04-01
2025-04-01
0001828318
envx:SolarEdgeTechnologiesInc.Member
2025-04-01
0001828318
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:FairValueInputsLevel1Member
2025-09-28
0001828318
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:FairValueInputsLevel2Member
2025-09-28
0001828318
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:FairValueInputsLevel3Member
2025-09-28
0001828318
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueMeasurementsRecurringMember
2025-09-28
0001828318
us-gaap:USTreasurySecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ShortTermInvestmentsMember
us-gaap:FairValueInputsLevel1Member
2025-09-28
0001828318
us-gaap:USTreasurySecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ShortTermInvestmentsMember
us-gaap:FairValueInputsLevel2Member
2025-09-28
0001828318
us-gaap:USTreasurySecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ShortTermInvestmentsMember
us-gaap:FairValueInputsLevel3Member
2025-09-28
0001828318
us-gaap:USTreasurySecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ShortTermInvestmentsMember
2025-09-28
0001828318
us-gaap:CorporateNoteSecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ShortTermInvestmentsMember
us-gaap:FairValueInputsLevel1Member
2025-09-28
0001828318
us-gaap:CorporateNoteSecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ShortTermInvestmentsMember
us-gaap:FairValueInputsLevel2Member
2025-09-28
0001828318
us-gaap:CorporateNoteSecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ShortTermInvestmentsMember
us-gaap:FairValueInputsLevel3Member
2025-09-28
0001828318
us-gaap:CorporateNoteSecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ShortTermInvestmentsMember
2025-09-28
0001828318
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ShortTermInvestmentsMember
us-gaap:FairValueInputsLevel1Member
2025-09-28
0001828318
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ShortTermInvestmentsMember
us-gaap:FairValueInputsLevel2Member
2025-09-28
0001828318
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ShortTermInvestmentsMember
us-gaap:FairValueInputsLevel3Member
2025-09-28
0001828318
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ShortTermInvestmentsMember
2025-09-28
0001828318
us-gaap:USTreasurySecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:OtherLongTermInvestmentsMember
us-gaap:FairValueInputsLevel1Member
2025-09-28
0001828318
us-gaap:USTreasurySecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:OtherLongTermInvestmentsMember
us-gaap:FairValueInputsLevel2Member
2025-09-28
0001828318
us-gaap:USTreasurySecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:OtherLongTermInvestmentsMember
us-gaap:FairValueInputsLevel3Member
2025-09-28
0001828318
us-gaap:USTreasurySecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:OtherLongTermInvestmentsMember
2025-09-28
0001828318
us-gaap:CorporateNoteSecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:OtherLongTermInvestmentsMember
us-gaap:FairValueInputsLevel1Member
2025-09-28
0001828318
us-gaap:CorporateNoteSecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:OtherLongTermInvestmentsMember
us-gaap:FairValueInputsLevel2Member
2025-09-28
0001828318
us-gaap:CorporateNoteSecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:OtherLongTermInvestmentsMember
us-gaap:FairValueInputsLevel3Member
2025-09-28
0001828318
us-gaap:CorporateNoteSecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:OtherLongTermInvestmentsMember
2025-09-28
0001828318
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:OtherLongTermInvestmentsMember
us-gaap:FairValueInputsLevel1Member
2025-09-28
0001828318
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:OtherLongTermInvestmentsMember
us-gaap:FairValueInputsLevel2Member
2025-09-28
0001828318
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:OtherLongTermInvestmentsMember
us-gaap:FairValueInputsLevel3Member
2025-09-28
0001828318
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:OtherLongTermInvestmentsMember
2025-09-28
0001828318
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:FairValueInputsLevel1Member
2025-09-28
0001828318
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:FairValueInputsLevel2Member
2025-09-28
0001828318
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:FairValueInputsLevel3Member
2025-09-28
0001828318
us-gaap:FairValueMeasurementsRecurringMember
2025-09-28
0001828318
envx:PrivatePlacementWarrantsMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:FairValueInputsLevel1Member
2025-09-28
0001828318
envx:PrivatePlacementWarrantsMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:FairValueInputsLevel2Member
2025-09-28
0001828318
envx:PrivatePlacementWarrantsMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:FairValueInputsLevel3Member
2025-09-28
0001828318
envx:PrivatePlacementWarrantsMember
us-gaap:FairValueMeasurementsRecurringMember
2025-09-28
0001828318
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:FairValueInputsLevel1Member
2024-12-29
0001828318
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:FairValueInputsLevel2Member
2024-12-29
0001828318
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:FairValueInputsLevel3Member
2024-12-29
0001828318
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueMeasurementsRecurringMember
2024-12-29
0001828318
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:FairValueInputsLevel1Member
2024-12-29
0001828318
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:FairValueInputsLevel2Member
2024-12-29
0001828318
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:FairValueInputsLevel3Member
2024-12-29
0001828318
us-gaap:FairValueMeasurementsRecurringMember
2024-12-29
0001828318
envx:PrivatePlacementWarrantsMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:FairValueInputsLevel1Member
2024-12-29
0001828318
envx:PrivatePlacementWarrantsMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:FairValueInputsLevel2Member
2024-12-29
0001828318
envx:PrivatePlacementWarrantsMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:FairValueInputsLevel3Member
2024-12-29
0001828318
envx:PrivatePlacementWarrantsMember
us-gaap:FairValueMeasurementsRecurringMember
2024-12-29
0001828318
us-gaap:MoneyMarketFundsMember
2025-09-28
0001828318
us-gaap:MoneyMarketFundsMember
us-gaap:CashEquivalentsMember
2025-09-28
0001828318
us-gaap:MoneyMarketFundsMember
us-gaap:ShortTermInvestmentsMember
2025-09-28
0001828318
us-gaap:MoneyMarketFundsMember
us-gaap:OtherLongTermInvestmentsMember
2025-09-28
0001828318
us-gaap:USTreasurySecuritiesMember
2025-09-28
0001828318
us-gaap:USTreasurySecuritiesMember
us-gaap:CashEquivalentsMember
2025-09-28
0001828318
us-gaap:USTreasurySecuritiesMember
us-gaap:ShortTermInvestmentsMember
2025-09-28
0001828318
us-gaap:USTreasurySecuritiesMember
us-gaap:OtherLongTermInvestmentsMember
2025-09-28
0001828318
us-gaap:CorporateNoteSecuritiesMember
2025-09-28
0001828318
us-gaap:CorporateNoteSecuritiesMember
us-gaap:CashEquivalentsMember
2025-09-28
0001828318
us-gaap:CorporateNoteSecuritiesMember
us-gaap:ShortTermInvestmentsMember
2025-09-28
0001828318
us-gaap:CorporateNoteSecuritiesMember
us-gaap:OtherLongTermInvestmentsMember
2025-09-28
0001828318
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
2025-09-28
0001828318
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
us-gaap:CashEquivalentsMember
2025-09-28
0001828318
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
us-gaap:ShortTermInvestmentsMember
2025-09-28
0001828318
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
us-gaap:OtherLongTermInvestmentsMember
2025-09-28
0001828318
us-gaap:CashEquivalentsMember
2025-09-28
0001828318
us-gaap:ShortTermInvestmentsMember
2025-09-28
0001828318
us-gaap:OtherLongTermInvestmentsMember
2025-09-28
0001828318
us-gaap:MoneyMarketFundsMember
2024-12-29
0001828318
us-gaap:MoneyMarketFundsMember
us-gaap:CashEquivalentsMember
2024-12-29
0001828318
us-gaap:MoneyMarketFundsMember
us-gaap:ShortTermInvestmentsMember
2024-12-29
0001828318
us-gaap:MoneyMarketFundsMember
us-gaap:OtherLongTermInvestmentsMember
2024-12-29
0001828318
us-gaap:CashEquivalentsMember
2024-12-29
0001828318
us-gaap:ShortTermInvestmentsMember
2024-12-29
0001828318
us-gaap:OtherLongTermInvestmentsMember
2024-12-29
0001828318
envx:PrivatePlacementWarrantsMember
2021-12-05
0001828318
envx:PrivatePlacementWarrantsMember
2025-07-21
0001828318
envx:PrivatePlacementWarrantsMember
2025-09-28
0001828318
envx:PrivatePlacementWarrantsMember
2024-12-29
0001828318
envx:PrivatePlacementWarrantsMember
us-gaap:FairValueInputsLevel3Member
2024-12-29
0001828318
envx:PrivatePlacementWarrantsMember
us-gaap:FairValueInputsLevel3Member
2023-12-31
0001828318
envx:PrivatePlacementWarrantsMember
us-gaap:FairValueInputsLevel3Member
2024-12-30
2025-09-28
0001828318
envx:PrivatePlacementWarrantsMember
us-gaap:FairValueInputsLevel3Member
2024-01-01
2024-09-29
0001828318
envx:PrivatePlacementWarrantsMember
us-gaap:FairValueInputsLevel3Member
2025-09-28
0001828318
envx:PrivatePlacementWarrantsMember
us-gaap:FairValueInputsLevel3Member
2024-09-29
0001828318
envx:PrivatePlacementWarrantsMember
us-gaap:MeasurementInputExpectedTermMember
2025-09-28
0001828318
envx:PrivatePlacementWarrantsMember
us-gaap:MeasurementInputExpectedTermMember
2024-12-29
0001828318
envx:PrivatePlacementWarrantsMember
us-gaap:MeasurementInputPriceVolatilityMember
2025-09-28
0001828318
envx:PrivatePlacementWarrantsMember
us-gaap:MeasurementInputPriceVolatilityMember
2024-12-29
0001828318
envx:PrivatePlacementWarrantsMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
2025-09-28
0001828318
envx:PrivatePlacementWarrantsMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
2024-12-29
0001828318
envx:PrivatePlacementWarrantsMember
us-gaap:MeasurementInputExpectedDividendRateMember
2025-09-28
0001828318
envx:PrivatePlacementWarrantsMember
us-gaap:MeasurementInputExpectedDividendRateMember
2024-12-29
0001828318
us-gaap:MachineryAndEquipmentMember
2025-09-28
0001828318
us-gaap:MachineryAndEquipmentMember
2024-12-29
0001828318
envx:BuildingAndLeaseholdImprovementsMember
2025-09-28
0001828318
envx:BuildingAndLeaseholdImprovementsMember
2024-12-29
0001828318
us-gaap:OfficeEquipmentMember
2025-09-28
0001828318
us-gaap:OfficeEquipmentMember
2024-12-29
0001828318
us-gaap:FurnitureAndFixturesMember
2025-09-28
0001828318
us-gaap:FurnitureAndFixturesMember
2024-12-29
0001828318
us-gaap:LandMember
2025-09-28
0001828318
us-gaap:LandMember
2024-12-29
0001828318
us-gaap:ConstructionInProgressMember
2025-09-28
0001828318
us-gaap:ConstructionInProgressMember
2024-12-29
0001828318
envx:StrategicRealignmentOfFab1Member
2024-01-01
2024-03-31
0001828318
us-gaap:ResearchAndDevelopmentExpenseMember
envx:StrategicRealignmentOfFab1Member
2024-01-01
2024-03-31
0001828318
us-gaap:SellingGeneralAndAdministrativeExpensesMember
envx:StrategicRealignmentOfFab1Member
2024-01-01
2024-03-31
0001828318
envx:StrategicRealignmentOfFab1Member
2024-04-01
2025-06-29
0001828318
us-gaap:MachineryAndEquipmentMember
envx:StrategicRealignmentOfFab1Member
2024-07-01
2024-09-29
0001828318
us-gaap:MachineryAndEquipmentMember
envx:StrategicRealignmentOfFab1Member
2024-01-01
2024-09-29
0001828318
envx:ConvertibleSeniorNotesDue2028Member
us-gaap:ConvertibleDebtMember
2025-09-28
0001828318
envx:ConvertibleSeniorNotesDue2028Member
us-gaap:ConvertibleDebtMember
2024-12-29
0001828318
envx:ConvertibleSeniorNotesDue2030Member
us-gaap:ConvertibleDebtMember
2025-09-28
0001828318
envx:ConvertibleSeniorNotesDue2030Member
us-gaap:ConvertibleDebtMember
2024-12-29
0001828318
envx:FloatingRateLoanDue2027Member
us-gaap:UnsecuredDebtMember
2025-09-28
0001828318
envx:FloatingRateLoanDue2027Member
us-gaap:UnsecuredDebtMember
2024-12-29
0001828318
envx:FloatingRateLoanDue2028Member
us-gaap:UnsecuredDebtMember
2025-09-28
0001828318
envx:FloatingRateLoanDue2028Member
us-gaap:UnsecuredDebtMember
2024-12-29
0001828318
envx:FixedRateLoanDue2026Member
us-gaap:UnsecuredDebtMember
2025-09-28
0001828318
envx:FixedRateLoanDue2026Member
us-gaap:UnsecuredDebtMember
2024-12-29
0001828318
envx:A3.0ConvertibleSeniorNotePurchaseOptionMember
us-gaap:ConvertibleDebtMember
2025-09-10
0001828318
envx:ConvertibleSeniorNotesDue2031Member
us-gaap:ConvertibleDebtMember
2025-09-28
0001828318
envx:A30ConvertibleSeniorNotesMember
us-gaap:ConvertibleDebtMember
2025-09-10
2025-09-10
0001828318
envx:A30ConvertibleSeniorNotesMember
2025-09-10
0001828318
envx:A30ConvertibleSeniorNotesMember
us-gaap:ConvertibleDebtMember
envx:DebtConversionConditionOneMember
2025-09-10
2025-09-10
0001828318
envx:A30ConvertibleSeniorNotesMember
us-gaap:ConvertibleDebtMember
envx:DebtConversionConditionTwoMember
2025-09-10
2025-09-10
0001828318
envx:A30ConvertibleSeniorNotesMember
us-gaap:ConvertibleDebtMember
envx:DebtConversionConditionOneMember
2025-09-10
0001828318
envx:A30ConvertibleSeniorNotesMember
us-gaap:ConvertibleDebtMember
2024-12-30
2025-09-28
0001828318
envx:A30ConvertibleSeniorNotesMember
us-gaap:ConvertibleDebtMember
2025-06-30
2025-09-28
0001828318
us-gaap:ShareBasedCompensationAwardTrancheOneMember
2025-09-28
0001828318
us-gaap:ShareBasedCompensationAwardTrancheTwoMember
2025-09-28
0001828318
us-gaap:ShareBasedCompensationAwardTrancheThreeMember
2025-09-28
0001828318
envx:ShareBasedCompensationAwardTrancheFourMember
2025-09-28
0001828318
envx:ConvertibleSeniorNotesDue2028Member
us-gaap:ConvertibleDebtMember
2023-04-20
0001828318
us-gaap:RelatedPartyMember
envx:A30ConvertibleSeniorNotesAffiliateNotesMember
us-gaap:ConvertibleDebtMember
2023-04-20
0001828318
envx:A30ConvertibleSeniorNotesMember
us-gaap:ConvertibleDebtMember
2024-07-01
2024-09-29
0001828318
envx:ConvertibleSeniorNotesDue2028Member
us-gaap:ConvertibleDebtMember
2024-12-30
2025-09-28
0001828318
envx:ConvertibleSeniorNotesDue2028Member
us-gaap:ConvertibleDebtMember
2024-01-01
2024-09-29
0001828318
us-gaap:LoansMember
2025-06-30
2025-09-28
0001828318
us-gaap:LoansMember
2024-07-01
2024-09-29
0001828318
us-gaap:LoansMember
2024-12-30
2025-09-28
0001828318
us-gaap:LoansMember
2024-01-01
2024-09-29
0001828318
envx:ConvertibleSeniorNotesDue2030Member
us-gaap:ConvertibleDebtMember
2023-04-20
2023-04-20
0001828318
2025-06-30
2025-09-28
0001828318
envx:SecuritiesClassActionCompliantMember
2023-01-25
2023-01-25
0001828318
us-gaap:SubsequentEventMember
2025-10-07
2025-10-07
0001828318
us-gaap:CommonStockMember
2025-06-30
0001828318
2025-07-07
0001828318
2025-07-21
0001828318
2025-07-22
0001828318
srt:ScenarioPreviouslyReportedMember
2024-07-01
2024-09-29
0001828318
srt:ScenarioPreviouslyReportedMember
2024-01-01
2024-09-29
0001828318
srt:RestatementAdjustmentMember
2024-07-01
2024-09-29
0001828318
srt:RestatementAdjustmentMember
2024-01-01
2024-09-29
0001828318
us-gaap:EmployeeStockOptionMember
2025-06-30
2025-09-28
0001828318
us-gaap:EmployeeStockOptionMember
2024-07-01
2024-09-29
0001828318
us-gaap:EmployeeStockOptionMember
2024-12-30
2025-09-28
0001828318
us-gaap:EmployeeStockOptionMember
2024-01-01
2024-09-29
0001828318
envx:RestrictedStockAndRestrictedStockUnitsRSUsMember
2025-06-30
2025-09-28
0001828318
envx:RestrictedStockAndRestrictedStockUnitsRSUsMember
2024-07-01
2024-09-29
0001828318
envx:RestrictedStockAndRestrictedStockUnitsRSUsMember
2024-12-30
2025-09-28
0001828318
envx:RestrictedStockAndRestrictedStockUnitsRSUsMember
2024-01-01
2024-09-29
0001828318
us-gaap:ConvertibleDebtSecuritiesMember
2025-06-30
2025-09-28
0001828318
us-gaap:ConvertibleDebtSecuritiesMember
2024-07-01
2024-09-29
0001828318
us-gaap:ConvertibleDebtSecuritiesMember
2024-12-30
2025-09-28
0001828318
us-gaap:ConvertibleDebtSecuritiesMember
2024-01-01
2024-09-29
0001828318
envx:PrivatePlacementWarrantsMember
2025-06-30
2025-09-28
0001828318
envx:PrivatePlacementWarrantsMember
2024-07-01
2024-09-29
0001828318
envx:PrivatePlacementWarrantsMember
2024-12-30
2025-09-28
0001828318
envx:PrivatePlacementWarrantsMember
2024-01-01
2024-09-29
0001828318
us-gaap:EmployeeStockMember
2025-06-30
2025-09-28
0001828318
us-gaap:EmployeeStockMember
2024-07-01
2024-09-29
0001828318
us-gaap:EmployeeStockMember
2024-12-30
2025-09-28
0001828318
us-gaap:EmployeeStockMember
2024-01-01
2024-09-29
0001828318
us-gaap:CostOfSalesMember
2025-06-30
2025-09-28
0001828318
us-gaap:CostOfSalesMember
2024-07-01
2024-09-29
0001828318
us-gaap:CostOfSalesMember
2024-12-30
2025-09-28
0001828318
us-gaap:CostOfSalesMember
2024-01-01
2024-09-29
0001828318
us-gaap:ResearchAndDevelopmentExpenseMember
2025-06-30
2025-09-28
0001828318
us-gaap:ResearchAndDevelopmentExpenseMember
2024-07-01
2024-09-29
0001828318
us-gaap:ResearchAndDevelopmentExpenseMember
2024-12-30
2025-09-28
0001828318
us-gaap:ResearchAndDevelopmentExpenseMember
2024-01-01
2024-09-29
0001828318
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2025-06-30
2025-09-28
0001828318
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2024-07-01
2024-09-29
0001828318
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2024-12-30
2025-09-28
0001828318
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2024-01-01
2024-09-29
0001828318
us-gaap:RestructuringChargesMember
2025-06-30
2025-09-28
0001828318
us-gaap:RestructuringChargesMember
2024-07-01
2024-09-29
0001828318
us-gaap:RestructuringChargesMember
2024-12-30
2025-09-28
0001828318
us-gaap:RestructuringChargesMember
2024-01-01
2024-09-29
0001828318
us-gaap:RestrictedStockUnitsRSUMember
2024-01-01
2024-06-30
0001828318
us-gaap:RestrictedStockUnitsRSUMember
2024-01-01
2024-09-29
0001828318
us-gaap:StockCompensationPlanMember
2025-09-28
0001828318
us-gaap:StockCompensationPlanMember
2024-12-30
2025-09-28
0001828318
us-gaap:EmployeeStockMember
2025-09-28
0001828318
us-gaap:EmployeeStockMember
2024-12-30
2025-09-28
0001828318
us-gaap:EmployeeStockOptionMember
2024-12-30
2025-09-28
0001828318
us-gaap:RestrictedStockUnitsRSUMember
2024-12-29
0001828318
us-gaap:PerformanceSharesMember
2024-12-29
0001828318
us-gaap:RestrictedStockUnitsRSUMember
2024-12-30
2025-09-28
0001828318
us-gaap:PerformanceSharesMember
2024-12-30
2025-09-28
0001828318
us-gaap:RestrictedStockUnitsRSUMember
2025-09-28
0001828318
us-gaap:PerformanceSharesMember
2025-09-28
0001828318
2024-05-01
2024-05-31
0001828318
us-gaap:OtherCurrentLiabilitiesMember
envx:A2024RestructuringPlanMember
2024-12-29
0001828318
us-gaap:RelatedPartyMember
2025-09-28
0001828318
envx:A30ConvertibleSeniorNotesAffiliateNotesMember
us-gaap:RelatedPartyMember
2025-06-30
2025-09-28
0001828318
envx:A30ConvertibleSeniorNotesAffiliateNotesMember
us-gaap:RelatedPartyMember
2024-07-01
2024-09-29
0001828318
envx:A30ConvertibleSeniorNotesAffiliateNotesMember
us-gaap:RelatedPartyMember
2024-01-01
2024-09-29
0001828318
envx:A30ConvertibleSeniorNotesAffiliateNotesMember
us-gaap:RelatedPartyMember
2024-12-30
2025-09-28
0001828318
envx:ConvertibleSeniorNotesDue2023Member
us-gaap:ConvertibleDebtMember
2025-09-28
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 
10-Q
x

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended 
September 28, 2025
OR
o

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from__________to __________
Enovix Corporation
(Exact Name of Registrant as Specified in Charter)
Delaware
001-39753
85-3174357
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
3501 W Warren Avenue
Fremont
, 
California

94538
(Address of Principal Executive Offices)
(
510
) 
695-2350
(Registrant’s Telephone Number)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class 
Trading
Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.0001 per share
ENVX
The Nasdaq Global Select Market
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. 
Yes

x
 No 
o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). 
Yes

x
 No 
o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
x
Accelerated filer
o
Non-accelerated filer
o
Smaller reporting company
o
Emerging growth company
o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 
o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No 
x
As of November 3, 2025, 
215,816,004

shares of common stock, par value $0.0001 per share, were issued and outstanding.
Table of Contents
Table of Contents
Page
PART I.
FINANCIAL INFORMATION
Item 1.
Financial Statements (unaudited)
1
Condensed Consolidated Balance Sheets as of 
September 28, 2025 and December 29, 2024
1
Condensed Consolidated Statements of Operations for the fiscal quarters ended and fiscal years-to-date ended 
September 28, 2025
 and 
September 29, 2024
2
Condensed Consolidated Statements of Comprehensive Income (Loss) for the fiscal quarters 
and fiscal years-to-date 
ended September 28, 2025

and

September 29, 2024
3
Condensed Consolidated Statements of Changes in Stockholders’ Equity for the fiscal quarters 
and fiscal years-to-date 
ended 
September 28, 2025 and September 29, 2024
4
Condensed Consolidated Statements of Cash Flows for the 
fiscal years-to-date 
ended 
September 28, 2025 and September 29, 2024
6
Notes to Condensed Consolidated Financial Statements
8
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
30
Item 3.
Quantitative and Qualitative Disclosure about Market Risks
41
Item 4.
Controls and Procedures
41
PART II.
OTHER INFORMATION
Item 1.
Legal Proceedings
42
Item 1A.
Risk Factors
42
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities
74
Item 3
Defaults Upon Senior Securities
74
Item 4
Mine Safety Disclosures
74
Item 5
Other Information
74
Item 6.
Exhibits
75
Signatures
77
Table of Contents
FORWARD LOOKING STATEMENTS
This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The statements contained in this Quarterly Report that are not purely historical are forward-looking statements. Forward-looking statements generally relate to future events or our future financial or operating performance and can be identified by words such as anticipate, believe, continue, could, estimate, expect, intend, may, might, plan, possible, potential, predict, project, should, will, would and similar expressions that convey uncertainty about future events or outcomes. In addition, any statements that refer to projections, forecasts, management’s expectations, hopes, beliefs, intentions or strategies regarding the future, are forward-looking statements. Examples of forward-looking statements in this Quarterly Report include, without limitation, statements about:
•
our future operating results, financial position, growth opportunities and guidance, and our anticipation that changes in the global trade environment do not pose a material risk to our outlook;
•
our commercialization plans, strategy and product development roadmap, including the AI-1 platform launch, AI Class of batteries, and the readiness, performance, timing, and customer qualification of our AI-1 smartphone battery, other batteries under development from the AI-1 platform, and the design of our next battery technology node;
•
our manufacturing strategy, including scale-up and operational readiness, including at Fab2 in Malaysia, our assets and facility expansion in South Korea, and the anticipated benefits of the SolarEdge asset purchase, and our ability to enhance per-zone capacity and reduce switching time between configurations;
•
our benchmarking of key battery metrics such as energy density and fast charge and competitive positioning, including our ability to maintain and expand a performance lead over other silicon-doped or conventional battery architectures, and our beliefs about our competitors’ inability to achieve further energy density enhancements using these techniques due to swelling; 
•
our expectations regarding our AI-1™ platform and our AI Class of batteries
•
customer interest, qualification activities, and expected adoption of our AI Class products across smartphone, smart eyewear, AI-powered devices, handheld computing, defense, drone, IoT, and EV segments; 
•
our ability to enter into or expand commercial agreements, including strategic partnerships, design wins, production contracts, and potential expansion of agreements with automotive OEMs;
•
the strategic value and potential for expansion of our acquired South Korea facility, and its role in supporting defense programs and Fab2 capacity; 
•
the impact of seasonal purchasing patterns, including defense procurement cycles;
•
the impacts of tariffs, trade policies, and regional market developments on our business strategy and demand outlook; 
•
anticipated trends, risks, and opportunities across our addressable markets and the broader economic environment, including interest rates, inflation, currency fluctuations, and global supply chain evolution; 
•
the timing and ability to raise additional capital through equity, debt, or other instruments to support operations, growth initiatives, or capital expenditures;
•
the impact of AI feature adoption on demand for energy-dense batteries; 
•
the timing and expected success of achieving technical milestones, including audits by OEMs, production ramp-up readiness, and securing purchase orders; and
•
our exposure to and management of global trade risks.
The forward-looking statements contained in this Quarterly Report on Form 10-Q are based on our current expectations and beliefs concerning future developments and their potential effects on us. It is not possible for us to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. Accordingly, you should not place undue reliance on any of these forward-looking statements. These forward-looking statements, and the assumptions underlying such statements, involve a number of risks and uncertainties, some of which are beyond our control. These risks and uncertainties include, but are not limited to, those described in Part II, Item 1A. “Risk Factors” of this Quarterly Report on Form 10-Q. Should one or more of these risks 
Table of Contents
or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may differ materially from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Table of Contents
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
ENOVIX CORPORATION 
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited) 
(In thousands, except share and par value amounts)
September 28,
2025
December 29,
2024
Assets
Current assets:
Cash and cash equivalents 
$
335,502

$
272,869

Short-term investments
223,316

—

Accounts receivable, net
4,631

4,566

Notes receivable, net
2,412

4

Inventory
15,224

7,664

Prepaid expenses and other current assets 
7,547

9,903

Total current assets 
588,632

295,006

Property and equipment, net 
174,585

167,947

Long-term investments
89,451

—

Customer relationship intangibles and other intangibles, net
32,827

36,394

Operating lease, right-of-use assets 
11,774

13,479

Goodwill
12,217

12,217

Other assets, non-current 
4,223

2,126

Total assets 
$
913,709

$
527,169

Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable 
$
21,311

$
9,492

Accrued expenses 
8,928

19,843

Accrued compensation 
7,214

8,228

Short-term debt
10,151

9,452

Deferred revenue 
7,689

3,650

Other liabilities 
5,281

3,036

Total current liabilities 
60,574

53,701

Long-term debt, net
518,348

169,820

Warrant liability
16,632

28,380

Operating lease liabilities, non-current 
11,413

13,293

Deferred revenue, non-current 
300

3,774

Deferred tax liability
9,325

8,784

Other liabilities, non-current 
14

14

Total liabilities 
616,606

277,766

Commitments and Contingencies (Note 9)
Stockholders’ equity:
Common stock, $
0.0001
 par value; authorized shares of 
1,000,000,000
; issued and outstanding shares of 
215,367,757
 and 
190,559,335
 as of September 28, 2025 and December 29, 2024, respectively 
22

19

Additional paid-in-capital 
1,296,114

1,067,951

Treasury stock, at cost
(
58,385
)
—

Accumulated other comprehensive loss
(
658
)
(
143
)
Accumulated deficit 
(
942,837
)
(
821,086
)
Total Enovix stockholders’ equity 
294,256

246,741

Non-controlling interest
2,847

2,662

Total equity
297,103

249,403

Total liabilities and equity 
$
913,709

$
527,169

See accompanying notes to these condensed consolidated financial statements.
1
Table of Contents
ENOVIX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
Fiscal Quarters Ended
Fiscal Years-to-Date Ended
(In thousands, except share and per share amounts)
September 28, 2025
September 29, 2024
September 28, 2025
September 29, 2024
Revenue 
$
7,990

$
4,317

$
20,556

$
13,357

Cost of revenue
6,589

4,959

16,952

16,454

Gross profit (loss)
1,401

(
642
)
3,604

(
3,097
)
Operating expenses:
Research and development 
28,180

24,220

82,257

102,073

Selling, general and administrative 
20,194

20,744

54,613

61,176

Restructuring cost
—

3,661

—

41,807

Total operating expenses 
48,374

48,625

136,870

205,056

Loss from operations 
(
46,973
)
(
49,267
)
(
133,266
)
(
208,153
)
Other income (expense):
Change in fair value of common stock warrants
1,867

29,899

11,778

17,359

Gain on bargain purchase of assets
—

—

4,761

—

Interest income
2,540

2,859

7,401

9,745

Interest expense
(
11,765
)
(
1,718
)
(
15,186
)
(
5,068
)
Other income (loss), net 
140

(
2,217
)
1,501

(
1,509
)
Total other income (loss), net 
(
7,218
)
28,823

10,255

20,527

Loss before income tax expense (benefit)
(
54,191
)
(
20,444
)
(
123,011
)
(
187,626
)
Income tax expense (benefit)
(
422
)
2,194

(
1,445
)
(
2,544
)
Net loss
(
53,769
)
(
22,638
)
(
121,566
)
(
185,082
)
Net gain (loss) attributable to non-controlling interests
(
56
)
(
102
)
185

(
306
)
Net loss attributable to Enovix
$
(
53,713
)
$
(
22,536
)
$
(
121,751
)
$
(
184,776
)
Net loss per share attributable to Enovix shareholders, basic
(1)
$
(
0.26
)
$
(
0.12
)
$
(
0.59
)
$
(
1.01
)
Weighted average number of common shares outstanding, basic
(1)
206,458,846

187,785,319

204,758,291

183,229,182

Net loss per share attributable to Enovix shareholders, diluted
(1)
$
(
0.27
)
$
(
0.28
)
$
(
0.59
)
$
(
1.01
)
Weighted average number of common shares outstanding, diluted
(1)
206,811,315

187,977,123

204,758,291

183,229,182

(1)

As required by ASC 260, 
Earnings Per Share
, the share and per share amounts for the periods presented above in the condensed consolidated financial statements have been retroactively adjusted to reflect the Warrant (as defined in Note 2 “Basis of Presentation and Summary of Significant Accounting Policies”) in July 2025. For more information on the adjusted net loss per share, please refer to Note 11 “Net Loss per Share” for more details.
See accompanying notes to these condensed consolidated financial statements.
2
Table of Contents
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(Unaudited)
Fiscal Quarters Ended
Fiscal Years-to-Date Ended
(In thousands)
September 28, 2025
September 29, 2024
September 28, 2025
September 29, 2024
Net loss
$
(
53,769
)
$
(
22,638
)
$
(
121,566
)
$
(
185,082
)
Other comprehensive income (loss), net of tax
Change in net foreign currency translation adjustments
(
11
)
(
61
)
(
242
)
34

Net unrealized gain (loss) on available-for-sale securities
(
256
)
4

(
273
)
(
14
)
Other comprehensive income (expense), net of tax
(
267
)
(
57
)
(
515
)
20

Comprehensive loss
(
54,036
)
(
22,695
)
(
122,081
)
(
185,062
)
Comprehensive gain (loss) attributable to non-controlling interest
(
56
)
(
102
)
185

(
306
)
Comprehensive loss attributable to Enovix
$
(
53,980
)
$
(
22,593
)
$
(
122,266
)
$
(
184,756
)
See accompanying notes to these condensed consolidated financial statements.
3
Table of Contents
ENOVIX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
(Unaudited)
Common Stock

Additional
Paid-in
Capital
Treasury Stock, at cost
Accumulated Other Comprehensive Loss
Accumulated 
Deficit
Total
Stockholders' Equity
Non-controlling Interests
Total
 Equity
(In thousands, except share amounts)
Shares
Amount
Balance as of December 29, 2024
190,559,335

$
19

$
1,067,951

$
—

$
(
143
)
$
(
821,086
)
$
246,741

$
2,662

$
249,403

Net loss
— 
— 
— 
— 
— 
(
23,510
)
(
23,510
)
(
21
)
(
23,531
)
Issuance of common stock upon exercise of stock options
81,621

— 
782

— 
— 
— 
782

— 
782

RSU vested, net of shares withheld
1,074,758

— 
(
1,761
)
— 
— 
— 
(
1,761
)
— 
(
1,761
)
Vesting of early exercised stock options
— 
— 
1

— 
— 
— 
1

— 
1

Repurchase of unvested restricted common stock
(
597
)
— 
— 
— 
— 
— 
— 
— 
— 
Stock-based compensation
— 
— 
12,931

— 
— 
— 
12,931

— 
12,931

Other comprehensive loss, net
— 
— 
— 
— 
(
41
)
— 
(
41
)
— 
(
41
)
Balance as of March 30, 2025
191,715,117

19

1,079,904

—

(
184
)
(
844,596
)
235,143

2,641

237,784

Net loss
—

—

—

—

—

(
44,528
)
(
44,528
)
262

(
44,266
)
Issuance of common stock under employee stock purchase plan
129,038

— 
711

— 
— 
— 
711

— 
711

RSUs vested, net of shares withheld
1,113,668

— 
(
1,092
)
— 
— 
— 
(
1,092
)
— 
(
1,092
)
Stock-based compensation
— 
— 
13,722

— 
— 
— 
13,722

— 
13,722

Other comprehensive loss, net
— 
— 
— 
— 
(
207
)
— 
(
207
)
— 
(
207
)
Balance as of June 29, 2025
192,957,823

19

1,093,245

—

(
391
)
(
889,124
)
203,749

2,903

$
206,652

Net loss
— 
— 
— 
— 
— 
(
53,713
)
(
53,713
)
(
56
)
(
53,769
)
Issuance of common stock upon exercise of stock options
256,114

— 
2,351

— 
— 
— 
2,351

— 
2,351

Issuance of common stock upon exercise of Warrants, net
26,526,344

3

225,424

— 
— 
— 
225,427

— 
225,427

Fair value of Warrants related to 2028 Convertible Senior Notes
— 
— 
9,223

— 
— 
— 
9,223

— 
9,223

RSUs vested, net of shares withheld
1,065,032

— 
(
2,002
)
— 
— 
— 
(
2,002
)
(
2,002
)
Repurchase of common stock
(
5,437,556
)
— 
— 
(
58,385
)
— 
— 
(
58,385
)
— 
(
58,385
)
Purchase of Capped Calls
— 
— 
(
45,288
)
— 
— 
— 
(
45,288
)
— 
(
45,288
)
Stock-based compensation
— 
— 
13,161

— 
— 
— 
13,161

— 
13,161

Other comprehensive loss, net
— 
— 
— 
— 
(
267
)
— 
(
267
)
— 
(
267
)
Balance as of September 28, 2025
215,367,757

$
22

$
1,296,114

$
(
58,385
)
$
(
658
)
$
(
942,837
)
$
294,256

$
2,847

$
297,103

See accompanying notes to these condensed consolidated financial statements.
4
Table of Contents
ENOVIX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (Continued)
(Unaudited)
Common Stock

Additional
Paid-in
Capital
Accumulated Other Comprehensive Loss
Accumulated 
Deficit
Total
Stockholders' Equity
Non-controlling Interests
Total
 Equity
(In thousands, except share amounts)
Shares
Amount
Balance as of December 31, 2023
167,392,315

$
17

$
857,037

$
(
62
)
$
(
598,845
)
$
258,147

$
2,956

$
261,103

Net loss
— 
— 
— 
— 
(
46,368
)
(
46,368
)
(
129
)
(
46,497
)
Issuance of common stock upon exercise of stock options
43,041

— 
96

— 
— 
96

— 
96

Issuance of common stock, net of issuance costs
639,138

— 
5,756

— 
— 
5,756

— 
5,756

RSU vested, net of shares withheld
1,683,618

— 
(
2,223
)
— 
— 
(
2,223
)
— 
(
2,223
)
Vesting of early exercised stock options
— 
— 
9

— 
— 
9

— 
9

Repurchase of unvested restricted common stock
(
19,638
)
— 
— 
— 
— 
— 
— 
— 
Stock-based compensation
— 
— 
13,852

— 
— 
13,852

— 
13,852

Other comprehensive income, net
— 
— 
— 
9

— 
9

— 
9

Balance as of March 31, 2024
169,738,474

17

874,527

(
53
)
(
645,213
)
229,278

2,827

232,105

Net loss
— 
— 
— 
— 
(
115,872
)
(
115,872
)
(
75
)
(
115,947
)
Issuance of common stock upon exercise of stock options
316,554

— 
2,697

— 
— 
2,697

— 
2,697

Issuance of common stock, net of issuance costs
3,719,881

1

34,203

— 
— 
34,204

— 
34,204

Issuance of common stock under employee stock purchase plan
148,371

— 
1,145

— 
— 
1,145

— 
1,145

Vesting of early exercised stock options
— 
— 
6

— 
— 
6

— 
6

RSUs vested, net of shares withheld
1,380,079

— 
(
1,093
)
— 
— 
(
1,093
)
— 
(
1,093
)
Repurchase of unvested restricted common stock
(
665
)
— 
— 
— 
— 
— 
— 
— 
Stock-based compensation
— 
— 
19,878

— 
— 
19,878

— 
19,878

Other comprehensive income, net
— 
— 
— 
68

— 
68

— 
68

Balance as of June 30, 2024
175,302,694

18

931,363

15

(
761,085
)
170,311

2,752

173,063

Net loss
— 
— 
— 
— 
(
22,536
)
(
22,536
)
(
102
)
(
22,638
)
Issuance of common stock upon exercise of stock options
193,447

— 
1,532

— 
— 
1,532

— 
1,532

Issuance of common stock upon exercise of Private Warrants
153,822

— 
2,276

— 
— 
2,276

— 
2,276

Vesting of early exercised stock options
— 
— 
5

— 
— 
5

— 
5

RSUs vested, net of shares withheld
1,985,662

— 
(
2,286
)
— 
— 
(
2,286
)
(
2,286
)
Repurchase of unvested restricted common stock
(
43,748
)
— 
— 
— 
— 
— 
— 
— 
Stock-based compensation
— 
— 
18,347

— 
— 
18,347

— 
18,347

Other comprehensive loss, net
— 
— 
— 
(
57
)
— 
(
57
)
— 
(
57
)
Balance as of September 29, 2024
177,591,877

$
18

$
951,237

$
(
42
)
$
(
783,621
)
$
167,592

$
2,650

$
170,242

See accompanying notes to these condensed consolidated financial statements.
5
Table of Contents
ENOVIX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
Fiscal Years-to-Date Ended 
(In thousands)
September 28, 2025
September 29, 2024
Cash flows used in operating activities:
Net loss
$
(
121,566
)
$
(
185,082
)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation, accretion and amortization
26,675

37,417

Stock-based compensation
37,973

48,630

Changes in fair value of common stock warrants
(
11,778
)
(
17,359
)
Gain on bargain purchase of assets
(
4,761
)
—

Impairment and loss on disposal of long-lived assets
—

38,249

Interest expense (non-cash)
9,222

—

Others
1,312

174

Changes in operating assets and liabilities:
Accounts and notes receivables
(
2,359
)
494

Inventory
(
7,247
)
(
827
)
Prepaid expenses and other assets
445

(
3,913
)
Accounts payable
6,539

(
10,018
)
Accrued expenses and compensation
(
2,781
)
3,175

Deferred revenue
702

(
502
)
Deferred tax liability
(
1,135
)
(
3,303
)
Other liabilities
467

190

Net cash used in operating activities
(
68,292
)
(
92,675
)
Cash flows from investing activities:
Purchase of property and equipment
(
17,216
)
(
59,830
)
Payment for business acquisition
(
10,000
)
—

Purchases of investments
(
370,133
)
(
31,812
)
Maturities of investments
58,145

106,621

Net cash provided by (used in) investing activities
(
339,204
)
14,979

Cash flows from financing activities:
Proceeds from issuance of convertible senior notes and loan borrowing
360,000

4,572

Payments of debt issuance costs
(
9,900
)
—

Repayment of debt
(
794
)
(
180
)
Purchase of Capped Calls
(
45,288
)
—

Proceeds from exercise of common stock warrants
232,106

—

Payments of issuance costs related to common stock and warrant dividends
(
5,995
)
—

Repurchase of common stock
(
58,385
)
—

Proceeds from the exercise of stock options and issuance of common stock under ATM, net of issuance costs
3,133

44,285

Payroll tax payments for shares withheld upon vesting of RSUs
(
4,855
)
(
5,601
)
Proceeds from issuance of common stock under employee stock purchase plan
711

1,145

Repurchase of unvested restricted common stock
—

(
4
)
Net cash provided by financing activities
470,733

44,217

Effect of exchange rate changes on cash, cash equivalents and restricted cash
(
409
)
1,303

Change in cash, cash equivalents, and restricted cash
62,828

(
32,176
)
Cash and cash equivalents and restricted cash, beginning of period
274,691

235,123

Cash and cash equivalents and restricted cash, end of period
$
337,519

$
202,947

See accompanying notes to these condensed consolidated financial statements.
6
Table of Contents
ENOVIX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Continued)
(Unaudited)
Fiscal Years-to-Date Ended 
(In thousands)
September 28, 2025
September 29, 2024
Supplemental cash flow disclosure:
Cash paid for interest
$
2,971

$
2,951

Cash paid for income taxes
1,072

164

Supplemental non-cash investing and financing activities:
Purchase of property and equipment included in liabilities
$
8,146

$
14,478

Cashless warrant exercise
—

2,276

Accrued debt issuance costs
1,500

—

Accrued issuance costs related to the Warrants
1,082

—

The following presents our cash, cash equivalents and restricted cash by category in the Condensed Consolidated Balance Sheets:
Fiscal Years-to-Date Ended 
(In thousands)
September 28, 2025
September 29, 2024
Cash and cash equivalents
$
335,502

$
200,912

Restricted cash included in prepaid expenses, other current assets and other assets, non-current
2,017

2,035

Total cash, cash equivalents, and restricted cash
$
337,519

$
202,947

See accompanying notes to these condensed consolidated financial statements.
7
Table of Contents
ENOVIX CORPORATION
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 1. 
Organization and Basis of Presentation
Organization 
Enovix Corporation (“we,” “us,” “our,” or “Enovix” or the “Company”) was incorporated in Delaware in 2006. We design, develop, manufacture, and commercialize next generation Lithium-ion, or Li-ion, battery cells that significantly increase the amount of energy density and storage capacity relative to conventional battery cells. Our batteries’ mechanical design, or “architecture,” allows us to use high performance chemistries while enabling safety and charge time advantages. Enovix is headquartered in Silicon Valley, a region of California, with offices and facilities in Asia.
Note 2. 
Basis of Presentation and Summary of Significant Accounting Policies
Basis of Presentation and Consolidation
The accompanying condensed consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States (“GAAP”).

The condensed consolidated financial statements include our accounts, our wholly-owned subsidiaries and majority-owned subsidiaries and the business combination from the closing date. All intercompany balances and transactions have been eliminated in consolidation.
Unaudited Interim Condensed Consolidated Financial Statements 
These accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the United States (“U.S.”) Securities and Exchange Commission (“SEC”) for interim financial reporting. These unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the related notes in our Annual Report on Form 10-K for the fiscal year ended December 29, 2024 (the “Form 10-K”).
In the opinion of management, these unaudited condensed consolidated financial statements reflect all adjustments, consisting of normal recurring items, considered necessary to present fairly our financial condition, results of operations, comprehensive income (loss), stockholders’ equity and cash flows for the periods presented above. The results of operations for the fiscal quarter and fiscal year to-date ended September 28, 2025 are not necessarily indicative of the operating results for the full year, and therefore should not be relied upon as an indicator of future results.
Use of Estimates 
The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities in the condensed consolidated financial statements and accompanying notes during the reporting periods. Estimates and assumptions include but are not limited to: depreciable lives for property and equipment and intangible assets, valuation for assets acquired in business acquisition, valuation for inventory, valuation allowance on deferred tax assets, assumptions used in income tax provisions, valuation of goodwill and intangible assets, assumptions used in stock-based compensation, assumptions used in the calculation of earnings per share related to the Warrants (as defined below) distributed as warrant dividend, incremental borrowing rate for operating right-of-use assets and lease liabilities and valuation of common stock warrants. Management bases its estimates on historical experience and on various other market-specific and relevant assumptions that it believes to be reasonable under the circumstances.
8
Table of Contents
ENOVIX CORPORATION
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
Liquidity and Capital Resources 
We have incurred operating losses and negative cash flows from operations since our inception through September 28, 2025 and expect to incur operating losses for the foreseeable future. As of September 28, 2025, we had working capital of $
528.1
 million and an accumulated deficit of $
942.8
 million. During the third fiscal quarter of 2025, we declared and issued a special dividend in the form of publicly-traded common stock warrants (the “Warrants”), which were distributed on or about July 21, 2025 (the “Warrant Dividend”) to the holders of our common stock and our 2028 Convertible Senior Notes (as defined below in Note 8 “Borrowings.” From the exercises of the Warrants, we raised gross proceeds of $
232.1
 million. (see Note 10 “Treasury Stock, Warrant Dividend and Warrants” for more details). 
In addition, we repurchased 
5,437,556
 shares of our common stock for $
58.4
 million during the third fiscal quarter of 2025 pursuant to our publicly announced stock repurchase plan (see Note 10 “Treasury Stock, Warrant Dividend and Warrants” for more details). 
In September 2025, we issued $
360.0
 million aggregate principal amount of our 2030 Convertible Senior Notes (as defined in Note 8 “Borrowings.”). See Note 8 “Borrowings” for more details. While we have taken actions to reduce operating expenses and working capital to align with anticipated revenue growth, we expect to continue to incur operating losses in the near term. We believe that our existing cash, cash equivalents and investments will be sufficient to meet the anticipated needs for at least the next twelve months from the issuance date of the accompanying condensed consolidated financial statements. Going forward, we may require additional financing for our future operations and expansion.
Summary of Significant Accounting Policies
There have been no changes to our significant accounting policies disclosed in Note 2 “Summary of Significant Accounting Policies,” of the notes to the consolidated financial statements for the fiscal year ended December 29, 2024, included in Part II, Item 8 of our Form 10-K.
Segment Reporting
We operate in 
one
 segment. Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision maker (“CODM”) in making decisions regarding resource allocation and assessing performance. Our Chief Executive Officer (“CEO”) has been identified as our CODM, who reviews operating results to make decisions and assesses performance for the Company as a whole. Total available cash and cash equivalents, total revenues and net loss are used by our CEO to evaluate key operating decisions, such as company strategy, and determine and allocate resources on a consolidated basis. Since we operate in one segment, all significant segment expenses and financial information required by “Segment Reporting” can be found in the condensed consolidated financial statements and the accompanying notes of the condensed consolidated financial statements.
Revenue
We recognize revenue in accordance with Accounting Standards Codification (“ASC”) 606, 
Revenue from Contracts with Customers, 
issued by Financial Accounting Standards Board (“FASB”). Our revenue consists of product revenue, resulting from the sale of lithium-ion batteries and battery pack products (“Product Revenue”), and service revenue, resulting from payments received from our customers based on executed engineering revenue contracts for the development of lithium-ion battery technology (“Service Revenue”).
Product Revenue
Product Revenue mainly relates to sales of lithium-ion batteries or battery packs. We recognize Product Revenue at a point in time when the performance obligation has been satisfied upon transfer of control of goods, which is upon product shipment, delivery or customer acceptance, depending on the applicable contract terms. For certain customized products with customer acceptance criteria specified in the contract, the performance obligation is satisfied upon our customer’s formal acceptance.
For the fiscal quarters ended 
September 28, 2025 and September 29, 2024, our product revenue was $
8.0
 million and $
4.3
 million, respectively. Of our total product revenue for the fiscal quarters 
ended 
September 28, 2025 and September 
9
Table of Contents
ENOVIX CORPORATION
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
29, 2024, approximately 
69
% and 
42
%, respectively, were from South Korea based on the billing location of the customers. 
For the fiscal years-to-date ended 
September 28, 2025 and September 29, 2024, our product revenue was $
20.6
 million and $
13.4
 million, respectively. Of our total product revenue for the 
fiscal years-to-date ended 
September 28, 2025 and September 29, 2024, approximately 
64
% and 
41
%, respectively, were from South Korea based on the billing location of the customers.
Service Revenue
We did not recognize Service Revenue for either of the fiscal quarters and fiscal years-to-date ended September 28, 2025 and September 29, 2024.
Income Tax
In accordance with the Accounting Standards Update (“ASU”) 740-270, 
Income Taxes - Interim Reporting
, issued by FASB for interim reporting for income tax, we calculate our income tax provision using the annualized effective tax rate method. The effective tax rate for the fiscal years-to-date ended September 28, 2025 and September 29, 2024 were 
1.17
% and 
1.36
%, respectively. Our effective tax rate differs from the statutory tax rate primarily due to valuation allowances on the U.S. operations, and a mix of income and losses among foreign jurisdictions. The decrease in our tax benefit for the fiscal quarter and year-to-date ended September 28, 2025 as compared to the same periods for prior year was attributable to a decrease in our estimated annualized effective tax for the current year resulting from the losses generated from certain foreign jurisdictions.
On July 4, 2025, the One Big Beautiful Bill Act (the “OBBBA”) was signed into U.S. law, which includes significant changes to the corporate income tax provisions. We currently do not anticipate to have a material impact to our tax provision on our condensed consolidated financial statements from the OBBBA as we have a full tax valuation allowance in the U.S.
Recently Adopted Accounting Pronouncements
In November 2023, the FASB issued ASU No. 2023-07, 
Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,
 which is intended to improve the reportable segment disclosure requirements. The amendments require disclosure of significant segment expenses that are regularly provided to the CODM, one or more measures of segment profit or loss, and other segment items on an annual and interim basis. This ASU is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. 
We adopted this ASU for our fiscal year 2024 annual financial statements and interim financial statements beginning in the first quarter of fiscal year 2025. The adoption of ASU 2023-07 did not change the way that we identify our reportable segment. Please see “Segment Reporting” above for our interim segment reporting disclosure.
Recently Issued Accounting Pronouncements
In December 2023, the FASB issued ASU 2023-09,
 Improvements to Income Tax Disclosures, 
which expanded the disclosure requirements for income taxes, specifically related to the rate reconciliation and income taxes paid. ASU 2023-09 is effective for the annual reporting periods beginning December 15, 2024, with early adoption permitted. As ASU 2023-09 only has an impact to our financial statement disclosures, we do not expect this ASU to have a significant impact to our consolidated financial statements and plan to adopt this ASU in our Annual Report on Form 10-K for the fiscal year ending December 28, 2025.
In November 2024, the FASB issued ASU 2024-03, 
Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures
, which requires disclosure of certain costs and expenses on an interim and annual basis in the notes to the financial statements. The standard is effective for the annual reporting periods beginning after December 15, 2026 and interim periods beginning after December 15, 2027, with early adoption permitted. We are currently evaluating the potential impact of the adoption of this ASU on our consolidated financial statement disclosures.
In July 2025, the FASB issued ASU 2025-05, 
Measurement of Credit Losses for Accounts Receivable and Contract Assets
, which simplifies the application of the current expected credit loss model for current accounts receivable and current contract assets under ASC 606. This ASU is effective for annual reporting periods beginning after December 15, 
10
Table of Contents
ENOVIX CORPORATION
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
2025, and interim reporting periods within those annual reporting periods. Early adoption is permitted. We are currently evaluating the potential impact of the adoption of this ASU on our consolidated financial statements and disclosures.
Note 3. 
Business Acquisition
On April 1, 2025, we entered into an asset transfer agreement for the acquisition of battery cell manufacturing assets from SolarEdge Technologies, Inc. (the “Seller”), located in South Korea, for a total purchase consideration of $
10.0
 million in cash (the “2025 Acquisition”). These assets include 
a battery cell manufacturing facility with approximately 
330,000
 square feet, land and certain machinery and equipment for manufacturing battery cells. W
e believe t
his acquisition will help further expand our manufacturing 
footprint, expedite scaled production and
 better position us to meet growing demand in the defense industry.
This acquisition of assets met the criteria for a business in accordance with FASB Accounting Standards Codification (“ASC”) (
Topic 805
), 
Business Combinations
 (“ASC 805”) and was accounted for as a business combination using the acquisition method of accounting. The values assigned in these financial statements represent management’s best estimate of fair values as of the acquisition date.
The following table summarizes the preliminary purchase price allocation based on the fair values of the assets acquired as of the acquisition date, which are subject to change within the measurement period as the fair value assessments are finalized (in thousands). We expect to finalize the purchase price allocation as soon as practicable, but no later than one year from the acquisition date.
Inventory
$
400

Property and equipment, net
16,069

Deferred tax liability
(
1,708
)
Fair value of net assets acquired
14,761

Total purchase consideration
(
10,000
)
Gain on bargain purchase
$
4,761

In connection with the 2025 Acquisition, we incurred $
0.7
 million of acquisition related costs associated with this acquisition for the fiscal year-to-date ended September 28, 2025, which were included in Selling, general and administrative expense in the Condensed Consolidated Statements of Operations. We did not incur acquisition costs associated with this acquisition for the fiscal quarter ended September 28, 2025.
Bargain Purchase
In accordance with ASC 805, we assessed whether all assets acquired have been appropriately identified, measured and recognized, subject to re-measurements to verify that the consideration paid and assets acquired have been properly valued. We recognized a gain on bargain purchase from the 2025 Acquisition as the estimated fair value of the identifiable assets acquired exceeded the purchase consideration by approximately $
4.8
 million, net of deferred tax liability recognized from this acquisition. The bargain purchase gain is reported in Other income (loss), net on the Condensed Consolidated Statement of Operations. Management believes the primarily reason for the bargain purchase is because we were able to complete the acquisition in an expedited manner with a good offer of a cash payment and no financial contingencies. We did not record any gain on bargain purchase of assets during the fiscal quarter ended September 28, 2025. For the fiscal year-to-date ended September 28, 2025, we recorded $
4.8
 million of gain on bargain purchase of assets in the Condensed Consolidated Statements of Operations.
Pro forma Information
Pro forma results of operations have not been presented because the effects of this acquisition were not material to our consolidated results of operations during the fiscal quarter and fiscal year-to-date ended September 28, 2025. The results of operations for this acquisition are included in our condensed consolidated financial statements from the date of acquisition onwards.
11
Table of Contents
ENOVIX CORPORATION
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
Note 4. 
Fair Value Measurement
The fair value of our financial assets and liabilities are determined in accordance with the fair value hierarchy established in ASC 820, 
Fair Value Measurements,
 issued by the FASB. The fair value hierarchy of ASC 820 requires an entity to maximize the use of observable inputs when measuring fair value and classifies those inputs into three levels:
Level 1:
Observable inputs, such as quoted prices (unadjusted) in active markets for identical assets or liabilities at the measurement date.
Level 2:
Observable inputs, other than Level 1 prices, such as quoted prices in active markets for similar assets and liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3:
Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
Our financial instruments consist primarily of cash and cash equivalents, short-term and long-term investments, accounts receivable, notes receivable, accounts payable, short-term and long-term debt, and warrant liabilities. Cash and cash equivalents are reported at their respective fair values on our Condensed Consolidated Balance Sheets. As of September 28, 2025 and December 29, 2024, the carrying values of accounts and notes receivables, accounts payable, short-term debt and accrued liabilities approximated the fair value based on the short maturity of those instruments. As of September 28, 2025 and December 29, 2024, we had cash and cash equivalents of $
335.5
 million and $
272.9
 million, respectively.
The following table details the fair value measurements of assets and liabilities that were measured at fair value on a recurring basis based on the following three-tiered fair value hierarchy per ASC 820,
 Fair Value Measurement
, as of September 28, 2025 and December 29, 2024 (in thousands). 
12
Table of Contents
ENOVIX CORPORATION
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
Fair Value Measurement using 
Level 1
Level 2
Level 3
Total
Fair Value
As of September 28, 2025
Assets:
Cash equivalents:
Money Market Funds
$
89,825

$
—

$
—

$
89,825

Short-term investments:
U.S. Treasuries
—

159,617

—

159,617

Corporate Notes and Debt Securities
—

43,281

—

43,281

U.S. Government Agency Debt Securities
—

20,418

—

20,418

Long-term investments:
U.S. Treasuries
—

65,917

—

65,917

Corporate Notes and Debt Securities
—

17,853

—

17,853

U.S. Government Agency Debt Securities
—

5,681

—

5,681

Total assets measured at fair value
$
89,825

$
312,767

$
—

$
402,592

Liabilities:
Private Placement Warrants
$
—

$
—

$
16,632

$
16,632

As of December 29, 2024
Assets:
Cash equivalents:
Money Market Funds
$
102,574

$
—

$
—

$
102,574

Total assets measured at fair value
$
102,574

$
—

$
—

$
102,574

Liabilities:

Private Placement Warrants
$
—

$
—

$
28,380

$
28,380

13
Table of Contents
ENOVIX CORPORATION
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
Cash Equivalents and Investments:
The following is a summary of cash equivalents and investments (in thousands).
Reported as
Amortized Cost
Unrealized Gain
Unrealized Loss
Estimated Fair Value
Cash Equivalents
Short-term Investments
Long-term Investments
As of September 28, 2025
Money Market Funds
$
89,825

$
—

$
—

$
89,825

$
89,825

$
—

$
—

U.S. Treasuries
225,740

—

(
206
)
225,534

—

159,617

65,917

Corporate Notes and Debt Securities
61,209

—

(
75
)
61,134

—

43,281

17,853

U.S. Government Agency Debt Securities
26,091

8

—

26,099

—

20,418

5,681

Total
$
402,865

$
8

$
(
281
)
$
402,592

$
89,825

$
223,316

$
89,451

As of December 29, 2024
Money Market Funds
$
102,574

$
—

$
—

$
102,574

$
102,574

$
—

$
—

Total
$
102,574

$
—

$
—

$
102,574

$
102,574

$
—

$
—

As of September 28, 2025 and December 29, 2024, the short-term investments had contractual maturity due within one year. 
Private Placement Warrants
Our liabilities are measured at fair value on a recurring basis, including warrants that were held by Rodgers Capital, LLC (the “Sponsor”) and certain of its members (the “Private Placement Warrants”). The fair value of the Private Placement Warrants is considered a Level 3 valuation and is determined using the Black-Scholes valuation model. Each whole Private Placement Warrant became exercisable for 
one
 whole share of our common stock at a price of $
11.50
 per share on December 5, 2021. In connection with the issuance of Warrants, our Board of Directors approved the change of the exercise price from $
11.50
 per Private Placement Warrant to an adjusted exercise price of $
10.66
 per Private Placement Warrant in accordance with the agreement of Private Placement Warrant. The adjusted exercise price was effective on July 21, 2025. 
As of both periods ended September 28, 2025 and December 29, 2024, we had 
5,500,000
 Private Placement Warrants outstanding. The fair value of the Private Placement Warrants was $
3.02
 per share as of September 28, 2025. 
14
Table of Contents
ENOVIX CORPORATION
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
The following tables summarize the changes for Level 3 items measured at fair value on a recurring basis using significant unobservable inputs (in thousands). 
As of
Private Placement Warrants

September 28, 2025
September 29, 2024
Fair value as of the beginning of the fiscal year
$
28,380

$
42,900

Cashless warrant exercise
—

(
2,276
)
Change in fair value
(
11,748
)
(
17,359
)
Fair value as of the end of the fiscal quarter
$
16,632

$
23,265

The following table summarizes the key assumptions used for determining the fair value of the Private Placement warrants.
Private Placement Warrants Outstanding as of September 28, 2025
Private Placement Warrants Outstanding as of December 29, 2024
Expected term (in years)
0.8
1.5
Expected volatility
89.2
%
95.0
%
Risk-free interest rate
3.8
%
4.3
%
Expected dividend rate
0.0
%
0.0
%
Convertible Senior Notes and Long-term Loans
We consider the fair value of our convertible senior notes to be a Level 2 measurement as they are not actively traded in the market. As of September 28, 2025, the fair value of 2028 and 2030 Convertible Senior Notes (as defined in Note 8 “Borrowings” and collectively, the “Convertible Senior Notes”) was approximately $
611.8
 million. As of September 28, 2025, our long-term loans are approximately close to their carrying value of $
0.6
 million.
Note 5. 
Property and Equipment
Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is computed on a straight-line basis over the estimated useful lives of the assets. 
Property and equipment as of September 28, 2025 and December 29, 2024, consisted of the following (in thousands).
September 28, 2025
December 29, 2024
Machinery and equipment
$
128,455

$
112,635

Building and leasehold improvements
41,947

33,658

Office equipment and software
5,927

5,411

Furniture and fixtures
17,166

16,821

Land
5,166

1,433

Construction in process
18,285

18,990

Total property and equipment
216,946

188,948

Less: accumulated depreciation
(
42,361
)
(
21,001
)
Property and equipment, net
$
174,585

$
167,947

15
Table of Contents
ENOVIX CORPORATION
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
The following table summarizes the depreciation and amortization expenses related to property and equipment, which are recorded within cost of revenue, research and development expense and selling, general and administrative expense in the Condensed Consolidated Statements of Operations (in thousands).
Fiscal Quarters Ended
Fiscal Years-to-Date Ended
September 28, 2025
September 29, 2024
September 28, 2025
September 29, 2024
Depreciation expense
$
7,700

$
4,683

$
21,538

$
32,643

In connection with our strategic realignment in 2023, we recognized accelerated depreciation expenses of approximately $
18.4
 million for Fab1 equipment in the first quarter of 2024, of which approximately $
18.3
 million and $
0.1
 million were recorded as research and development expense, and selling, general and administrative expense, respectively, in the Condensed Consolidated Statements of Operations. After the first quarter of 2024 and thereafter, we did 
no
t record any accelerated depreciation expenses for Fab1 equipment.
Fab1 Long-Lived Asset Disposals
During the fiscal quarter and fiscal year-to-date ended September 29, 2024, we recorded $
3.1
 million and $
38.2
 million, respectively, of loss on disposal of our Fab1 long-lived assets, including machinery and equipment, leasehold improvements and other assets located in Fremont, California as a part of the 2024 Restructuring Plan (as defined below) and it was recorded as Restructuring Cost in the Condensed Consolidated Statement of Operations. See Note 13 “Restructuring Costs” for more information.
Note 6. 
Inventory
Inventory consists of the following components (in thousands).
September 28, 2025
December 29, 2024
Raw materials
$
6,743

$
3,616

Work-in-process
7,183

2,989

Finished goods
1,298

1,059

Total inventory
$
15,224

$
7,664

Inventory is stated at the lower of cost or net realizable value (“NRV”) on a first-in and first-out basis. Inventory costs include direct materials, direct labor, and manufacturing overhead. When the estimated net realizable values are below the manufacturing costs, a charge to cost of revenue is recorded for finished goods and work in process inventories. 
As of both September 28, 2025 and December 29, 2024, we had an 
immaterial
 amount of inventory reserve, including excess or obsolete inventory reserve.

Note 7. 
Leases 
We have operating lease agreements primarily for offices and manufacturing spaces located in various locations with lease periods expiring between 2024 and 2030, some of which include options to extend the leases for up to 
five years
.
The components of lease costs were as follows (in thousands): 
16
Table of Contents
ENOVIX CORPORATION
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
Fiscal Quarters Ended
 Fiscal Years-to-Date Ended
September 28, 2025
September 29, 2024
 September 28, 2025
September 29, 2024
Operating lease cost
$
1,067

$
1,347

$
3,257

$
3,192

Supplemental lease information: 
As of
Operating leases
September 28, 2025
December 29, 2024
Weighted-average remaining lease term
4.3
 years
5.0
 years
Weighted-average discount rate
8.5
%
8.5
%
Supplemental cash flow information related to leases are as follows (in thousands): 
Fiscal Years-to-Date Ended
September 28, 2025
September 29, 2024
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases
$
3,408

$
2,687

Maturities of Lease Liabilities

The following is a schedule of maturities of lease liabilities as of September 28, 2025 (in thousands).
Operating leases

2025 (remaining 3 months)
$
933

2026
3,725

2027
3,767

2028
3,827

2029
2,758

Thereafter
1,099

Total
16,109

Less: imputed interest
(
1,824
)
Present value of lease liabilities
$
14,285

Note 8. 
Borrowings
Short-Term Debt
Our asset secured loans have fixed and floating interest rates with various maturity dates. From time to time, we renew our short-term loans once they reach the maturity dates. The current portion of long-term loans is recorded as short-term debt based on time remaining until maturity. As of September 28, 2025, short-term debt was $
10.2
 million, which comprised of $
9.9
 million of short-term loans with less than one-year term and $
0.2
 million of the current portion of long-term loans. As of December 29, 2024, short-term debt was $
9.5
 million, which comprised of $
9.3
 million of short-term loans with less than one-year term and $
0.2
 million of the current portion of long-term loans. As of September 28, 2025 and December 29, 2024, the weighted average interest rates on the short-term loans were approximately 
4.8
%. and 
5.2
%, respectively.

17
Table of Contents
ENOVIX CORPORATION
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
Long-Term Debt
Our long-term debt, net consists of the following (in thousands).
As of
Annual Interest Rate
Maturity Date
September 28, 2025
December 29, 2024
2028 Convertible Senior Notes
3.0

%
May 1, 2028
$
172,500

$
172,500

2030 Convertible Senior Notes
4.8

%
September 15, 2030
360,000

—

Long-term loans
Floating rate
3.4

%
June 30, 2027
236

283

Floating rate
3.4

%
June 30, 2028
355

340

Fixed rate
5.2

%
February 3, 2026
—

914

Total Convertible Senior Notes and other borrowings
533,091

174,037

Less: unamortized debt issuance costs
(
14,506
)
(
4,047
)
Long-term debt
518,585

169,990

Current portion of long-term debt
(
237
)
(
170
)
Long-term debt, net
$
518,348

$
169,820

Long-term Loans
Our long-term loans bear interest at either fixed or floating rates, as indicated in the table above. As of September 28, 2025, total long-term loans outstanding was $
0.6
 million, including a current portion of the long-term loans of $
0.2
 million. As of December 29, 2024, total long-term loans outstanding was $
1.5
 million, including a current portion of the long-term loans of $
0.2
 million.
2030 Convertible Senior Notes
On September 10, 2025, we issued $
360.0
 million aggregate principal amount of convertible senior notes (the “2030 Convertible Senior Notes”), pursuant to an indenture, dated as of September 15, 2025 (the “Indenture”), between the Company and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”). The offerings and sale of the 2030 Convertible Senior Notes were made by us to the initial purchasers in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), for resale by the initial purchasers to qualified institutional buyers (as defined in the Securities Act) pursuant to the exemption from registration provided by Rule 144A under the Securities Act. The issuance included the exercise in full by the initial purchasers of their option to purchase an additional $
60.0
 million aggregate principal amount of the 2030 Convertible Senior Notes. As of September 28, 2025, the total principal amount outstanding of the 2030 Convertible Senior Notes was $
360.0
 million.
The 2030 Convertible Senior Notes are unsecured obligations of the Company and bear interest at a rate of 
4.75
% per year from September 15, 2025, and will be pay interest semiannually in arrears on March 15 and September 15 of each year, beginning on March 15, 2026. The 2030 Convertible Senior Notes will mature on September 15, 2030 unless earlier converted, redeemed or repurchased.
The net proceeds from the issuance of the 2030 Convertible Senior Notes were $
348.6
 million, after deducting the initial purchasers’ discounts and commissions and the estimated offering expenses payable by us. We used $
45.3
 million of the net proceeds from the offering to pay the cost of the capped call transactions entered into in connection with the offering (see “2030 Capped Call Transaction” section for more details). We intend to use the remaining net proceeds for general corporate purposes, which may include to fund a portion of the purchase price for potential acquisitions.
The conversion rate for the 2030 Convertible Senior Notes will initially be 89.2160 shares of our common stock per $1,000 principal amount of the 2030 Convertible Senior Notes, which is equivalent to an initial conversion price of $
11.21
 per share of our common stock, subject to adjustment under certain circumstances in accordance with the terms of the Indenture.
18
Table of Contents
ENOVIX CORPORATION
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
Holders of the 2030 Convertible Senior Notes may convert all or any portion of their notes, in integral multiples of $1,000 principal amount, at their option at any time prior to the close of business on the business day immediately preceding June 15, 2030 only under the following conditions:
•
during any fiscal quarter commencing after the fiscal quarter ending on December 28, 2025 (and only during such fiscal quarter), if the last reported sale price of the Company’s common stock for at least 
20
 trading days (whether or not consecutive) during a period of 
30
 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 
130
% of the conversion price on each applicable trading day;
•
during the 
five
 business day period after any 
ten
 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per $1,000 principal amount of notes for each trading day of the measurement period was less than 
98
% of the product of the last reported sale price of our common stock and the conversion rate on each such trading day;
•
if we call the 2030 Convertible Senior Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date, but only with respect to the 2030 Convertible Senior Notes called (or deemed called) for redemption; or
•
upon the occurrence of specified corporate events as set forth in the Indenture.
On or after June 15, 2030 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their notes, at any time, in integral multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing conditions.
Upon conversion, we may satisfy this conversion obligation by paying or delivering, as the case may be, cash, shares of our common stock, or a combination of cash and shares of our common stock, at our election, in the manner and subject to the terms and conditions provided in the Indenture. 
We may not redeem the 2030 Convertible Senior Notes prior to September 20, 2028. We may redeem for cash all or any portion of the 2030 Convertible Senior Notes, at our option, on or after September 20, 2028, if the liquidity condition is satisfied and the last reported sale price of our common stock has been at least 
130
% of the conversion price then in effect for at least 
20
 trading days (whether or not consecutive) during any 
30
 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which er provide notice of redemption at a redemption price equal to 
100
% of the principal amount of the 2030 Convertible Senior Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If we redeem less than all the outstanding 2030 Convertible Senior Notes, at least $
150.0
 million aggregate principal amount of 2030 Convertible Senior Notes must be outstanding and not subject to redemption as of, and after giving effect to, delivery of the relevant redemption notice. No sinking fund is provided for 2030 Convertible Senior Notes.
If we undergo a “fundamental change,” as defined in the Indenture, holders may require us to repurchase for cash all or any portion of the 2030 Convertible Senior Notes at a fundamental change repurchase price equal to 
100
% of the principal amount of the 2030 Convertible Senior Notes to be repurchased, plus accrued and unpaid interest, if any, to, but excluding, the fundamental change repurchase date.
The Indenture includes customary covenants and sets forth certain events of default, upon the occurrence and during the continuance of which the 2030 Convertible Senior Notes may be declared immediately due and payable.
Debt Issuance Costs
In accounting for the issuance of the 2030 Convertible Senior Notes, we accounted for the 2030 Convertible Senior Notes as liability instruments and considered it as single units of account pursuant to the Accounting Standards Update (“ASU”) No. 2020-06, 
Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40)
,

(“ASU 2020-06”). Accrued interest for the 2030 Convertible Senior Notes was recorded as Accrued expenses on the Condensed Consolidated Balance Sheet. Costs incurred in connection with the issuance of debt are deferred and amortized as interest expense over the term of the related debt using the effective interest method. To the extent that the debt is outstanding, the debt issuance costs were recorded as a reduction to Long-term debt, net on the Condensed Consolidated Balance Sheet. For the fiscal quarter and fiscal year-to-date ended September 28, 2025, we incurred approximately $
11.4
 million of debt issuance costs relating to the issuance of the 2030 Convertible Senior Notes.
19
Table of Contents
ENOVIX CORPORATION
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
2030 Capped Call Transactions
In connection with the issuance of the 2030 
Convertible Senior Notes
, we paid 
$
45.3
 million
 to enter into multiple capped call transactions with certain financial institutions (the “2030 Capped Calls”) during the fiscal quarter ended September 28, 2025. The 2030 Capped Calls are generally expected to reduce the potential dilution to our common stock upon any conversion of the 2030 
Convertible Senior Notes
 and/or offset any cash payments we are required to make in excess of the principal amount of the converted 2030 
Convertible Senior Notes
, as the case may be, with such reduction and/or offset subject to a cap. Because the expirations of the 2030 Capped Calls do not match the maturity of the 2030 Convertible Senior Notes, the 2030 Capped Calls will not offset the actual dilutive impact of the 2030 Convertible Senior Notes to our common stock and/or the actual cash payments we are required to make upon any conversion of the 2030 
Convertible Senior Notes
.
We recorded the 2030 Capped Calls as a reduction of stockholders' equity, not as derivatives, as the 2030 Capped Calls met certain applicable accounting criteria. No subsequent remeasurement is required. The 
table below summarizes the key terms, subject to certain adjustments, of the 2030 Capped Calls transactions related to the 2030 Convertible Senior Notes (in dollars):
2030 Capped Calls
Tranche 1
Tranche 2
Tranche 3
Tranche 4
Initial strike price per share
$
11.21

$
11.21

$
11.21

$
11.21

Initial cap price per share
$
16.47

$
17.84

$
18.76

$
20.13

Premiums per Option
$
1.05

$
1.40

$
1.57

$
1.63

Expiration dates
From February 10, 2026 to March 10,2026
From August 13, 2026 to September 10,2026
From February 10, 2027 to March 10,2027
From August 11, 2028 to September 8,2028
Final termination date
July 8, 2026
January 5, 2027
July 7, 2027
January 5, 2029
2028 Convertible Senior Notes
On April 20, 2023, we issued $
172.5
 million aggregate principal amount of 
3.0
% convertible senior notes due 2028 (the “2028 Convertible Senior Notes”), including $
10.0
 million principal amount of the 2028 Convertible Senior Notes (the “Affiliate Notes”) issued to an entity affiliated with Thurman John Rodgers, Chairman of our Board of Directors, in a concurrent private placement. As of both periods ended September 28, 2025 and December 29, 2024, total outstanding Convertible Senior Notes was $
172.5
 million.
The 2028 Convertible Senior Notes are unsecured obligations of the Company and bear interest at a rate of 
3.0
% per year from April 20, 2023, and will be payable semiannually in arrears on May 1 and November 1 of each year, beginning on November 1, 2023. The 2028 Convertible Senior Notes will mature on May 1, 2028 unless earlier converted, redeemed or repurchased.
20
Table of Contents
ENOVIX CORPORATION
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
Interest
The following table summarizes the interest expense related to Convertible Senior Notes and loans (excluding the interest expense recorded in connection with the Warrants), which are recorded within Interest expense in the Condensed Consolidated Statements of Operations (in thousands).
Fiscal Quarter Ended
Fiscal Years-to-Date Ended
September 28, 2025
September 29, 2024
September 28, 2025
September 29, 2024
Coupon interest
$
2,043

$
1,294

$
4,631

$
3,881

Amortization of debt issuance costs
378

275

941

817

Total interest expense on Convertible Senior Notes
2,421

1,569

5,572

4,698

Loan interest
121

148

391

369

Total interest expense related to Convertible Senior Notes and loans
$
2,542

$
1,717

$
5,963

$
5,067

During the fiscal quarter ended September 28, 2025, we recognized $
9.2
 million as interest expense for the fair value of the Warrants issued to the note holders of 2028 Convertible Senior Notes. See Note 10 “Treasury Stock, Warrant Dividend and Warrants” for more information.
As of the fiscal quarter ended September 28, 2025 and December 29, 2024, we had $
2.9
 million and $
0.9
 million of accrued interest liability, respectively.
Debt Maturity
The following table summarizes our long-term debt maturities, based on outstanding principal by years (in thousands).
September 28, 2025
2025 (remaining 3 months)
$
119

2026
236

2027
177

2028
172,559

2029
—

2030
360,000

Total gross amount of long-term debt
$
533,091

Note 9. 
Commitments and Contingencies 
Purchase Commitments 
As of September 28, 2025 and December 29, 2024, our commitments included approximately $
6.6
 million and $
17.4
 million, respectively, of our open purchase orders and contractual obligations that occurred in the ordinary course of business, including commitments with contract manufacturers and suppliers for which we have not received goods or services, commitments for capital expenditures and construction-related activities for which we have not received the goods or services. Although open purchase orders are considered enforceable and legally binding, the terms generally allow us an option to cancel, reschedule, and adjust the requirements based on our business needs prior to the delivery of goods or performance of services. For lease obligations, please refer to Note 7 “Leases” for more details. For the Convertible Senior Notes obligation and other borrowings, please refer to Note 8 “Borrowings” for more details.
21
Table of Contents
ENOVIX CORPORATION
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
Performance Obligations
As of September 28, 2025, we had $
8.0
 million of performance obligations, which comprised total deferred revenue and customer order deposits. We currently expect to recognize approximately 
96
% of deferred revenue as revenue within the next 
twelve months
.
Litigation
From time to time, we are subject to a variety of claims, lawsuits, investigations, and proceedings concerning matters arising in connection with our business activities, including product liability, intellectual property, commercial, insurance, securities laws, contract disputes, and employment matters. Certain of these lawsuits and claims are described in further detail below. We intend to vigorously defend against each of these allegations.
A liability and related charge to earnings is recorded in the condensed consolidated financial statements for legal contingencies when the loss is considered probable and the amount can be reasonably estimated. The assessment is re-evaluated each accounting period and is based on all available information, including the impact of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to each case. The outcomes of outstanding legal matters are inherently unpredictable and subject to uncertainties. While there can be no assurance of a favorable outcome of these legal matters, we currently believe that the outcome of these matters will not have a material adverse effect on our results of operations, liquidity or financial position.
Securities Class Action Complaint
In January 2023, purported Company stockholders filed securities class action complaints in the U.S. District Court for the Northern District of California against Enovix and certain of its current and former officers and directors (collectively, the “defendants”). The complaints, which were later consolidated, allege violations of Sections 10(b) and 20(a) of the Exchange Act, and Rule 10b-5 promulgated thereunder, relating to alleged material misstatements or omissions in public statements related to our manufacturing scale-ups and testing of new equipment. Following consolidation of the cases and court appointment of 
two
 purported Company stockholder lead plaintiffs, a consolidated complaint, In regards to Enovix Corp. Securities Litigation, Case No. 23-cv-00071-SI (N.D. Cal.), was filed on July 7, 2023. The consolidated complaint alleges substantially similar claims, including allegations that the defendants made material misstatements or omissions in public statements related to testing of new equipment. 
On January 30, 2024, the court granted the defendants’ motion to dismiss the consolidated complaint. Plaintiffs subsequently filed a second amended complaint on March 19, 2024. The plaintiffs seek unspecified damages, interest, fees and costs on behalf of a putative class of persons and entities that purchased and/or acquired shares of Enovix or its predecessor entity’s common stock between August 10, 2021 and October 3, 2023. To date, no class has been certified by the court.
On July 23, 2024, the court granted in part and denied in part defendants’ motion to dismiss the second amended complaint. In June 2025, we filed a motion for partial judgment on the pleadings to eliminate certain alleged misstatements currently at issue in the case. On October 7, 2025, the court granted our motion in full and dismissed 
two
 of the 
three
 remaining alleged misstatements at issue in the litigation. The case is now proceeding on the 
one
 alleged misstatement.
In September 2024, we received two demands under Section 220 of the Delaware General Corporation Law for corporate books and records related to this matter, which could result in separate proceedings. In November 2024, a related derivative lawsuit was filed in Alameda County, California, which lawsuit has been stayed pending resolution of the securities action.
Based on information currently available, we have not recorded a liability related to these matters in our condensed consolidated financial statements as of September 28, 2025, because we cannot reasonably estimate the amount or range of potential losses.
Guarantees and Indemnifications 
In the normal course of business, we enter into contracts and agreements that contain a variety of representations and warranties and provide for general indemnifications. In addition, we purchased performance bonds for guarantee of our performance obligations for certain projects. Our exposure under these agreements is unknown because it involves claims that may be made against us in the future but have not yet been made. To date, we have not paid any claims or 
22
Table of Contents
ENOVIX CORPORATION
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
been required to defend any action related to our indemnification obligations. However, we may record charges in the future as a result of these indemnification obligations. 
We also have indemnification obligations to our officers and directors for specified events or occurrences, subject to some limits, while they are serving at our request in such capacities. There have been no claims to date and we have director and officer insurance that may enable us to recover a portion of any amounts paid for future potential claims. We believe the fair value of these indemnification agreements is minimal. Accordingly, we have not recorded any liabilities relating to these obligations for the period presented.
Note 10. 
Treasury Stock, Warrant Dividend and Warrants
Common Stock Repurchase Plan
On June 30, 2025, our Board of Directors authorized a repurchase plan to buyback up to $
60.0
 million of shares of our common stock (the “Repurchase Plan”). Prior to the adoption of the Repurchase Plan on June 30, 2025, we did not have a repurchase plan in place in prior years.
During the fiscal quarter ended September 28, 2025, we repurchased 
5,437,556
 shares of our common stock for $
58.4
 million pursuant to the Repurchase Plan. The costs for these common stock repurchases are recorded to Treasury Stock, at Cost, on our Condensed Consolidated Balance Sheet. 
As of September 28, 2025, we had $
1.6
 million of capacity for further repurchases of common stock available under the Repurchase Plan. We may make repurchases from time to time through open market purchases or through privately negotiated transactions. Pursuant to the Repurchase Plan, the timing and number of shares of common stock repurchased will be determined at our discretion. We may modify, suspend or discontinue the Repurchase Plan at any time and we are not obligated to repurchase any specific number of shares of common stock.
Warrant Dividend
On July 7, 2025, we declared a special dividend in the form of the Warrants to the holders of record of our common stock as of the close of business on July 17, 2025 (the “Record Date”). Pursuant to the terms of the warrant agreement, dated July 21, 2025, between us and Computershare Inc. and its affiliate, Computershare Trust Company N.A., as Warrant Agent (the “2025 Warrant Agreement”), each holder of record of common stock on the Record Date received 
one
 Warrant for every 
seven
 shares of common stock held, rounded down to the nearest whole number. In addition, holders of our 2028 Convertible Senior Notes as of the Record Date received Warrants, at the same time and on the same terms, without having to convert their Notes, subject to the terms of the 2025 Warrant Agreement and the indenture governing the 2028 Convertible Senior Notes. At the time of issuance, each Warrant entitled the holder to purchase 
one
 share of common stock at an exercise price of $
8.75
 per Warrant, subject to certain adjustments. The Warrants were exercisable only for cash. On July 21, 2025, 
29,233,276
 Warrants were issued and distributed to the holders of record of common stock and 2028 Convertible Senior Notes as of the Record Date. In accordance with ASC 815, 
Derivative and Hedging
, we classified the Warrants as equity instruments.
Under the terms of 2025 Warrant Agreement, the Warrants would expire and cease to be exercisable at 5:00 p.m. New York City time on October 1, 2026 (the “Expiration Date”) subject to the Early Expiration Price Condition (defined below). In August 2025, the Early Expiration Price Condition was met and we elected to set August 29, 2025 as the alternate expiration date for the Warrants. On August 29, 2025, the outstanding Warrants expired and ceased to be exercisable. 
The Warrants were listed on the Nasdaq Stock Market LLC under the ticker “ENVXW” and commenced trading on July 22, 2025. As the Warrants expired on August 29, 2025, any outstanding Warrants were voided as of 5:00 pm New York time on August 29, 2025. ENVXW ceased trading on Nasdaq Stock Market LLC on that date. 
Early Expiration Price Condition and Date for the Warrants
Upon the occurrence of the first 
30
 consecutive trading day period (the “Reference Period”) that includes 
20
 trading days on which the daily volume-weighted average price (“VWAP”) of a share of common stock is at least equal to $
10.50
, subject to certain adjustments provided for in the 2025 Warrant Agreement (such occurrence, the “Early 
23
Table of Contents
ENOVIX CORPORATION
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
Expiration Price Condition”, and the last of such 
20
 trading days, the “Early Expiration Price Condition Date”), the Expiration Date of the Warrants would automatically accelerate to the date (the “Early Expiration Date”) that is the business day immediately following the Early Expiration Price Condition Date. We had elected to set the Early Expiration Date on August 29, 2025 after the Early Expiration Price Condition was met. 
Warrants issued to 2028 
Convertible Senior Notes’
 holders
The Warrants issued to the 2028 Convertible Senior Notes’ holders were considered discretionary. As a result, we recognized $
9.2
 million as interest expense for the fair value of the Warrants issued to the note holders of 2028 Convertible Senior Notes during the fiscal quarter ended September 28, 2025.
Warrant exercises and issuance costs
We accounted for the Warrants in accordance with ASC 815, 
Derivative and Hedging
. The Warrants are classified as equity financial instruments as the Warrants are indexed to our common stock and require settlement in shares with no net cash settlement provisions. We recorded the issuance of the Warrants to additional paid in capital on the Consolidated Balance Sheet based on the fair value of the Warrants as of July 21, 2025, the date of issuance, The net impact of these entries to the additional paid in capital was 
zero
. No fair value remeasurement of the Warrants, as equity instruments, is required for the subsequent periods.
During the fiscal quarter and fiscal year-to-date ended September 28, 2025, 
26,526,344
 Warrants were exercised with the exercise price of $
8.75
 per Warrant and we received gross cash proceeds of $
232.1
 million from these exercises. Cash received upon exercises of the Warrants were recorded to common stock and additional paid in capital on the Condensed Consolidated Balance Sheets.
In connection with the issuance of Warrants, we incurred $
7.9
 million of issuance costs, of which $
6.6
 million was recorded to additional paid in capital on the Condensed Consolidated Balance Sheets as they were directly attributable to the issuance of common stock upon exercises of Warrants. The remaining portion of the issuance costs were expensed as incurred.
Private Placement Warrants
As of September 28, 2025 and December 29, 2024, we had 
5,500,000
 Private Placement Warrants outstanding. which were originally issued in a private placement to the Sponsor and certain of its members. Each whole Private Placement Warrant became exercisable for 
one
 whole share of our common stock at a price of $
11.50
 per share on December 5, 2021. 
In connection with the issuance of Warrants, our Board of Directors approved the change of the exercise price from $
11.50
 per Private Placement Warrant to an adjusted exercise price of $
10.66
 per Private Placement Warrant in accordance with the agreement of Private Placement Warrant. The adjusted exercise price was effective on July 21, 2025. For the fair value of the Private Placement Warrants, see Note 4 “Fair Value Measurement.”
Note 11. 
Net Loss per Share
The following table sets forth the computation of our basic and diluted net EPS of common stock for the periods presented below (in thousands, except share and per share amount). 
24
Table of Contents
ENOVIX CORPORATION
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
Fiscal Quarters Ended
Fiscal Years-to-Date Ended
September 28, 2025
September 29, 2024
September 28, 2025
September 29, 2024
Numerator:
Net loss attributable to common stockholders - basic
$
(
53,713
)
$
(
22,536
)
$
(
121,751
)
$
(
184,776
)
Decrease in fair value of Private Placement Warrants
(
1,837
)
(
29,899
)
—

—

Net loss attributable to common stockholders - diluted
$
(
55,550
)
$
(
52,435
)
$
(
121,751
)
$
(
184,776
)
Denominator:
Weighted-average shares outstanding used in computing net loss per share of common stock, basic
(1)
206,458,846

187,785,319

204,758,291

183,229,182

Dilutive effect of Private Placement Warrants
352,469

191,804

—

—

Weighted-average shares outstanding used in computing net loss per share of common stock, diluted
(1)
206,811,315

187,977,123

204,758,291

183,229,182

Net loss per share of common stock
(1)
:
Basic
$
(
0.26
)
$
(
0.12
)
$
(
0.59
)
$
(
1.01
)
Diluted
$
(
0.27
)
$
(
0.28
)
$
(
0.59
)
$
(
1.01
)
(1)
 As required by ASC 260, 
Earnings Per Share
, the share and per share amounts for the periods presented in the above table have been retroactively adjusted to reflect the Warrants issued in July 2025 (see Note 10 “Treasury Stock, Warrant Dividend and Warrants” for more details). The following reconciliation table showed the effect of the Warrants to the previously reported shares and net loss per share amount (in thousands, except share and per share amount). 
25
Table of Contents
ENOVIX CORPORATION
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
September 29, 2024
Fiscal Quarter
Fiscal Year-to-Date
Numerator:
Net loss attributable to common stockholders - basic and diluted (as reported)
$
(
22,536
)
$
(
184,776
)
Dilutive effect of Private Placement Warrants
(
29,899
)
—

Weighted-average shares outstanding used in computing net loss per share of common stock, diluted
(
52,435
)
(
184,776
)
Denominator:
Weighted-average shares outstanding used in computing net loss per share of common stock, basic (as previously reported)
176,680,578

172,393,869

Effect of the Warrants
11,104,741

10,835,313

Weighted-average shares outstanding used in computing net loss per share of common stock, basic (as adjusted)
187,785,319

183,229,182

Weighted-average shares outstanding used in computing net loss per share of common stock, diluted (as previously reported)
176,872,382

172,393,869

Effect of the Warrants
11,104,741

10,835,313

Weighted-average shares outstanding used in computing net loss per share of common stock, diluted (as adjusted)
187,977,123

183,229,182

Net loss per share of common stock:
Basic (as previously reported)
$
(
0.13
)
$
(
1.07
)
Basic (as adjusted)
$
(
0.12
)
$
(
1.01
)
Diluted (as previously reported)
$
(
0.30
)
$
(
1.07
)
Diluted (as adjusted)
$
(
0.28
)
$
(
1.01
)
The following table discloses shares of the securities that were not included in the diluted EPS calculation above because they are anti-dilutive for the periods presented above. 
Fiscal Quarters Ended
Fiscal Years-to-Date Ended
September 28, 2025
September 29, 2024
September 28, 2025
September 29, 2024
Stock options outstanding
1,254,707

1,835,751

1,254,707

1,835,751

Restricted stock units and performance restricted stock units outstanding
13,647,149

15,126,611

13,647,149

15,126,611

Assumed conversion of Convertible Senior Notes
15,994,994

11,053,800

12,700,865

11,053,800

Private Placement Warrants outstanding
—

—

5,500,000

5,500,000

Employee stock purchase plan estimated shares
296,202

229,671

296,202

229,671

26
Table of Contents
ENOVIX CORPORATION
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
The holders of Private Placement Warrants, unvested restricted stock units and stock options do not have rights to receive common stock dividends or common stock dividend equivalents.
Note 12. 
Stock-based Compensation
We issue equity awards to our employees and non-employees in the form of stock options, restricted stock units (“RSUs”) and performance based RSUs (“PRSUs”). Additionally, we also offer an employee stock purchase plan (“ESPP”) to our eligible employees. We use Black-Scholes option pricing model to value our stock options granted and the estimated shares to be purchased under the ESPP. For both RSUs and PRSUs, we use our common stock price, which is the last reported sales price on the grant date to value those securities.
In general, we recognize stock-based compensation expense on a straight-line basis over the requisite service period and records forfeitures as they occur. For PRSUs, we use the graded vesting method to calculate the stock-based compensation expense. At each reporting period, we would recognize and adjust the stock-based compensation expense based on its probability assessment in meeting its PRSUs' performance conditions.
Stock-based Compensation Expense
The following table summarizes the total stock-based compensation expense, by operating expense category, recognized in the Condensed Consolidated Statements of Operations for the periods presented below (in thousands).
Fiscal Quarters Ended
Fiscal Years-to-Date Ended
September 28, 2025
September 29, 2024
September 28, 2025
September 29, 2024
Cost of revenue
$
280

$
101

$
757

$
196

Research and development
5,754

5,914

19,050

19,771

Selling, general and administrative
(1)
5,803

10,707

18,166

27,447

Restructuring cost
—

111

—

1,216

Total stock-based compensation expense
$
11,837

$
16,833

$
37,973

$
48,630

(1)
    During the quarter ended June 30, 2024, we engaged a consulting company for its services and issued RSUs in exchange for its services. In connection with this service agreement, we recorded approximately $
4.4
 million and $
9.1
 million of stock-based compensation expense for the fiscal quarter and fiscal year-to-date ended September 29, 2024, respectively.
For the fiscal years-to-date ended September 28, 2025 and September 29, 2024, we capitalized $
0.6
 million and $
2.4
 million, respectively, of stock-based compensation as property and equipment, net on the Condensed Consolidated Balance Sheets. There was 
no
 recognized tax benefit related to stock-based compensation for the periods presented. In addition, we accrued a $
1.4
 million of bonus to be settled in equity awards as accrued compensation on the Condensed Consolidated Balance Sheet as of September 28, 2025.
As of September 28, 2025, there was approximately $
101.8
 million of unrecognized stock-based compensation expense related to unvested equity awards, which are expected to be recognized over a weighted-average period of 
3.0
 years. As of September 28, 2025, there was approximately $
0.6
 million of unrecognized stock-based compensation related to the ESPP, which is expected to be recognized over a period of 
1.2
 years.
27
Table of Contents
ENOVIX CORPORATION
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
Stock Option Activity
The following table summarizes stock option activities for the fiscal quarter ended September 28, 2025 (in thousands, except share and per share amount).
Number of
Options
Outstanding 
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Life (Years)
Aggregate
Intrinsic
Value 
(1) (2)
Balances as of December 30, 2024
1,751,118
$
10.05

Exercised
(
337,735
)
9.28

$
1,632

Forfeited
(
158,676
)
13.83

Balances as of September 28, 2025
1,254,707
$
9.78

5.5
$
1,269

(1)
The intrinsic value of options exercised is based upon the value of our stock at exercise.
(2)
The aggregate intrinsic value of the stock options outstanding as of September 28, 2025 represents the value of our closing stock price at $
10.09
 on the last trading day of the quarter ended September 28, 2025 in excess of the exercise price multiplied by the number of options outstanding.
Unvested early exercised stock options which are subject to repurchase by us are not considered participating securities as those shares do not have non-forfeitable rights to dividends or dividend equivalents. Unvested early exercised stock options are not considered outstanding for purposes of the weighted average outstanding share calculation until they vest. 
Early Exercise of Options
As of September 28, 2025, 
6,154
 shares remained subject to our right of repurchase as a result of early exercised stock options. The remaining liability related to early exercised shares as of September 28, 2025 was immaterial and was recorded in other current liabilities in the Condensed Consolidated Balance Sheet. 
Restricted Stock Unit and Performance Restricted Stock Unit Activities
The following table summarizes RSUs and PRSUs activities for the fiscal quarter ended September 28, 2025 (in thousands, except share and per share amount).
RSUs
PRSUs
Number of
Shares
Outstanding
Weighted Average
Grant Date Fair Value 
Number of
Shares
Outstanding
Weighted Average
Grant Date Fair Value
Issued and unvested shares balances as of December 30, 2024
11,154,455

$
9.61

2,017,646

$
7.71

Granted
6,030,359

7.95

1,537,067

7.44

Vested
(
3,731,405
)
9.36

(
227,679
)
8.31

Forfeited
(
1,914,691
)
9.91

(
1,218,603
)
7.73

Issued and unvested shares outstanding as of September 28, 2025
11,538,718

$
8.77

2,108,431

$
7.43

Equity Award Modification
In connection with the 2024 Restructuring Plan (as defined in Note 13 “Restructuring Costs”), there was 
one
 equity award modification in May 2024, which accelerated the vesting condition of a former executive’s RSUs as a part of his 
28
Table of Contents
ENOVIX CORPORATION
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
consulting and separation agreement. During the fiscal quarter ended September 29, 2024, we recognized an immaterial amount of stock-based compensation expense related to the equity modifications. For fiscal year-to-date ended September 29, 2024, we recognized $
1.3
 million of stock-based compensation expense related to the modifications for the fiscal year-to-date ended September 29, 2024.
For the fiscal year-to-date ended September 28, 2025, there was 
one
 equity award modification, which extended the exercise period for the vested options. We did not have an equity modification during the fiscal quarter ended September 28, 2025. For fiscal year-to-date ended September 28, 2025, we recognized an 
immaterial
 amount of stock-based compensation related to the equity award modification.
Note 13. 
Restructuring Costs
2024 Restructuring Plan
In May 2024, our Board of Directors approved a restructuring plan (the “2024 Restructuring Plan”) designed to reduce operating costs and support our strategic goals. The restructuring liability was included in Other current liability on our Condensed Consolidated Balance Sheets. The 2024 Restructuring Plan was substantially complete in fiscal year 2024. As of December 29, 2024, we had $
0.4
 million of the restructuring liability and the restructuring liability was paid in cash during the fiscal year-to-date ended September 28, 2025. As of September 28, 2025, we did not have restructuring liability on our Condensed Consolidated Balance Sheets.
In connection with the 2024 Restructuring Plan, we recorded estimated pre-tax restructuring and related charges of $
3.7
 million and $
41.8
 million during the fiscal quarter and fiscal year-to-date ended September 29, 2024. These restructuring costs were reflected in Restructuring cost in the Condensed Consolidated Statements of Operations. The restructuring costs for the fiscal year-to-date ended September 29, 2024 included non-cash charges of $
38.2
 million of loss on disposals of Fab1 long-lived asset in Fremont, California and $
1.2
 million of stock-based compensation expense, and cash charges of $
1.6
 million of severance and termination benefits and $
0.8
 million of other charges.
For the fiscal quarter and fiscal year-to-date ended September 28, 2025, we did 
not
 record any restructuring and related charges.

Note 14. 
Related Party Transactions
Employment Relationship
As of September 28, 2025, we employed 
one
 family member of our CEO, who assists with sales in North America.
Affiliate Notes
On April 20, 2023, we issued $
172.5
 million aggregate principal amount of 2028 Convertible Senior Notes, which included $
10.0
 million principal amount of the Affiliate Notes that were issued to an entity affiliated with Thurman John “T.J.” Rodgers, our Chairman, in a concurrent private placement. The Affiliate Notes were recorded in Long-term debt, net on our Condensed Consolidated Balance Sheets. 
For fiscal quarters ended September 28, 2025 and September 29, 2024, we recorded $
0.1
 million, for each respective quarter, of interest expense related to the Affiliate Notes in our Condensed Consolidated Statements of Operations. For fiscal years-to-date ended September 28, 2025 and September 29, 2024, we recorded $
0.2
 million, for each respective period, of interest expense related to the Affiliate Notes. See Note 8 “Borrowings” for more information. 
In connection with the Warrants issued to 2028 Convertible Senior Notes’ holders, we recorded $
0.5
 million as interest expense for the fair value of the Warrants issued to the affiliate note holders during the fiscal quarter and fiscal year-to-date ended September 28, 2025.
29
Table of Contents
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis provide information that the management of Enovix Corporation (referred as to “we,” “us,” “our” and “Enovix”) believes is relevant to an assessment and understanding of Enovix’s condensed consolidated results of operations and financial condition as of September 28, 2025 and for the fiscal quarter and fiscal year-to-date ended September 28, 2025 and should be read together with the condensed consolidated financial statements that are included elsewhere in this Quarterly Report on Form 10-Q. This discussion and analysis contain forward-looking statements based upon our current expectations, estimates and projections that involve risks and uncertainties. Actual results and timing of selected events may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth in the section titled “Risk Factors” and elsewhere in this Quarterly Report on Form 10-Q. 
Business Overview
We design, develop and have started to commercially manufacture an advanced silicon-anode lithium-ion battery using our proprietary cell architecture that increases energy density and maintains high cycle life. This enables us to use silicon as the only active lithium cycling material in the anode whereas industry incumbents have historically combined only a modest amount of silicon with graphite. We have applied an equally innovative approach to develop proprietary roll-to-stack production tools for existing lithium-ion battery manufacturing lines and increase megawatt hour capacity. Our silicon anode battery architecture allows lithium-ion batteries to be produced smaller and more efficiently at scale than current alternatives. With our acquisition of Routejade, Inc. in 2023, we also offer conventional lithium-ion batteries, which expands our suite of battery offerings to our customers. In April 2025, we acquired assets from SolarEdge located in close proximity to Routejade in South Korea, which expands our manufacturing facilities and this acquisition is expected to help position us to meet growing demand in the defense industry. 
Enovix is headquartered in Silicon Valley, a region of California, with offices and facilities in Asia.
Key Trends, Opportunities and Uncertainties
As we are a growing global company, we are closely monitoring evolving changes in the macroeconomic environment, including inflationary pressures, tariffs, interest rates, and market volatility, that may have potential impacts to our operations. 
We generate revenue from the sale of (a) lithium-ion batteries and battery pack products (“Product Revenue”) and (b) engineering revenue contracts (“Service Revenue”) for the development of lithium-ion battery technology. Our performance and future success depend on several factors that present significant opportunities, but also pose risks and challenges as described in the section titled “Risk Factors” included elsewhere in this Quarterly Report on Form 10-Q. 
Q3 2025 Highlights:
Following is a summary of the activities in the third quarter of 2025: 
•
Revenue:
 Our revenue for the fiscal quarter ended September 28, 2025 was $8.0 million. The $3.7 million, or 85%, increase compared to the prior year’s fiscal quarter ended September 29, 2024 was primarily attributable to strong customer demand for our defense products.
•
Independent Validation: 
AI-1™ smartphone battery performance was validated by an independent testing firm as having the highest energy-density reported for a smartphone battery. 
•
Commercial Programs:
 For smartphones, our lead customer will perform additional lifecycle testing following our design revision, which reflects collaborative, multi-year partnership typical of first-of-its-kind architecture.
We continued to expand engagement across the smart eyewear, an emerging category that leverages our smartphone-level energy density in compact form factors. We delivered over 1,000 AI-1™ battery packs to our lead customer and samples to nine other unique smart eyewear original equipment manufacturers (“OEMs”) and Original Design Manufacturers (“ODMs”), some of which are expected to have products launched in 2026.
In defense and industrial markets, our South Korea operations have shipped over $20 million of product for the fiscal year-to-date ended September 28, 2025 to our customers, including two of South Korea’s major three military contractors.
30
Table of Contents
•
Manufacturing and Operations
: During the fiscal quarter ended September 28, 2025, we achieved yield improvements across equipment zones at our production facility in Malaysia (“Fab2”). Capacity in our Zone 4 (Formation) increased and now exceeds HVM requirements for an additional line.
In South Korea, we integrated the facilities and assets acquired in the second quarter of 2025, which expanded available floor space and added coating equipment capacity. We commenced building our first South Korea based cell-manufacturing a dedicated line for our 100% active-silicon-anode batteries.
•
Warrant Dividend:
 In July 2025, 
w
e declared and issued a special Warrant Dividends to shareholders of record of our common stock as of the close of business on July 17, 2025 (the “Record Date”), and the holders of our 2028 Convertible Senior Notes as of the Record Date. A total of 26,526,344 Warrants were exercised for net proceeds of $224.2 million after deducting commissions and offering expenses. We intend to use the proceeds from the Warrant exercises to support scale-up at Fab2 in Malaysia and for general corporate purposes. Please see Note 10 “Treasury Stock, Warrant Dividend and Warrants” of the notes to our condensed consolidated financial statements in Part I of this Quarterly Report on Form 10-Q for further information.
•
Convertible Senior Notes Due 2030: 
In September 2025, we issued $360.0 million in our 2030 Convertible Senior Notes. The net proceeds from the issuance of 2030 Convertible Senior Notes were $348.6 million, after deducting the initial purchasers’ discounts and commissions and the offering expenses payable by us. We used $45.3 million of the net proceeds from the offering to pay the cost of the capped call transactions related to the 2030 Convertible Senior Notes. We intend to use the remaining net proceeds from the offering of the 2030 Convertible Senior Note for general corporate purposes, which may include to fund a portion of the purchase price for potential acquisitions. Please see Note 8 “Borrowings” of the notes to our condensed consolidated financial statements in Part I of this Quarterly Report on Form 10-Q for further information.
•
Share Repurchase:
 During Q3 2025, we purchased 5,437,556 shares of our common stock for $58.4 million pursuant to the Repurchase Plan. Please see Note 10 “Treasury Stock, Warrant Dividend and Warrants” of the notes to our condensed consolidated financial statements in Part I of this Quarterly Report on Form 10-Q for further information.
Market Focus and Market Expansion
We are focused on five strategic market sectors: Smartphone, Internet of Things (“IoT”), Computing, Defense and Electric Vehicles (“EVs”). 
We prioritize large, high-value markets, such as smartphones and smart eyewear, where the need for higher energy density commands a premium. We believe that the surge in AI-powered devices has validated our strategy and driven significant pull for our products. We believe that our go-to-market strategy positions us on an expedient path to profitability while maintaining a competitive edge in innovation.
Commercialization
Our commercialization strategy involves identifying customer requirements and determining where our battery architecture will offer the greatest value, and pursuing customer engagements that meet our reference design strategy — to partner with leading suppliers and establish our AI-1™ battery products as the baseline design for hardware platforms, enabling broader adoption across multiple device makers that follow the same reference architecture. We continue to be actively engaged with other smartphone OEMs to ensure a rapid ramp once we are established in the market. 
In smart eyewear, we continue to make strong progress across multiple OEM programs worldwide. Under our supply agreement with a leading Silicon Valley customer, we delivered over 1,000 battery packs from our AI-1™ platform, which are now undergoing customer qualification. Several additional OEMs have initiated product testing and validation of our AI-1™ augmented reality (“AR”) battery, while a leading AR processor supplier has received samples as part of a broader ecosystem collaboration to enable next-generation smart eyewear.
Product Development
In the second quarter of 2025, we finalized and launched the AI-1™ platform with the AI-1™ battery for smartphones achieving an energy density level superior to any commercially available alternative. The AI-1™ product platform incorporates elements of our EX-1M and EX-2M technology nodes. We believe the AI-1™ battery architecture is purpose-built for AI-enabled smartphones and wearables, combining energy density, strong safety performances and 
31
Table of Contents
compatibility with high-speed automated assembly. Our product development strategy is in our estimation tightly aligned with the goals of meeting the market needs of higher energy density, cycle life, and fast charge while maintaining safety.
We advanced our own electrochemistry with the AI-1™ smartphone battery, which incorporates elements of our EX-1M and EX-2M silicon battery technology nodes, with greater energy density and fast charge potential. To further extend what we believe is our established leadership position, we have finalized the design of our next battery technology node, which will unlock further improvements in energy density over our previous technologies. During the third quarter of 2025, AI-1™ smartphone battery performance was validated by an independent testing firm as having the highest energy-density battery reported for a smartphone battery.
Access to Capital
Assuming we experience no significant delays in the research and development and manufacture of our battery nor any deterioration in capital efficiency, we believe we will meet longer-term expected future cash requirements and obligations through a combination of available cash, cash equivalents, investments and future debt financings, projected revenues and access to other public or private equity offerings and potential strategic arrangements.
Regulatory Landscape
We operate in an industry that is subject to many established consumer safety and environmental regulations, which have generally become more stringent over time. Additional regulations, if adopted, could result in additional operating costs associated with compliance.
Components of Results of Operations
Revenue
We recognize revenue within the scope of Accounting Standards Codification (“ASC”) 606, 
Revenue from Contracts with Customers.
 Our revenue consists of product revenue, resulting from the sale of lithium-ion batteries. and battery pack products (“Product Revenue”), and service revenue, resulting from payments received from our customers based on executed engineering revenue contracts for the development of lithium-ion battery technology (“Service Revenue”). We did not recognize any Service Revenue during either of the fiscal quarters ended September 28, 2025 and September 29, 2024. 
Our Product Revenue is primarily generated from selling lithium-ion batteries or battery packs. Product Revenue is recognized once we have satisfied the performance obligations as defined in the sales agreement, which is generally satisfied upon transfer of control of goods. Control is transferred upon delivery for our products. For certain customized products with customer acceptance criteria specified in the sales agreement, the performance obligations are generally satisfied upon our customer’s acceptance. Payment terms can vary depending on the contract and it is generally required within 90 days or less from the delivery date or the acceptance date of our product. The amount of revenue recognized reflects the consideration for the product sold.
Cost of Revenue
Cost of revenue includes materials, labor, depreciation and amortization expense, freight costs and other direct costs related to manufacturing our products and service contracts. Labor consists of personnel-related expenses such as salaries and benefits, and stock-based compensation. We anticipate that cost of revenue will continue to increase as we optimize and bring-up our production line.
Our inventory is stated at the lower of cost or net realizable value (“NRV”) on a first-in and first-out basis. Determining net realizable value of finished goods and work in process inventories involves projecting average selling prices. When the estimated net realizable values are below the manufacturing costs, a charge to cost of revenue is recorded.
Capitalization of certain costs are recognized as an asset if they relate directly to a customer contract, generate or enhance resources of the entity that will be used in satisfying future performance obligations, and are expected to be recovered. If these three criteria are not met, the costs are expensed in the period incurred. Deferred costs are recognized as cost of revenue in the period when the related revenue is recognized.
32
Table of Contents
Operating Expenses
Research and Development Expenses
Research and development expenses consist of engineering services, allocated facilities costs, depreciation, development expenses, materials, labor and stock-based compensation related primarily to our (i) technology development, (ii) design, construction, and testing of preproduction prototypes and models, and (iii) certain costs related to the design, construction and operation of our pilot plant that are not of a scale economically feasible to us for commercial production. Research and development costs are expensed as incurred.
To date, research and development expenses have consisted primarily of personnel-related expenses for scientists, experienced engineers and technicians as well as costs associated with the expansion and ramp up of our engineering and manufacturing facility, and materials and supplies to support the product development and process engineering efforts. As we ramp up our engineering operations to complete the development of batteries and required process engineering to meet customer specifications, we anticipate that research and development expenses will continue to increase for the foreseeable future as we expand hiring of scientists, engineers and technicians and continue to invest in additional plant and equipment for product development, building prototypes and testing of batteries. We have research and development teams in the U.S., Malaysia, South Korea and India. 
Selling, General and Administrative Expenses
Selling, general and administrative expenses consist of personnel-related expenses, marketing expenses, allocated facilities expenses, depreciation expenses, travel expenses, acquisition costs, and professional services expenses, including legal, human resources, audit, accounting and tax-related services. Personnel-related costs consist of salaries, benefits and stock-based compensation. Facilities costs consist of rent and maintenance of facilities.
We are expanding our personnel headcount to support the ramping up of commercial manufacturing. Accordingly, we expect our selling, general and administrative expenses to continue to increase in the near term.
Other Income (Expense)
Other income and expense primarily consists of dividend income, interest income, interest expense, foreign currency transaction gain or loss, one-time income resulting from import duty forgiveness, one-time gain from bargain purchase of assets resulting from a business acquisition, and fair value adjustments for outstanding common stock warrants.
Income Tax Expense (Benefit)
Our income tax provision consists of an estimate for U.S. federal, state and foreign income taxes based on enacted rates, as adjusted for allowable credits, deductions, uncertain tax positions, changes in deferred tax assets and liabilities, and changes in the tax law. We maintain a valuation allowance against the full value of our U.S. and state net deferred tax assets because we believe the recoverability of the tax assets is not more likely than not. We are subject to foreign statutory taxation for our international operations.
33
Table of Contents
Results of Operations
Comparison of Fiscal Quarter Ended September 28, 2025 to Fiscal Prior Year's Quarter Ended September 29, 2024
The following table sets forth our condensed consolidated operating results for the periods presented below (in thousands): 
Fiscal Quarters Ended
September 28, 2025
September 29, 2024
Change ($)

% Change

Revenue 
$
7,990 
$
4,317 
$
3,673 
85 
%
Cost of revenue
6,589 
4,959 
1,630 
33 
%
Gross profit (loss)
1,401 
(642)
2,043 
N/M
Operating expenses:
Research and development 
28,180 
24,220 
3,960 
16 
%
Selling, general and administrative 
20,194 
20,744 
(550)
(3)
%
Restructuring cost
— 
3,661 
(3,661)
N/M
Total operating expenses 
48,374 
48,625 
(251)
(1)
%
Loss from operations 
(46,973)
(49,267)
2,294 
(5)
%
Other income (expense):
Change in fair value of common stock warrants
1,867 
29,899 
(28,032)
(94)
%
Interest income
2,540 
2,859 
(319)
(11)
%
Interest expense
(11,765)
(1,718)
(10,047)
585 
%
Other income (loss), net
140 
(2,217)
2,357 
N/M
Total other income (loss), net 
(7,218)
28,823 
(36,041)
(125)
%
Loss before income tax expense (benefit)
(54,191)
(20,444)
(33,747)
165 
%
Income tax expense (benefit)
(422)
2,194 
(2,616)
(119)
%
Net loss
$
(53,769)
$
(22,638)
$
(31,131)
138 
%
N/M – Not meaningful
Revenue
Revenue for the fiscal quarter ended September 28, 2025 was $8.0 million, compared to $4.3 million of revenue for the fiscal quarter ended September 29, 2024. Our revenues were primarily generated from our product shipments to South Korea defense contractors and consumer electronics customers. The increase in revenue of $3.7 million, or 85% was primarily attributable to an increase in our sales to South Korea defense contractors. Of the total revenue recognized for the fiscal quarters ended September 28, 2025 and September 29, 2024, $5.4 million and $1.4 million of revenue, respectively, resulted from sales to one South Korean defense contractor.
Cost of Revenue
Cost of revenue for the fiscal quarter ended September 28, 2025 was $6.6 million, compared to $5.0 million during the fiscal quarter ended September 29, 2024. The increase in cost of revenue of $1.6 million, or 33%, was primarily attributable to an increase in production cost resulted from products mixed sold during the current fiscal quarter as compared to the same period last fiscal year.
Research and Development Expenses
Research and development (“R&D”) expenses for the fiscal quarter ended September 28, 2025 were $28.2 million, compared to $24.2 million during the fiscal quarter ended September 29, 2024. The increase of $4.0 million, or 16%, was primarily attributable to a $0.6 million net increase in salaries, employee benefits and stock-based compensation expenses primarily due to lower headcount in the U.S offset by higher headcount in other regions, a $2.6 million increase in depreciation, a $0.9 million increase in equipment repair and maintenance and increases in other R&D expenses. These increases were partially offset by lower common expenses allocated to R&D and other miscellaneous expenses.
34
Table of Contents
Sellin
g,
 General and Administrative Expenses
Selling, general and administrative expenses for the fiscal quarter ended September 28, 2025 were $20.2 million, compared to $20.7 million during the fiscal quarter ended September 29, 2024. The decrease of $0.6 million, or 3%, was primarily attributable to a $4.9 million net decrease in stock-based compensation expenses, which was mainly due to lower headcount in U.S. resulted from the 2024 Restructuring Plan last fiscal year, which partially offset by increases in professional service fees of $1.7 million, which mainly due to the shareholder’s suit, one-time Warrant Dividend costs of $1.4 million, and other miscellaneous expenses. 
Restructuring Cost
In May 2024, we initiated the 2024 Restructuring Plan to relocate our Fab1 manufacturing operations in Fremont, California to Malaysia. For the quarter ended September 29, 2024, we recorded additional pre-tax restructuring charges of $3.7 million, which primarily consisted of non-cash charges of $3.1 million of loss on disposals of Fab1 long-lived assets in Fremont and $0.2 million of other charges. There was no restructuring cost for the fiscal quarter ended September 28, 2025.
Change in Fair Value of Common Stock Warrants
The changes in fair value of common stock warrants of $1.9 million and $29.9 million for the fiscal quarters ended September 28, 2025 and September 29, 2024, respectively, were attributable to the decrease in the fair value of the outstanding Private Placement Warrants. The decrease in fair value of Private Placement Warrants was primarily due to a decrease in our common stock price for each respective quarter. In addition, the exercise price of the Private Placement Warrants was adjusted to $10.66 per share from $11.50 per share in connection with the Warrants issued during the fiscal quarter ended September 28, 2025 in connection with the Warrant Dividend. For more information on the Warrants and related matters, please see Note 10 “Treasury Stock, Warrant Dividend and Warrants” of the notes to our condensed consolidated financial statements in Part I of this Quarterly Report on Form 10-Q for further information.
Interest Expense
Interest expense for the fiscal quarter ended September 28, 2025 was $11.8 million, compared to $1.7 million during the fiscal quarter ended September 29, 2024. The increase of $10.0 million or 585% was attributable to one-time charge of $9.2 million for the rights with the Warrants issued to the holders of 2028 Convertible Senior Notes. In addition, there was a $0.8 million increase in interest expense resulting from the issuance of the 2030 Convertible Senior Notes during the fiscal quarter ended September 28, 2025.
Other income (loss), net
Other income, net for the fiscal quarter ended September 28, 2025 was $0.1 million, compared to $2.2 million of other loss, net for the fiscal quarter ended September 29, 2024. The change was primarily related to the strength of U.S dollars against other foreign currencies in the fiscal quarter ended September 28, 2025 as compared to the same quarter of last year.
Income Tax Expense (Benefit)
Income tax benefit for the fiscal quarter ended September 28, 2025 was $0.4 million, compared to $2.2 million of income tax expense for the fiscal quarter ended September 29, 2024. The tax expense or benefit was calculated based on the estimated annualized effective tax rate. The change of $2.6 million or 119% in tax was primarily attributable to a decrease in our estimated annualized effective tax rate for the current year.
35
Table of Contents
Comparison of Fiscal Year-to-date Ended September 28, 2025 to Prior Fiscal Year-to-date Ended September 29, 2024
The following table sets forth our condensed consolidated operating results for the periods presented below (in thousands): 
Fiscal Years-to-Date Ended
September 28, 2025
September 29, 2024
Change ($)

% Change

Revenue 
$
20,556 
$
13,357 
$
7,199 
54 
%
Cost of revenue
16,952 
16,454 
498 
3 
%
Gross profit (loss)
3,604 
(3,097)
6,701 
N/M
Operating expenses:
Research and development 
82,257 
102,073 
(19,816)
(19)
%
Selling, general and administrative 
54,613 
61,176 
(6,563)
(11)
%
Restructuring cost
— 
41,807 
(41,807)
N/M
Total operating expenses 
136,870 
205,056 
(68,186)
(33)
%
Loss from operations 
(133,266)
(208,153)
74,887 
(36)
%
Other income (expense):
Change in fair value of common stock warrants
11,778 
17,359 
(5,581)
N/M
Gain on bargain purchase of assets
4,761 
— 
4,761 
N/M
Interest income
7,401 
9,745 
(2,344)
(24)
%
Interest expense
(15,186)
(5,068)
(10,118)
200 
%
Other income (loss), net 
1,501 
(1,509)
3,010 
N/M
Total other income, net 
10,255 
20,527 
(10,272)
(50)
%
Income tax benefit
(1,445)
(2,544)
1,099 
(43)
%
Net loss
$
(121,566)
$
(185,082)
63,516 
(34)
%
N/M – Not meaningful
Revenue
Revenue for the fiscal year-to-date ended September 28, 2025 was $20.6 million, compared to $13.4 million for the prior fiscal year-to-date ended September 29, 2024. Our revenues were primarily generated from our product shipments to South Korea defense contractors and consumer electronics customers. The increase in revenue of $7.2 million was primarily attributable to an increase in our sales to South Korea defense contractors. Of the total revenue recognized for the fiscal years-to-date ended September 28, 2025 and September 29, 2024, $12.3 million and $4.5 million of revenue, respectively, resulted from sales to one South Korean defense contractor.
Cost of Revenue
Cost of revenue for the fiscal year-to-date ended September 28, 2025 was $17.0 million, compared to $16.5 million during the prior fiscal year-to-date ended September 29, 2024. The increase in cost of revenue of $0.5 million, or 3%, was primarily attributable to 
a non-recurring inventory step-up amortization of $1.9 million recorded for the fiscal year-to-date ended 
September 29, 2024 in connection with the acquisition of Routejade. There was no similar charge for the current fiscal year-to date ended September 28, 2025. This decrease was partially offset by an increase in production costs in connection with an increase in revenue.
Research and Development Expenses
Research and development expenses for the fiscal year-to-date ended September 28, 2025 were $82.3 million, compared to $102.1 million during the prior fiscal year-to-date ended September 29, 2024. The decrease of $19.8 million, or 19%, was primarily attributable to a $12.8 million net decrease in depreciation expense, which included a $18.3 million of a one-time accelerated deprecation recorded in the fiscal year-to-date ended September 29, 2024 in connection with the 2023 restructuring plan. In addition, there were a $3.7 million net decrease in salaries, employee benefits and stock-based compensation expenses primarily due to lower headcount in the U.S resulting from the 2024 
36
Table of Contents
Restructuring Plan, a $3.8 million decrease in material and consumable costs, a $1.1 million decrease in facility and technology costs, and decreases in other miscellaneous expenses, partially offset by a $2.5 million increase in tooling and equipment and increases in other miscellaneous expenses.
Sellin
g,
 General and Administrative Expenses
Selling, general and administrative expenses for the fiscal year-to-date periods ended September 28, 2025 was $54.6 million, comparing to $61.2 million for the prior fiscal year-to-date periods ended September 29, 2024. The decrease of $6.6 million, or 11%, was primarily attributable to a $12.0 million net decrease in salaries, employee benefits and stock-based compensation expenses, which was mainly due to lower headcount in U.S. resulted from the 2024 Restructuring Plan last fiscal year. This decrease was partially offset by one-time Warrant Dividend costs of $1.4 million, a $1.2 million increase in common expense allocations to R&D, a $1.1 million increase in repair and maintenance costs, a $1.0 million increase in depreciation expense and increases in other miscellaneous expenses.
Restructuring Cost
In May 2024, we initiated the 2024 Restructuring Plan to relocate our Fab1 manufacturing operations in Fremont, California to Malaysia. As a result, we recorded pre-tax restructuring charges of $41.8 million for the fiscal year-to-date ended September 29, 2024, which consisted of 1) non-cash charges of $38.2 million of loss on disposals of Fab1 long-lived assets in Fremont and $1.2 million of stock-based compensation expense, and 2) cash charges of $1.6 million of severance and termination benefits and $0.8 million of other charges. There was no restructuring cost for the fiscal year-to-date ended September 28, 2025.
Change in Fair Value of Common Stock Warrants
The change in fair value of common stock warrants of $11.8 million for the fiscal year-to-date ended September 28, 2025 and $17.4 million for the fiscal year-to-date ended September 29, 2024 were attributable to decreases in the fair value of the 5,500,000 Private Placement Warrants. The decrease in fair value of Private Placement Warrants for both periods were primarily due to the decreases in our common stock price during the fiscal year-to-date ended September 28, 2025 and September 29, 2024. In addition, the exercise price of the Private Placement Warrants was adjusted to $10.66 per share from $11.50 per share in connection with the Warrants issued during the fiscal quarter ended September 28, 2025. For more information on the Warrants and related matters, please see Note 10 “Treasury Stock, Warrant Dividend and Warrants” of the notes to our condensed consolidated financial statements in Part I of this Quarterly Report on Form 10-Q for further information.
Gain on Bargain Purchase of Assets
In April 2025, we acquired battery cell manufacturing assets from SolarEdge Technologies, Inc., located in South Korea for total purchase consideration of $10.0 million in cash. As a result of this business acquisition, we recorded $4.8 million of gain on bargain purchase as the estimated fair value of the acquired assets exceeded the purchase consideration. There was no gain on bargain purchase for the fiscal year-to-date ended September 29, 2024.
Interest Income
Interest income for the fiscal year-to-date ended September 28, 2025 was $7.4 million, compared to $9.7 million for the fiscal year-to-date ended September 29, 2024. The decrease of $2.3 million or 24% was primarily due to the fact that we had lower cash balance for the fiscal year-to-date ended September 28, 2025 as compared to the fiscal year-to-date ended September 29, 2024 together with lower interest rate for the current year. 
Interest Expense
Interest expense for the fiscal year-to-date ended September 28, 2025 was $15.2 million, compared to $5.1 million during the fiscal year-to-date ended September 29, 2024. The increase of $10.1 million or 200% was attributable to one-time charge of $9.2 million for the rights with the Warrants issued to the holders of 2028 Convertible Senior Note. In addition, there was a $0.8 million increase in interest expense resulting from the issuance of the 2030 Convertible Senior Notes during the fiscal quarter ended September 28, 2025.
Other income (loss), net
Other income, net for the fiscal year-to-date ended September 28, 2025 was $1.5 million, compared to $1.5 million of other loss, net for the fiscal year-to-date ended September 29, 2024. The increase of $3.0 million was primarily due to the fact that we had a one-time import duty forgiveness of $2.4 million in the fiscal year-to-date ended September 28, 
37
Table of Contents
2025 and the strength of U.S dollars against other foreign currencies in the current period as compared to the same period last year.
Income Tax Benefit
Income tax benefit for the fiscal year-to-date ended September 28, 2025 was $1.4 million, compared to $2.5 million for the fiscal year-to-date ended September 29, 2024. The tax benefit was calculated based on the estimated annualized effective tax rate. The decrease of $1.1 million or 43% in tax benefit was primarily attributable to lower income tax benefit on the losses generated from certain foreign jurisdictions.
Liquidity and Capital Resources
As of September 28, 2025, we had cash, cash equivalents, restricted cash, and short-term investments of $560.8 million, long-term investments of $89.5 million, 
working capital of $528.1 million and an accumulated deficit of $942.8 million. Our cash equivalents and investments primarily consist of U.S. government agency securities, U.S. Treasuries, money market mutual funds, and corporate notes and debt securities.
Material Cash Requirements
We use cash to fund operations, meet working capital requirements and fund our capital expenditures. For the remainder of fiscal year 2025, we expect that our spending in cost of revenues and operating expenses will continue to increase as we ramp up our operations.
For the fiscal year-to-date ended September 28, 2025, we used $17.2 million of our cash to fund our acquisitions of property and equipment and $10.0 million of payment for an acquisition of battery cell manufacturing assets in South Korea. We expect to increase our property and equipment purchases in the near future to support the build-out of our manufacturing facilities and our battery manufacturing production. For more information regarding our purchase commitments, please see the contractual obligations and commitments section below.
In July 2025, we declared and issued the Warrant Dividend to shareholders of record of our common stock and the holders of 2028 Convertible Senior Notes as of the close of business on July 17, 2025 (the “Record Date”). A total of 26,526,344 Warrants were exercised for proceeds of $224.2 million, net of commissions and offering expenses. We intend to use the proceeds from the Warrant exercises to support Fab2 scale-up and for general corporate purposes. Please see Note 10 “Treasury Stock, Warrant Dividend and Warrants” of the notes to our condensed consolidated financial statements in Part I of this Quarterly Report on Form 10-Q for further information.
In September 2025, we issued $360.0 million aggregate principal amount of the 2030 Convertible Senior Notes with an interest rate of 4.75%, which will mature on September 15, 2030. The net proceeds of the 2030 Convertible Senior Notes were approximately $348.6 million, after deducting the initial purchasers’ discounts and commissions and the estimated offering expenses payable by us. We used approximately $45.3 million of the net proceeds from the offerings to pay the cost of the capped call transactions related to the 2030 Convertible Senior Notes. We intend to use the remaining net proceeds for working capital and general corporate purposes, which may include to fund a portion of the purchase prices for future potential acquisition. Please see Note 8 “Borrowings” of the notes to our condensed consolidated financial statements in Part I of this Quarterly Report on Form 10-Q for further information.
Additionally, during the third quarter of 2025, our Board of Directors authorized the Repurchase Plan. Pursuant to the Repurchase Plan, we repurchased 5,437,556 shares of our common stock for $58.4 million for the fiscal year-to-date ended September 28, 2025 and we may make repurchases from time to time through open market purchases or through privately negotiated transactions. As of September 28, 2025, we had $1.6 million remaining capacity available under the Repurchase Plan. For more details, please see Note

10 “Treasury Stock, Warrant Dividend and Warrants” of the notes to our condensed consolidated financial statements in Part I of this Quarterly Report on Form 10-Q for further information.
We have incurred operating losses and negative cash flows from operations since inception through September 28, 2025 and expect to incur operating losses in the near future. Based on the anticipated spending and timing of expenditures, we currently expect that our cash will be sufficient to meet our funding requirements over the next twelve months from the date this Quarterly Report on Form 10-Q is filed. We believe we will meet longer-term expected future cash requirements and obligations through a combination of available cash, cash equivalents and future debt financings, projected revenues and access to other public or private equity offerings as well as potential strategic arrangements. We have made our estimates on historical experience and various other relevant factors and we believe that they are 
38
Table of Contents
reasonable. Actual results may differ from our estimates and we could utilize our available capital resources sooner than we expect. 
Summary of Cash Flows
The following table provides a summary of cash flow data for the periods presented below (in thousands). 
Fiscal Years-to-Date Ended 
September 28, 2025
September 29, 2024
Change ($)
Net cash used in operating activities
$
(68,292)
$
(92,675)
$
24,383 
Net cash provided by (used in) investing activities
(339,204)
14,979 
(354,183)
Net cash provided by financing activities
470,733 
44,217 
426,516 
Effect of exchange rate changes on cash, cash equivalents and restricted cash
(409)
1,303 
(1,712)
Change in cash, cash equivalents, and restricted cash
$
62,828 
$
(32,176)
$
95,004 
Fiscal Quarter Ended September 28, 2025 Compared to Prior Year Fiscal Quarter Ended September 29, 2024 
Operating Activities
Our cash flows used in operating activities to date have been primarily comprised of operating expenses. We continue to increase hiring for employees and materials in supporting the ramping up of commercial manufacturing. We expect our cash used in operating activities to increase before we start to generate any material cash inflows from commercially manufacturing and selling our batteries.
Net cash used in operating activities was $68.3 million for the fiscal year-to-date ended September 28, 2025. Net cash used in operating activities consisted of net loss of $121.6 million, adjusted for non-cash items and the effect of changes in working capital. Non-cash adjustments primarily include stock-based compensation expense of $38.0 million, depreciation and amortization expense, net of accretion of $26.7 million, non-cash interest expense of $9.2 million related to the fair value adjustment related to the Warrants issued in July 2025 in connection with the Warrant Dividend, the change in fair value of the Private Placement Warrants of $11.8 million, and gain on bargain purchase of assets of $4.8 million resulted from the acquisition of assets in Korea. 
Net cash used in operating activities was $92.7 million for the fiscal year-to-date ended September 29, 2024. Net cash used in operating activities consisted of net loss of $185.1 million, adjusted for non-cash items and the effect of changes in working capital. Non-cash adjustments primarily include stock-based compensation expense of $48.6 million, depreciation and amortization expense, net of accretion of $37.4 million, impairment and disposals of Fab1 long-lived assets of $38.2 million, and the change in fair value of Private Placement Warrants of $17.4 million.
Investing Activities
Our cash flows used in investing activities to date have been primarily comprised of purchases of property and equipment, as well as short-term investment activities. We expect the costs to acquire property and equipment to increase in the future as we continue to build-out and develop our battery manufacturing production capabilities in Malaysia, including our Fab2 facility in Malaysia, and in South Korea. Net cash used in investment activities was $339.2 million for the fiscal year-to-date ended September 28, 2025, which primarily consisted of $17.2 million of equipment purchases, $370.1 million of short-term investment purchases and $10.0 million of payment for an acquisition of assets in South Korea, partially offset by maturities of $58.1 million of short-term investments.
For additional information regarding the acquisition of assets in Korea, please see Note 3 “Business Acquisition” of the notes to our condensed consolidated financial statements in Part I of this Quarterly Report on Form 10-Q. 
Net cash provided by investing activities for the fiscal year-to-date ended September 29, 2024 was $15.0 million, which primarily consisted of maturities of $106.6 million of short-term investments, partially offset by $59.8 million of equipment purchases and $31.8 million of short-term investment purchases.
Financing Activities
Net cash provided by financing activities was $470.7 million for the fiscal year-to-date ended September 28, 2025, which primarily consisted of $350.1 million of net proceeds from the issuance of the 2030 Convertible Senior Notes, 
39
Table of Contents
$226.6 million of net proceeds from the exercise of Warrants, $3.8 million of proceeds from the exercise of stock options and employee stock purchase plan (“ESPP”) to purchase our common stock, partially offset by $58.4 million used to buyback shares of our common stock pursuant to the Repurchase Plan, $45.3 million of capped call purchases in connection with the 2030 Convertible Senior Notes transactions, $4.9 million of payroll tax payments for shares withheld upon vesting of restricted stock units and $0.8 million of loan payments.
Net cash provided by financing activities was $44.2 million for the fiscal year-to-date ended September 29, 2024, which primarily consisted of $4.6 million of gross proceeds from the borrowings of loans, $44.3 million of proceeds from the issuance of our common stock through an ATM offering and proceeds from exercise of stock options to purchase our common stock and $1.1 million of proceeds from our ESPP to purchase our common stock, partially offset by $5.6 million of payroll tax payments for shares withheld upon vesting of restricted stock units. 
Contractual Obligations and Commitments
As of September 28, 2025, we had $172.5 million aggregate principal amount of 3.0% 2028 Convertible Senior Notes outstanding, which will mature on May 1, 2028 unless earlier converted, redeemed or repurchased. During the fiscal quarter ended September 28, 2025, we issued $360.0 million aggregate principal amount of 2030 Convertible Senior Notes with an interest rate of 4.75%, which will mature on September 15, 2030. 
In addition, we had $10.5 million of asset secured loans, of which $10.2 million are classified as short-term debt on our Condensed Consolidated Balance Sheet as of September 28, 2025. Please see Note 8 “Borrowings” of the notes to our condensed consolidated financial statements in Part I of this Quarterly Report on Form 10-Q for further information.
We lease our headquarters in Fremont, California, our Fab2 production facility in Penang, Malaysia, and offices in India and China. For the lease payment schedule, please see Note 7 “Leases” of the notes to our condensed consolidated financial statements in Part I of this Quarterly Report on Form 10-Q.
We expect to enter into other commitments to support our product development, the build-out of our manufacturing facilities, and our business development, which are generally cancellable upon notice. Additionally, from time to time, we enter into agreements in the normal course of business with various vendors, which are generally cancellable upon notice. Payments due upon cancellation consist only of payments for services provided or expenses incurred, including non-cancellable obligations of service providers, up to the date of cancellation. As of September 28, 2025, our commitments included approximately $6.6 million of our open purchase orders, including equipment purchase orders, and contractual obligations that occurred in the ordinary course of business. For contractual obligations, please See Note 9 “Commitments and Contingencies” of the notes to our condensed consolidated financial statements in Part I of this Quarterly Report on Form 10-Q for further information.
Critical Accounting Policies and Estimates
The preparation of our condensed consolidated financial statements in conformity with GAAP requires our management to make estimates and assumptions that affect the reported amounts of assets and liabilities in our consolidated financial statements and accompanying notes. We base these estimates on historical experience and on various other assumptions that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results may differ materially from these estimates. These estimates and assumptions include but are not limited to: depreciable lives for property and equipment and intangible assets, valuation for assets acquired in business acquisition, valuation for inventory, valuation allowance on deferred tax assets, assumptions used in income tax provisions, valuation of goodwill and intangible assets, assumptions used in stock-based compensation, assumptions used in the calculation of earnings per share related to the Warrants as warrant dividend, incremental borrowing rate for operating right-of-use assets and lease liabilities and valuation of common stock warrants. Certain accounting policies have a more significant impact on our condensed consolidated financial statements due to the size of the financial statement elements and prevalence of their application. 
There have been no material changes to our critical accounting policies and estimates disclosed in Part II, Item 7 of the Annual Report on Form 10-K, except for the additions to the accounting policies on investments as noted in Note 2 “Summary of Significant Accounting Policies” of the notes to the condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q. 
Recent Accounting Pronouncements
See Note 2 “Summary of Significant Accounting Policies” of the notes to our condensed consolidated financial statements in Part I of this Quarterly Report on Form 10-Q for further information.
40
Table of Contents
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We are exposed to a variety of market and other risks, including the effects of changes in interest rates, and inflation, as well as risks to the availability of funding sources, hazard events, and specific asset risks.
Interest Rate Risk
The market risk inherent in our financial instruments and financial position represents the potential loss arising from adverse changes in interest rates. As of September 28, 2025, we had cash, cash equivalents, restricted cash, and investments totaling $650.3 million. Our cash, cash equivalents, restricted cash, and investments are held in cash deposits, 
U.S. government agency securities, U.S. Treasuries, money market mutual funds, and corporate notes and debt securities
. The primary objectives of our investment activities are the preservation of capital and the fulfillment of liquidity needs. Our short-term and long-term investments consist of highly liquid fixed-income securities and we do not enter into investments for trading or speculative purposes. Due to the nature of these instruments, we do not believe that an immediate 10% increase or decrease in interest rates would have a material effect on the fair value of our investment portfolio. 
As of September 28, 2025, we had $172.5 million of 2028 Convertible Senior Notes with an annual interest rate of 3.00% and $360.0 million of 2030 Convertible Senior Notes with an annual interest rate of 4.75%, which accounted for approximately 98% of our total debt before debt issuance costs, and the other borrowings are mostly with fixed interest rates. As such, we do not believe that we are exposed to any material interest rate risk as a result of our borrowing activities.
Uncertain financial markets could result in a tightening in the credit markets, a reduced level of liquidity in many financial markets, and extreme volatility in fixed income and credit markets.
Foreign Currency Risk
For the fiscal quarter ended September 28, 2025, we conducted operations primarily in the U.S. and in Asia. The majority of our expenses, and capital purchasing activities are transacted in U.S. dollars. Our operations outside of the U.S. are subject to risks typical of operations outside of the U.S. including, but not limited to, differing economic conditions, changes in political climate, differing tax structures, other regulations and restrictions, and foreign exchange rate volatility. If a hypothetical 10% adverse change in foreign currency exchange rate was applied to our monetary assets and liabilities as of September 28, 2025, the effect of such change would not be material to our condensed consolidated financial condition or our results of operations.
Given the impact of foreign currency exchange rates has not been material to our historical operating results, we have not entered into derivative or hedging transactions, but we may do so in the future if our exposure to foreign currency should become more significant. As our international operations grow, we will continue to reassess our approach to managing risk relating to fluctuations in foreign currency rates.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in the reports that we file or submit under the Securities Exchange Act of 1934 (‘Exchange Act”) is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, to allow timely decisions regarding required disclosure.
As of September 28, 2025, our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Based on the evaluation, our Chief Executive Officer and our Chief Financial Officer concluded, as of September 28, 2025, that our disclosure controls and procedures were effective at a reasonable assurance level. 
Changes in Internal Control over Financial Reporting
There has been no change in our internal control over financial reporting (as defined in Rules 13a-15(d) and 16d-15(d) under the Exchange Act) that occurred during the quarter ended September 28, 2025 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. 
41
Table of Contents
Inherent Limitations on Effectiveness of Controls
Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal controls, will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected.
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
Refer to the heading “Litigation” in Note 9 “Commitments and Contingencies” of the notes to the condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q for information regarding our legal proceedings.
Item 1A. Risk Factors.
Investing in our securities involves a high degree of risk. Before you make a decision to buy our securities, you should carefully consider the risks and uncertainties described below together with all of the other information contained in this Quarterly Report on Form 10-Q, including our unaudited condensed consolidated financial statements and related notes and in the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” If any of the events or developments described below were to occur, our business, prospects, operating results and financial condition could suffer materially, the trading price of our securities could decline and you could lose all or part of your investment. The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently believe to be immaterial may also adversely affect our business. The risks facing our business have not changed substantively from those discussed in our Annual Report on Form 10-K, except for those risks marked with an asterisk (*).
SUMMARY OF RISK FACTORS
Below is a summary of material factors that make an investment in our securities speculative or risky. Importantly, this summary does not address all of the risks and uncertainties that we face. 
•
We will need to improve our energy density, cycle life, fast charging, capacity roll off and gassing metrics in order to stay ahead of competition over time, which is difficult and we may not be able to do.
•
We rely on a new and complex manufacturing process for our operations, and achieving volume production involves a significant degree of risk and uncertainty in terms of operational performance such as yield and costs.
•
If we cannot successfully scale our
 manufacturing facilities to produce our lithium-ion battery cell in sufficient quantities to meet expected demand, improve productivity and bring additional facilities online, we may be unable to achieve our profitability targets and our business will be negatively impacted and could fail.
•
We rely on a manufacturing agreement with a Malaysia-based company for some of the facilities, procurement, and personnel needs of our operations. Changes to our relationship with such third-party contract manufacturer, expected or unexpected, may result in delays or disruptions that could harm our business.
•
Our operations in international markets, including our manufacturing operations, expose us to operational, financial and regulatory risks, as well as risks relating to geopolitical tensions and conflicts, including changes to trade policies and regulations.
•
We may not be able to source or establish supply relationships for necessary components and raw materials, or may be required to pay costs for components and raw materials that are more expensive than anticipated, including as a result of trade barriers, trade sanctions, export restrictions, tariffs, embargoes or shortages and other general economic and political conditions, which could delay the introduction of our product and negatively impact our business.
•
We may be unable to adequately control the costs associated with our operations and the components necessary to build our lithium-ion battery cells.
42
Table of Contents
•
Lengthy sales cycles, unpredictable safety risks and certain provisions of defense and other customer contracts may negatively impact our ability to maintain and grow our customer base, which could adversely affect our business and future prospects. 
•
If our batteries fail to perform as expected, our ability to develop, market and sell our batteries could be harmed.
•
We have a concentration of customer accounts in the defense sector, and key market sectors such as smartphones and smart eyewear; dependence on these customer accounts may create a risk to our financial stability.
•
Our future growth and success depend on our ability to qualify new customers and the customer qualification cycles can take years to complete.
•
We may not be able to accurately estimate the future supply and demand for our batteries, which could result in a variety of inefficiencies in our business and hinder our ability to generate revenue. If we fail to accurately predict our manufacturing requirements, we could incur additional costs or experience delays.
•
We have a history of financial losses and expect to incur significant expenses and continuing losses for the foreseeable future.
•
If we are unable to develop our business and effectively commercialize our products as anticipated, we may not be able to generate revenue or achieve profitability.
•
We face significant barriers in our attempts to produce our products, our products are still under development, and we may not be able to successfully develop our products at commercial scale. If we cannot successfully overcome those barriers, our business will be negatively impacted and could fail.
•
We have acquired and may continue to acquire other businesses, which could require significant management attention, disrupt our business, and dilute stockholder value.
•
Fluctuations in foreign currency exchange rates or interest rates have had, and could continue to have, an adverse impact on our financial condition and results of operations.
•
Operational problems with our manufacturing equipment subject us to safety risks which, if not adequately addressed, could have a material adverse effect on our business, results of operations, cash flows, financial condition or prospects.
•
The battery market continues to evolve and is highly competitive, and we may not be successful in competing in this industry or establishing and maintaining confidence in our long-term business prospects among current and future partners and customers.
•
Our failure to keep up with rapid technological changes and evolving industry standards may cause our batteries to become less marketable or obsolete, resulting in a decrease in demand for our batteries and harm our ability to grow revenue and expand margins.
•
If we are unable to attract and retain key employees and qualified personnel on a global basis, our business and prospects could be harmed.
•
We have previously been, currently are, and may in the future be involved in class-action lawsuits and other litigation matters that are expensive and time-consuming. If resolved adversely, lawsuits and other litigation matters could seriously harm our business.
•
We may not have adequate funds to finance our operating needs and our growth, and may need to raise additional capital, which we may not be able to do.
•
Servicing our debt requires a significant amount of cash, and we may not have sufficient cash flow from our business to pay our substantial debt.
•
We rely heavily on our intellectual property portfolio. If we are unable to protect our intellectual property rights, our business and competitive position would be harmed.
•
The trading price of our common stock may be volatile, and the value of our common stock may decline.
•
Changes in tax laws or regulations that are applied adversely to us or our customers may have a material adverse effect on our business, cash flow, financial condition or results of operations.
43
Table of Contents
Risks Related to Our Manufacturing and Scale-Up
We will need to improve our energy density, cycle life, fast charging, capacity roll off and gassing metrics in order to stay ahead of competition over time, which is difficult, and we may not be able to do.
Our roadmap to improve our energy density, cycle life, fast charging, capacity roll off and gassing metrics requires us to implement higher energy density materials for both cathodes and anodes, and electrolyte and separator materials. To successfully use these materials, we will have to optimize our cell designs including, but not limited to formulations, thicknesses, geometries, materials, chemistries and manufacturing tolerances and techniques. It could take us longer than we anticipate to incorporate these new materials, or we might not be able to achieve certain cell performance specifications required by customers. Further, we will need to make improvements in our technology to achieve our energy density, cycle life, fast charge, capacity roll off and gassing metrics improvement roadmap. These improvements may not be possible, or could take longer, or be more difficult than forecasted. If we are unable to improve our packaging technology, this could reduce the performance of our products and delay the availability of products to customers, which would negatively impact our competitive potential.
We rely on a new and complex manufacturing process for our operations, and achieving volume production involves a significant degree of risk and uncertainty in terms of operational performance such as yield and costs.
Although we have developed our lithium-ion battery technology, we rely heavily on a new and complex manufacturing process for the production of our lithium-ion battery cells, which is not currently operating at scale. To meet our projected future demand, we need to increase our manufacturing throughput and yield metrics. We expect that meeting our goals to improve throughput and yield will be a multi-quarter or potentially longer endeavor. We have in the past, and may in the future, experience delays in meeting these goals. We have more than one solution to improve manufacturing throughput and yield metrics, and it is uncertain which solution will be optimized for commercial scale. We use numerous vendors for subcomponents of the battery; changes in materials or vendor selection, or the failure of our solutions to improve yield, could negatively impact our ability to meet our throughput and yield metric goals.
The work required to develop these manufacturing processes and integrate equipment into the production of our lithium-ion battery cells, including achieving our goals for throughput and yield, is time intensive and requires us to work closely with numerous equipment and tooling providers to ensure that the equipment works properly for our unique battery technology. The integration of new equipment into our production process involves a significant degree of uncertainty and risk, and we have not in the past and may not in the future be able to achieve our goals for throughput and yield. Further, the integration work may result in the delay in the scaling up of production or result in additional costs to our battery cells, particularly if we encounter issues with performance or if we are unable to customize products for certain of our customers. We expect that certain customers may require several months or longer to complete technology qualification before accepting a product that is manufactured at high volume on the Gen2 lines, if at all. In addition, even if we are able to achieve volume production for the existing uses of our batteries, we may face challenges relating to the scaling up of production for new uses of our batteries, including in the EV market and the market for AI-powered devices.
Our large-scale Gen2 manufacturing lines require large-scale machinery. We need one or more tooling vendors to produce custom products for our customers. Such machinery or tooling equipment has in the past suffered, and may in the future suffer, unexpected malfunctions from time to time and will require repairs and spare parts to resume operations, which may not be available when needed. Our tooling vendors may be new to the battery space or to producing silicon batteries and it may take longer to qualify and effectively utilize such tooling to make custom batteries. Further, our tooling may not be adequate for the various products our customers may demand and we may have to procure new or additional tooling to make products suitable for the market.
In addition, unexpected malfunctions of our production equipment have in the past significantly affected, and may in the future significantly affect, the intended operational efficiency. Qualified labor is needed to remedy any such equipment malfunction, which may not be readily available. Because this equipment has not previously been used to build lithium-ion battery cells, the operational performance and costs associated with the maintenance and repair of this equipment can be difficult to predict and may be influenced by factors outside of our control, such as, but not limited to, (i) failures by suppliers to deliver necessary components of our products in a timely manner and at prices and volumes acceptable to us, (ii) environmental hazards and remediation, (iii) difficulty or delays in obtaining governmental permits, (iv) damages or defects in systems, (v) cybersecurity intrusion and related disruptions; and (vi) industrial accidents, fires, seismic activity and other natural disasters. Further, we have in the past experienced power outages at our facilities, and may again in the future. If outages are more frequent or longer in duration than expected, it could impact our ability to 
44
Table of Contents
manufacture batteries in a timely manner. If our production equipment does not achieve the projected levels of its output or our production equipment becomes obsolete, it may be necessary to record an impairment charge to reduce the carrying value of our machinery and equipment, which would adversely affect our results of operations and financial condition.
Even if we are able to successfully complete development of and modify, as necessary, this new and complex manufacturing process, we may not be able to produce our lithium-ion batteries in commercial volumes in a cost-effective manner.
If we cannot successfully scale our manufacturing facilities to produce our lithium-ion battery cell in sufficient quantities to meet expected demand, improve productivity and bring additional facilities online, we may be unable to achieve our profitability targets and our business will be negatively impacted and could fail.
In 2024, we relocated our Fab1 manufacturing operations from Fremont, California to Fab2 in Malaysia. In 2024 we completed site acceptance testing (“SAT”) and began production of batteries on our Agility line, and completed factory acceptance testing (“FAT”), and SAT, for our High-Volume Manufacturing (“HVM”) line in Malaysia. However, our profitability targets rely on our ability to aggressively reduce the capital costs of our production lines and implement productivity improvements. If such efficiency gains are unsuccessful, we may be unable to achieve our target margin and profitability goals. We expect that our current manufacturing lines will be sufficient to produce batteries in commercial scale, but not in high enough volumes to meet our expected customer demand. Therefore, we anticipate bringing additional facilities online at Fab2 and further refining our approach to improve yields over time. To the extent we continue to experience challenges with improving yields, we may have difficulty accepting additional customers due to capacity constraints, which could delay our growth. If we are unable to successfully build and manage such additional manufacturing lines, or otherwise further refine our approach to improve yields, our business will be negatively impacted and could fail.
Even if we overcome the manufacturing challenges and achieve volume production of our lithium-ion battery, if the cost, performance characteristics or other specifications of the battery fall short of our or our customers’ expectations and targets, our sales, product pricing and margins would likely be adversely affected. Our long-term target economics at scale assume we are able to obtain certain pricing levels for our batteries. If these assumptions are incorrect and/or customer demand is lower than expected, we may fail to achieve our target revenue and profitability goals. 
We rely on a manufacturing agreement with a Malaysia-based company for some of the facilities, procurement, and personnel needs of our operations. Changes to our relationship with such third-party contract manufacturer, expected or unexpected, may result in delays or disruptions that could harm our business.
In July 2023, we entered into a 10-year manufacturing agreement (as amended, the “YBS Agreement”) with YBS International Berhad (“YBS”), a Malaysia-based investment holding company with operational segments including electronic manufacturing and assembly, high-precision engineering, precision machining and stamping, among others. If we are able to overcome the challenges in designing and refining our manufacturing process, YBS will have multiple lines to produce commercial volumes of our lithium-ion batteries to meet our expected customer demands. 
In October 2024, we entered into an amendment to the YBS Agreement, which modified certain payment terms and responsibilities of the parties. Pricing under the YBS Agreement is set on a cost-plus basis and we are subject to a minimum purchase commitment. This means that regardless of the level of manufacturing services YBS provides to us, we are obligated to pay a certain threshold amount each month over the term of the YBS Agreement. The ten-year term of the YBS Agreement expires in July 2033, subject to customary termination provisions.
 Our manufacturing arrangement with YBS creates risks due to our reliance on YBS for certain aspects of our manufacturing facility operations, including procurement and personnel. Further, manufacturing in Malaysia is subject to possible disruptions due to power outages, equipment malfunction and failures, and supply chain disruptions relating to raw materials or components, among others. Our manufacturing operations may also be adversely affected by natural disasters and climate change. Other events, including political or public health crises, may affect our production capabilities or that of our suppliers, including lack of supplies. As a result, in addition to disruptions to operations, our insurance premiums may increase, or we may not be able to fully recover any sustained losses through insurance. 
If this 
manufacturing arrangement does not perform as expected, it may
 materially and adversely affect our results of operations, financial condition and prospects.
45
Table of Contents
In addition, the YBS Agreement exposes us to risks because it limits our control and oversight over the management of manufacturing processes, capacity constraints, delivery timetables, product quality assurance and costs. If we fail to effectively manage our relationship with YBS; if YBS is unable to meet our manufacturing requirements in a timely manner; or if we experience delays, disruptions or quality control problems, it may materially and adversely affect our business, prospects, financial condition and results of operations.
Our operations in international markets, including our manufacturing operations, expose us to operational, financial and regulatory risks, as well as risks relating to geopolitical tensions and conflicts, including changes to trade policies and regulations.*
In 2023 we acquired Routejade, a battery manufacturer in South Korea, and established a research and development center in Hyderabad, India, which supports the product and manufacturing teams in our other locations. In the second half of 2024, we relocated all manufacturing activities to Malaysia and established a subsidiary in Shenzhen, China. In April 2025, we acquired a second manufacturing facility and related assets in South Korea. As of the end of 2024, following the shift of our manufacturing facilities to Malaysia and a reduction in force that primarily affected our U.S. operations, a higher percentage of our employees and a significant portion of our business operations are located overseas, while our leadership team is primarily located in the U.S. Additionally, relationships with customers and potential customers outside of the U.S. accounted for a significant portion of our revenues during 2024, and in the first half of 2025.
While we are continuing to adapt to and develop strategies to address international markets and to manage our international activities and geographically diverse workforce, there is no guarantee that such efforts will have the desired effect. We have in the past and may continue to experience operational challenges associated with global business operations and a globally dispersed workforce, such as coordinating activities across multiple time zones and cultures and maintaining consistent operations standards across diverse locations. In addition, effective collaboration between R&D and manufacturing teams located overseas, and other parts of the organization, may be hindered by distance, language and cultural differences, which may have a negative impact on product innovation and overall operational efficacy. 
We expect that our international activities will continue to grow for the foreseeable future as we continue to pursue opportunities in existing and new international markets, which will require significant dedication of management attention and financial resources.
As a result of having significant international operations, including our manufacturing operations, we are subject to a number of risks, including:
•    burdens of complying with a wide variety of laws and regulations;
•    unexpected changes in regulatory requirements;
•    exposure to political or economic instability and general economic fluctuations in the countries we operate;
•    changes in currency exchange rates;
•    changes in diplomatic and trade relationships;
•    trade restrictions;
•    terrorist activities, natural disasters, epidemics, pandemics and other outbreaks, including the regional or local impacts of any such activity;
•    political, economic and social instability, war or armed conflict;
•    differing employment practices and laws and labor disruptions, including strikes and other work stoppages, strains on the available labor pool, labor unrest, changes in labor costs and other employment dynamics;
•    the imposition of government controls;
•    lesser degrees of intellectual property protection;
•    tariffs and customs duties, or other barriers to some international markets, and the classifications of our goods by applicable governmental bodies; and
46
Table of Contents
•    a legal system subject to undue influence or corruption.
The current geopolitical climate and certain actions by the U.S. administration in 2025 has created uncertainty regarding and fluctuations in trade policies, and our operations and business are subject to these uncertainties given the extent of our international operations and dependencies on international supply chains and access to international employees. These factors and risks could negatively affect our international business operations, increase the difficulty or cost of selling our products in (or restrict our access to) certain foreign markets, divert management’s attention, and increase our costs, which would adversely affect our business, operating results, growth prospects and financial condition.
Changes in global trade policies, including the imposition of new and higher tariffs or the imposition of other barriers to international trade, could have a material adverse effect on our revenues and operating results.*
The United States has recently imposed or proposed significant new tariffs on a large number of products and components imported into the U.S. and could propose additional tariffs or increases to those already in place. It is unknown whether and to what extent these tariffs will remain in place or if other new laws or regulations will be adopted. While the United States has exempted certain technology products, the tariffs that remain in place, and certain reciprocal tariffs in effect between China and the U.S. for example, could cause the costs of our products to increase and the demand for our products to decrease. 
Further, tariffs, trade restrictions and other protectionist measures could restrict our ability to source components or raw materials.
Due to our international operations, we face heightened risks relating to trade policies and disputes that result in increased tariffs, trade barriers, retaliatory tariffs and other trade restrictions and protectionist measures. 
There is broad uncertainty regarding the timing, content and extent of global trade policy changes in the U.S. and abroad, including the extent of retaliatory actions, and we cannot predict the impact, if any, that these changes will have on our business, financial condition and results or operations.
Given this dynamic and uncertain environment, it is not possible to know with any degree of certainty what the negative direct and indirect consequences of tariffs could be on our business financial results. We believe the direct impact of tariffs on our business is likely to be manageable given the location of our international operations in Malaysia, India and South Korea; however, the indirect effects of U.S. tariffs on products containing our batteries could be significant. 
We may not be able to source or establish supply relationships for necessary components and raw materials, or we may be required to pay costs for components and raw materials that are more expensive than anticipated, including as a result of trade barriers, trade sanctions, export restrictions, tariffs, embargoes or shortages and other general economic or political conditions, which could delay the introduction of our products and negatively impact our business.*
We rely on third-party suppliers for components necessary to develop and manufacture our lithium-ion batteries, including key supplies, such as our anode, cathode, electrolyte, and separator materials. If we are unable to enter into commercial agreements with these suppliers on beneficial terms, or these suppliers experience difficulties ramping up their supply of materials to meet our requirements, or delays in providing or developing the necessary materials, or cease providing or developing the necessary materials, we could experience delays in delivering on our timelines.
The unavailability of any equipment component could result in delays in constructing the manufacturing equipment, idle manufacturing facilities, product design changes and loss of access to important technology and tools for producing and supporting our lithium-ion batteries production, as well as impact our capacity. Moreover, significant increases in our production or product design changes by us may in the future require us to procure additional components in a short amount of time. We have faced in the past, and may face in the future, suppliers who are unwilling or unable to sustainably meet our timelines or our cost, quality and volume needs, or to do so may cost us more, which may require us to replace them with other sources, which may further impact our timelines and costs. While we believe that we will be able to secure additional or alternate sources for most of our components, there is no assurance that we will be able to do so quickly or at all. Any inability or unwillingness of our suppliers to deliver necessary product components at timing, prices, quality and volumes that are acceptable to us could have a material impact on our business, prospects, financial condition, results of operations and cash flows. 
47
Table of Contents
Our business depends on the continued supply of certain materials for our products and we expect to incur significant costs related to procuring materials required to manufacture and assemble our batteries. The cost of our batteries depends in part upon the prices and availability of raw materials such as lithium, silicon, graphite, nickel, cobalt, copper and/or other metals. The prices for these materials fluctuate and their available supply has been, and may continue to be, unstable depending on market conditions and global demand for these materials, including as a result of increased global production of EVs and energy storage products, inflationary pressures, supply chain disruption caused by pandemics or other public health crises, and war or other armed conflicts, including Russia’s invasion of Ukraine. 
We have also experienced a need for expedited freight services associated with supply chain challenges, resulting in higher logistics costs. 
Moreover, we may not be able to negotiate purchase agreements and delivery lead-times for such materials on advantageous terms. In addition, several large battery companies are developing and manufacturing key supplies such as cathode material on their own, and as a result such supplies may be proprietary to these companies. Reduced availability of these materials or substantial increases in the prices for such materials has increased, and may continue to increase, the cost of our components and consequently, the cost of our products. There can be no assurance that we will be able to recoup increasing costs of our components, including as a result of recent inflationary pressures, by increasing prices, which in turn would increase our operating costs and negatively impact our prospects.
Any disruption in the supply of components or materials could temporarily disrupt production of our batteries until an alternative supplier is able to supply the required material. Changes in business conditions, unforeseen circumstances, governmental changes, labor shortages, the effects of pandemics or other public health crises and other factors beyond our control or which we do not presently anticipate, could also affect our suppliers’ ability to deliver components to us on a timely basis. Our suppliers may go into bankruptcy or receivership based on conditions associated with their business. For example, one of our equipment suppliers went into receivership in the first half of 2024. To the extent our equipment suppliers experience business continuity challenges in the future, it may disrupt our production timelines, negatively impact our ability to successfully configure the equipment to run at its target performance and limit our ability to operate such equipment.
Currency fluctuations, trade barriers, trade sanctions, export restrictions, tariffs, embargoes or shortages and other general economic or political conditions may limit our ability to obtain key components for our lithium-ion batteries or significantly increase freight charges, raw material costs and other expenses associated with our business, which could further materially and adversely affect our results of operations, financial condition and prospects. For example, the recent tariffs imposed by the U.S. and reciprocal tariffs imposed or proposed by China and the tension in U.S.-China trade relations has created uncertainty in our industry and may negatively affect certain of our suppliers. It is difficult to predict what further trade-related actions governments may take and our business may be negatively impacted if we are unable to quickly and effectively react to such actions. In particular, our facilities are located in Malaysia, India and South Korea and our products require materials and equipment manufactured outside these countries, including China. If such materials and equipment do not fall under any exemption to the newly imposed tariffs or reciprocal tariffs, or are subject to other trade barriers or restrictions, such as China’s Regulation on Export Control of Dual-Use Items, it could materially impact our ability to obtain materials and equipment, or effective alternative sources of such items, on commercially reasonable terms.
Any of the foregoing could materially and adversely affect our results of operations, financial condition and prospects.
We may be unable to adequately control the costs associated with our operations and the components necessary to build our lithium-ion battery cells.
We will require significant capital to develop and grow our business and expect to incur significant expenses, including those relating to raw material procurement, leases, sales and distribution as we build our brand and market our batteries, and general and administrative costs as we scale our operations. Our ability to become profitable in the future will not only depend on our ability to successfully market our lithium-ion batteries and services, but also to control our costs. A large fraction of the cost of our battery, like most commercial batteries, is driven by the cost of component materials, such as anode and cathode powder, separator, pouch material, and current collectors. It also includes machined parts that are part of the package. Our cost reduction road map is based on extensive discussions with vendors, customers, industry analysts and independent research; however, an assumed cost reduction over time may be inaccurate if our forecasted demand does not materialize as planned. These estimates may prove inaccurate, which would adversely affect the expected profitability margins for our batteries.
If we are unable to cost-efficiently manufacture, market, sell and distribute our lithium-ion batteries and services, our margins, profitability and prospects would be materially and adversely affected. We have not yet produced any 
48
Table of Contents
lithium-ion battery cells at significant volume, and our forecasted cost advantage for the production of these cells at scale, compared to conventional lithium-ion cells, will require us to achieve certain goals in connection with rates of throughput, use of electricity and consumables, yield and rate of automation demonstrated for mature battery, and battery material and manufacturing processes, that we have not yet achieved and may not achieve in the future. We intend to improve productivity and reduce the costs of our production lines relative to the first line we built. In addition, we are planning continuous productivity improvements going forward. If we are unable to achieve these targeted rates or productivity improvements, our business will be adversely impacted. 
Additionally, we have previously undertaken restructuring plans to manage our operating expenses and we may do so again in the future. For example, in October 2023 we initiated a strategic realignment of Fab1 in Fremont to refocus the facility from a manufacturing hub to a facility focused on new product development, which resulted in a plan of workforce reduction. We subsequently accelerated our manufacturing operations in Malaysia and discontinued manufacturing operations at our Fab1 facility beginning in May 2024, resulting in a second plan of workforce reduction. We incurred significant restructuring charges associated with equipment disposals in connection with the relocation of manufacturing operations from Fab1 in California, to Fab2 in Malaysia, and may in the future incur, material costs and charges in connection with restructuring plans and initiatives. There can be no assurance that any restructuring plans and initiatives, including the 2024 Restructuring Plan, as defined and further discussed in Note 
13
 “Restructuring Costs” in the notes to the condensed consolidated financial statements in Part I, Item 1 of this Quarterly Report on Form 10-Q, will be successful in managing our operating expenses. Any restructuring plans may adversely affect our operations and ability to recruit and retain skilled and motivated personnel, result in a loss of continuity and accumulated knowledge, or inefficiency during the transition period, and will likely require a significant amount of employees’ time and focus, all of which may divert attention away from operating and growing our business. For more information on our restructuring plans, see Note 
13
 “
Restructuring Costs
” in 
the notes to the condensed consolidated financial statements
 in Part I, Item 1 of this Quarterly Report on Form 10-Q.
If we fail to achieve some or all of the expected benefits of any restructuring plans, which may be impacted by factors outside of our control, our business, operating results, and financial condition could be adversely affected.
Risks Related to Our Customers
Lengthy sales cycles, unpredictable safety risks and certain provisions of defense and other customer contracts may negatively impact our ability to maintain and grow our customer base, which could adversely affect our business and future prospects.
Our customers’ products are typically on yearly or longer refresh cycles. Due to the lengthy sales cycles, if we miss qualification timing by even a small amount, the impact to our production schedule, revenue and profits could be large and may mean that our guidance or revenue forecasts for fiscal year do not materialize as expected. While we intend to meet all qualification criteria, some field reliability risks remain such as cycle life, long-term high-temperature storage capacity and swelling, among others. Batteries are known in the market to have historically faced risks associated with safety, and therefore customers can be reluctant to take risks on new battery technologies. Since new battery technologies have not been widely adopted by customers in the battery market, it may be difficult for us to overcome customer risk objections. If unanticipated product safety problems arise, it may raise warranty costs and adversely affect revenue and profit.
Our sales to defense customers often involve standard form contracts, which may not be subject to negotiation. In particular, certain of these contracts involve unlimited damages provisions that could result in large-scale liabilities.
If our batteries fail to perform as expected, our ability to develop, market and sell our batteries could be harmed.*
We have experienced a limited number of returns of batteries that have failed to perform as expected. As commercial production of our lithium-ion battery cells increases, our batteries have in the past and may in the future contain defects in design and manufacture that may cause them to not perform as expected or that may require repairs, recalls and design changes. Our batteries are inherently complex and incorporate technology and components that have not been used for other applications and that may contain defects and errors, particularly when first introduced. We have a limited frame of reference from which to evaluate the long-term performance of our lithium-ion batteries. There can be no assurance that we will be able to detect and fix any defects in our lithium-ion batteries prior to the sale to potential consumers. If our batteries fail to perform as expected, we could lose design wins and customers may delay deliveries, terminate further orders or initiate product recalls, each of which could adversely affect our sales and brand and could adversely affect our business, prospects and results of operations. 
49
Table of Contents
Our cell architecture is different than other batteries and may behave differently in certain customer use applications that we have not evaluated. This could limit our ability to deliver to certain applications, including, but not limited to smartphone, IoT, smart eyewear, action cameras, portable gaming and smartwatches, and other AI-powered devices. In addition, we have limited historical data on the performance and reliability of our batteries over time. If our batteries fail unexpectedly in the field, such failures could result in significant warranty costs and/or reputational harm. For example, the electrodes and separator structure of our battery are different from traditional lithium-ion batteries and therefore could be susceptible to different and unknown failure modes, leading our batteries to fail and cause a safety event in the field, which could further result in the failure of our end customers’ products as well as the loss of life or property. Any safety event in the field, but in particular, one in which the end product failure results in significant loss, could result in severe financial penalties for us, including the loss of revenue, cancellation of supply contracts and the inability to win new business due to the reputational harm that results. In addition, some of our supply agreements require us to fund some or all of the cost of a recall and replacement of end products affected by our batteries. 
We have a concentration of customer accounts in the defense sector, and key market sectors such as smartphones and smart eyewear; dependence on these customer accounts may create a risk to our financial stability.* 
We face risks associated with customer concentration, which could adversely affect our financial condition, results of operations, and business prospects. As a result of our Routejade acquisition in October 2023, our current revenue stream is derived largely from a limited number of key customers, including defense contractors. A single customer, who is a defense subcontractor in South Korea, accounted for approximately 50% of our total revenue for the fiscal year 2024 and 60% of our total revenue for the fiscal year-to-date ended 
September 28, 2025
. Any adverse changes in the purchasing behavior, financial stability, or strategic direction of these key customers could significantly impact our revenue. The terms and conditions of contracts with these key customers may not provide us with sufficient protection against fluctuations in demand, changes in pricing, or competitive pressures. For example, we rely on certain significant customer accounts in the smartphone and smart eyewear markets. 
Further, we rely on a single supplier for components to manufacture products for our defense customers and any disruption in the supply of components would negatively impact our ability to perform under such contracts and significantly negatively impact our revenues and profit margin. Should we have to replace our single supplier, or renegotiate the terms of our current supplier agreement, we may be unable to establish or obtain competitively favorable terms, which would also negatively impact our revenues and profit margin under our defense customer contracts. 
Moreover, the expiration, termination, or renegotiation of contracts, whether from the integration of these customers as a result of the acquisition or otherwise, could lead to uncertainty and volatility in our revenue stream. Lack of diversification increases our susceptibility to adverse events affecting our key customers in the defense sector and smartphone and smart eyewear markets, among others, including other AI-powered devices. The loss of a significant customer or a substantial reduction in business volume from key accounts could have a material adverse effect on our financial performance, cash flows, and ability to fund our operations, capital expenditures, and strategic initiatives. While we may seek to mitigate the risks associated with customer concentration through diversification efforts, expanded market reach, and enhanced customer relationship management, there can be no assurance that such measures will be successful in offsetting the potential adverse impacts of customer concentration.
In addition, government contracts associated with customers in the defense sector may be subject to procurement laws relating to the award, administration and performance of those contracts. Additionally, governmental entities are variously pursuing policies that may affect our ability to sell our products and services. Changes in government procurement policy, priorities, regulations, technology initiatives and/or technical and compliance requirements may negatively impact our ability to continue to earn revenue from government and defense customers. 
Our future growth and success depend on our ability to qualify new customers and the customer qualification cycles can take years to complete.
Our growth will depend in large part on our ability to qualify new customers. We have invested heavily in qualifying our customers and plan to continue to do so. We are in the early stages of growth in our existing markets, and we expect to substantially raise brand awareness by connecting directly with our customers. We anticipate that these activities will lead to additional deliveries, and, as a result, increase our base of qualified customers. An inability to attract new customers would substantially impact our ability to grow revenue or improve our financial results.
Customer qualification cycles are long and it can take many years for our products to qualify for customer shipment. There are numerous and rigorous safety, performance and other tests that we need to pass to achieve a customer design 
50
Table of Contents
win. If we fail to qualify new customers in a timely manner, our business, financial condition and operating results may be harmed.
Our future growth and success depend on our ability to sell effectively to, and manage relationships with, large enterprise and defense customers.
Our potential customers are manufacturers of products that tend to be large enterprises and organizations, including defense customers. Therefore, our future success will depend on our ability to effectively sell our products to such large customers. Sales to these end-customers involve risks that may not be present (or that are present to a lesser extent) with sales to smaller customers. These risks include, but are not limited to, increased purchasing power and leverage held by large customers in negotiating contractual arrangements with us and longer sales cycles and the associated risk that substantial time and resources may be spent on a potential end-customer that elects not to purchase our lithium-ion battery solutions.
Large organizations often undertake a significant evaluation process that results in a lengthy sales cycle. In addition, product purchases by large organizations are frequently subject to budget constraints, multiple approvals and unanticipated administrative, processing and other delays. Finally, large organizations typically have longer implementation cycles, require greater product functionality and scalability, require a broader range of services, demand that vendors take on a larger share of risks, require acceptance provisions that can lead to a delay in revenue recognition and expect greater payment flexibility. All of these factors can add further risk to business conducted with these potential customers.
We may not be able to accurately estimate the future supply and demand for our batteries, which could result in a variety of inefficiencies in our business and hinder our ability to generate revenue. If we fail to accurately predict our manufacturing requirements, we could incur additional costs or experience delays.

It is difficult to predict our future revenue and therefore accurately budget for our expenses, and we may have limited insight into trends that may emerge and affect our business. We anticipate being required to provide forecasts of our demand to our current and future suppliers prior to the scheduled delivery of products to potential customers. Currently, there is no historical basis for making judgments on the demand for our batteries or our ability to develop, manufacture and deliver batteries, or our profitability in the future. If we overestimate our requirements, our suppliers may have excess inventory, which would indirectly increase our costs. If we underestimate our requirements, our suppliers may have inadequate inventory, which could interrupt manufacturing of our products and result in delayed shipments and revenue. Factors outside our control may also affect the demand for our batteries. For example, many of the expected end products for our batteries are manufactured in China. If the political situation between China and the U.S. were to deteriorate, it could prevent our customers from purchasing our batteries. 
Lead times for materials and components that our suppliers order may vary significantly and depend on factors such as the specific supplier, contract terms and demand for each component at a given time. If we fail to order sufficient quantities of product components in a timely manner, the delivery of batteries to our potential customers could be delayed, which would harm our business, financial condition and operating results.
Increases in sales of our lithium-ion battery cells may expose us to the risks associated with manufacturing batteries for unique customer specifications and increase our dependency upon specific customers, including due to the costs to develop and qualify our system solutions.

The development of our lithium-ion battery cells is dependent, in part, upon successfully identifying and meeting our customers’ specifications for those products. Developing and manufacturing lithium-ion batteries with specifications unique to a customer increases our reliance upon that customer for purchasing our products at sufficient volumes and prices in a timely manner. If we fail to identify or develop products on a timely basis, or at all, that comply with our customers’ specifications or achieve design wins with customers, we may experience a significant adverse impact on our revenue and margins. Even if we are successful in selling lithium-ion batteries to our customers in sufficient volume, we may be unable to generate sufficient profit if per-unit manufacturing costs exceed per-unit selling prices. Manufacturing lithium-ion batteries to customer specifications requires a longer development cycle, as compared to discrete products, to design, test and qualify, which may increase our costs. We have limited experience with this customer design process and limited capacity at Fab2. If we are unsuccessful in meeting customer specifications and/or providing anticipated post-delivery product support services, we may be unable to effectively manage our business, including to develop products for multiple customers’ design specifications in a timely manner, which could harm our financial condition and operating results.
51
Table of Contents
Risks Related to Our Business
We have a history of financial losses and expect to incur significant expenses and continuing losses for the foreseeable future.*
We incurred n
et loss attributable to Enovix 
of approximately $121.8 million and $184.8 million, respectively, for the fiscal years-to-date ended
 September 28, 2025 and September 29, 2024
 and had an accumulated deficit of approximately $942.8 million as of 
September 28, 2025
. We believe that we will continue to incur operating and net losses each quarter until at least the time we begin significant production of our lithium-ion batteries. 
We currently expect that we will continue to incur losses in future periods as we, among other things: (i) continue to incur additional expenses in connection with the development of our manufacturing process and the manufacturing of our batteries; (ii) secure additional manufacturing lines and invest in manufacturing capabilities; (iii) build up inventory of components for our batteries; (iv) build up supplies of batteries for projected demand; (v) increase our sales and marketing activities; (vi) develop our distribution infrastructure; and (vii) increase our general and administrative functions to support our growing operations. We may find that these efforts are more expensive than we currently anticipate or that these efforts may not result in substantial increase in our revenue, which would further increase our losses.
If we are unable to develop our business and effectively commercialize our products as anticipated, we may not be able to generate revenue or achieve profitability.
For our silicon batteries, the growth and development of our operations will depend on the successful commercialization and market acceptance of our products and our ability to manufacture products at scale while timely meeting customers’ demands. Our silicon batteries are in the early stages of commercialization and certain aspects of our technology have not been fully field tested. For example, there is no certainty that, once shipped, our products will operate as expected, and we may not be able to generate sufficient customer confidence in our latest designs and ongoing product improvements. For our graphite batteries, we may not be able to maintain or sustain our existing customers. Our customers’ battery needs are dependent on their end market demand, and they may place purchase orders and cancel them due to lack of demand. There are inherent uncertainties in our ability to predict future demand for our products and, as a consequence, we may have inadequate production capacity to meet demand, or alternatively, have excess available capacity. Our inability to predict the extent of customer adoption of our proprietary technologies makes it difficult to evaluate our future prospects.
If we experience significant delays or order cancellations from these customers, or if we fail to develop our products in accordance with contract specifications, then our operating results and financial condition will be adversely affected. In addition, there is no assurance that if we alter or change our products in the future, that the demand for these new products will develop, which could adversely affect our business and any possible revenue. If our products are not deemed desirable and suitable for purchase and we are unable to establish a customer base, we may not be able to generate revenue or attain profitability. In addition, if we are unable to deliver our engineering services on a timely basis, we may be unable to attract and engage new or existing customers for engineering service contracts and we may not be able to generate revenue or attain profitability.
We face significant barriers in our attempts to produce our products, our products are still under development, and we may not be able to successfully develop our products at commercial scale. If we cannot successfully overcome those barriers, our business will be negatively impacted and could fail.
Producing lithium-ion batteries that meet the requirements for wide adoption by industrial and consumer applications is a difficult undertaking. We are still in the early stage of commercialization and face significant challenges achieving the long-term energy density targets for our products and producing our products in commercial volumes. Some of the challenges that could prevent the widespread adoption of our lithium-ion batteries include difficulties with 
(i) increasing the volume, yield and reliability of our cells, (ii) increasing manufacturing capacity to produce the volume of cells needed to meet demand, (iii) optimizing higher volume manufacturing equipment for scale, (iv) packaging our batteries to ensure adequate cycle life, (v) material cost reductions, (vi) qualifying new vendors, (vii) expanding supply chain capacity, (viii) the completion of rigorous and challenging battery safety testing required by our customers or partners, including but not limited to, performance, cycle life and abuse testing and (x) the development of the final manufacturing processes for optimal yield and throughput.
52
Table of Contents
We have accelerated our manufacturing operations at Fab2 in Malaysia. In 2024, we completed SAT and began production of batteries on our Agility line, and commenced shipping samples to customers. We also completed FAT, and subsequently SAT, for our HVM line in fiscal year 2024. In the second quarter of 2025, we launched our AI-1 platform and delivered samples of our AI-1 smartphone battery to our lead OEM customer and in the third quarter of 2025, we continued to deliver cells to our Al-1 customers for smartphone battery and smart eyewear customers; however, we may encounter yield, material cost, performance and manufacturing process challenges as we develop additional customer-specific products from the AI-1 platform and ramp to volume commercial production. Further, we are likely to encounter engineering challenges as we increase the capacity of our batteries and efficiency of our manufacturing process. If we are unable to overcome these challenges in producing our batteries, our business could fail.
The Gen2 manufacturing equipment requires qualified labor to inspect the parts to ensure proper assembly. We have already experienced equipment malfunctions, and the lack of qualified labor to inspect our batteries may further slow our production and impact our manufacturing costs and production schedule. 
Even if we complete development and achieve volume production of our lithium-ion batteries, if the cost, performance characteristics or other specifications of the batteries fall short of our targets, our sales, product pricing and margins will be adversely affected.
We have acquired and may continue to acquire other businesses, which could require significant management attention, disrupt our business, and dilute stockholder value.*
In October 2023, we acquired Routejade, a manufacturer of lithium-ion batteries in South Korea, and in April 2025, acquired a second manufacturing facility in South Korea from SolarEdge. Although we have limited experience with acquisitions, we may in the future undertake acquisitions of other companies, products or technologies for the ongoing development and expansion of our operations. We may be unable to identify suitable acquisition candidates and/or complete acquisitions on favorable terms, if at all. If we do complete acquisitions, we may not ultimately strengthen our competitive position or achieve our goals, and any acquisitions we complete could be viewed negatively by existing and potential customers, vendors, suppliers, business partners or investors. For example, while we believe that the SolarEdge assets and facility expansion in South Korea will support capacity expansion at Fab2 and add production capacity for South Korean defense programs, there is no assurance that we will be able to realize these strategic benefits from the SolarEdge acquisition. In addition, we may not be able to integrate acquired businesses successfully or effectively manage the combined company following an acquisition. If we fail to successfully integrate our acquisitions, or the people or technologies associated with acquisitions, into our company, the results of operations of the combined company could be adversely affected. 
Any integration process will require significant time and resources, attention from management and will likely disrupt the ordinary functioning of our business, and we may not be able to manage the process successfully, which could harm our business. In addition, we may not successfully evaluate or utilize the acquired technology and accurately forecast the financial impact of an acquisition transaction, including accounting charges. We may not be able to fully realize the anticipated profits or other benefits of any particular transaction in the timeframe we expect or at all due to competition, market trends, additional costs or investments, the actions of advisors, suppliers or other third parties, or other factors. Future acquisitions may result in, significant costs and expenses. Further, if we fail to identify significant issues with any acquisition target during the due diligence process, we may be liable for significant and unforeseen liabilities.
We have previously, and may in the future, pay cash, incur debt or issue equity securities to pay for any such acquisition, any of which could negatively affect our financial condition or the value of our capital stock. The sale of our equity to finance any such acquisitions could result in dilution to our stockholders. If we incur more debt, it will result in increased fixed obligations and could also subject us to covenants or other restrictions that would impede our ability to flexibly operate our business.
Fluctuations in foreign currency exchange rates and interest rates have had, and could continue to have, an adverse impact on our financial condition and results of operations. 
We are exposed to the effects of changes in both foreign currency exchange rates and interest rates. Because a significant portion of our cash and investments are held in U.S. Treasury securities and other interest-bearing instruments, movements in interest rates can materially affect our investment income and the fair value of our marketable securities. Rising rates generally increase interest income on new investments, while falling rates could reduce interest income. In addition, we conduct a portion of our operations outside of the United States, including South Korea, 
53
Table of Contents
Malaysia and other countries in Asia. Fluctuations in foreign currency exchange rates, particularly for the Korean won, Indian rupee, and Malaysian ringgit, could affect our financial condition and results of operations.
Operational problems with our manufacturing equipment subject us to safety risks which, if not adequately addressed, could have a material adverse effect on our business, results of operations, cash flows, financial condition or prospects.* 
Operational problems with our manufacturing equipment subject us to safety risks which, if not adequately addressed, could result in the personal injury to or death of workers, the loss of production equipment, damage to manufacturing facilities, monetary losses, delays and unanticipated fluctuations in production. From time to time, we have experienced fires at our manufacturing facilities. While we have retained industry experts and designed our factories with appropriate safety precautions to address the fire risk of manufacturing batteries and to minimize the impact of any such event, if these precautions are inadequate or an event larger than expected, such occurrences could result in significant equipment, product or facility damage that could lead to manufacturing delays, adversely affect the timing of deliveries to customers and require additional cash to recover. 
In addition, operational problems may result in environmental damage, administrative fines, increased insurance costs and potential legal liabilities. All of these operational problems could have a material adverse effect on our business, results of operations, cash flows, financial condition or prospects. Further, if other battery manufacturers experience fire hazards that result in personal injury or death, it may lead to public perception challenges and unfavorable conditions for all industry participants, regardless of their individual safety records. 
Lithium-ion battery modules in the marketplace have been observed to catch fire or vent smoke and flame, and such events have raised concerns over the use of such batteries.
We develop lithium-ion battery cells for industrial and consumer equipment and intend to supply these lithium-ion battery cells for industrial and consumer applications. Historically, lithium-ion batteries in laptops and cellphones have been reported to catch fire or vent smoke and flames, and more recently, news reports have indicated that several EVs that use high-power lithium-ion batteries caught on fire. Any such adverse publicity or reports reflecting fire and other safety hazards associated with the use of high-power batteries in automotive or other industrial or consumer applications will negatively affect our business and prospects. In addition, any failure of our battery cells may cause damage to the industrial or consumer equipment or lead to personal injury or death and may subject us to lawsuits. 
Our risks in this area are particularly pronounced given our lithium-ion batteries and BrakeFlow
TM
 technology have not yet been commercially tested or mass produced. We may have to recall our battery cells, which would be time-consuming and expensive. A product liability claim could generate substantial negative publicity about our batteries and business and inhibit or prevent commercialization of other future battery candidates, which would have a material adverse effect on our brand, business, prospects and operating results. Our insurance coverage might not be sufficient to cover all potential product liability claims. Any lawsuit seeking significant monetary damages either in excess of our coverage, or outside of our coverage, may have a material adverse effect on our reputation, business and financial condition. We may not be able to secure additional product liability insurance coverage on commercially acceptable terms or at reasonable costs when needed, particularly if we do face liability for our products and are forced to make a claim under our policy.
Further, product liability claims, injuries, defects or other problems experienced by other companies in the lithium-ion battery market could lead to unfavorable market conditions for the industry as a whole, and may have an adverse effect on our ability to attract new customers, thus harming our growth and financial performance.
The battery market continues to evolve and is highly competitive, and we may not be successful in competing in this industry or establishing and maintaining confidence in our long-term business prospects among current and future partners and customers.

The battery market in which we compete continues to evolve and is highly competitive. Our current competitors have, and future competitors may have, greater resources than we do and may also be able to devote greater resources to the development of their current and future technologies. These competitors also may have greater access to customers and may be able to establish cooperative or strategic relationships amongst themselves or with third parties that may further enhance their resources and competitive positioning. Furthermore, existing and potential customers have developed, and may in the future develop, their own battery technologies with improvements in energy density faster than they have historically and what we have assumed, continue to reduce cost and expand supply of conventional 
54
Table of Contents
batteries and therefore reduce our energy density advantage and price premium, which would negatively impact the prospects for our business or negatively impact our ability to sell our products at a market-competitive price and sufficient margins. 
Developments in alternative technologies, improvements in batteries technology made by competitors, or changes in our competitors’ respective business models may materially adversely affect the sales, pricing and gross margins of our batteries. If a competing technology is developed that has superior operational or price performance, our business will be harmed. Further, our financial modeling assumes that, in addition to improving our core architecture over time, we are able to retain access to state-of-the-art industry materials as they are developed. If industry battery competitors develop their own proprietary materials, we would be unable to access these and would lose our competitive advantage in the market. If we fail to accurately predict and ensure that our battery technology can address customers’ changing needs or emerging technological trends, or if our customers fail to achieve the benefits expected from our lithium-ion batteries, our business will be harmed.
We must continue to commit significant resources to develop our battery technology in order to establish a competitive position, and these commitments will be made without knowing whether such investments will result in products potential customers will accept. There is no assurance we will successfully identify new customer requirements or develop and bring our batteries to market on a timely basis, or that products and technologies developed by others will not render our batteries obsolete or noncompetitive, any of which would adversely affect our business and operating results. Further, if we are unable to improve our energy density at a rate faster than the industry, our competitive advantage will erode. In addition, if we fail to produce batteries in large scale volume production at reduced unit cost, it may negatively impact our competitive advantage in the industry.
Customers will be less likely to purchase our batteries if they are not convinced that our business will succeed in the long term. Similarly, suppliers and other third parties will be less likely to invest time and resources in developing business relationships with us if they are not convinced that our business will succeed in the long term. Accordingly, in order to build and maintain our business, we must maintain confidence among current and future partners, customers, suppliers, analysts, ratings agencies and other parties in our long-term financial viability and business prospects. Maintaining such confidence may be particularly complicated by certain factors including those that are largely outside of our control, such as our limited operating history, market unfamiliarity with our products, any delays in scaling manufacturing, delivery and service operations to meet demand, competition and uncertainty regarding our production and sales performance compared with market expectations. In addition, due to competition, we may face pricing pressure and may not be able to charge the prices we would like or achieve profitability on the timeline we plan.
We could face state-sponsored competition from overseas and may not be able to compete in the market on the basis of price.

One or more foreign governments, including the Chinese government, have concluded that battery technology and battery manufacturing is a national strategic priority and therefore have instituted official economic policies meant to support these activities. These policies may provide our competitors with artificially lower costs. If these lower costs materialize and enable competitive products to be sold into our markets at prices that, if applied to us, would cause us to become unprofitable, our ability to continue operating could be threatened.
Our failure to keep up with rapid technological changes and evolving industry standards may cause our batteries to become less marketable or obsolete, resulting in a decrease in demand for our batteries and harm our ability to grow revenue and expand margins.
The lithium-based battery market is characterized by changing technologies and evolving industry standards, which are difficult to predict. This, coupled with frequent introduction of new products and models, has shortened product life cycles and may render our batteries less marketable or obsolete. Also, our ability to grow revenue and expand margins will depend on our ability to develop and launch new product designs that are attractive to our customers. If we fail to invest in the development of new products and technologies, we may lose the opportunity to compete effectively or at all. Third parties, including our competitors, may improve their technologies or even achieve technological breakthroughs that could decrease the demand for our batteries. Our ability to adapt to evolving industry standards and anticipate future standards and market trends will be a significant factor in maintaining and improving our competitive position and our prospects for growth.
55
Table of Contents
If we are unable to attract and retain key employees and qualified personnel on a global basis, our business and prospects could be harmed.*
Our success depends on our ability to attract and retain our executive officers, key employees and other qualified personnel on a global basis, and, as a relatively small company with key talent residing in a limited number of employees, our operations and prospects may be severely disrupted if we lose any one or more of their services. There have been, and may continue to be, changes in our management team resulting from the departure or onboarding of executives and key employees, which could disrupt our business. For example, in addition to turnover of key executive positions in 2023, our Chief Financial Officer stepped down in December 2024, we created a new role and appointed a Chief Accounting Officer at the end of December 2024, and appointed a new Chief Financial Officer in April 2025. Such changes in our executive management team or workforce may be disruptive to our business, divert management’s attention, result in a loss of knowledge and negatively impact employee morale. 
If we encounter further turnover or difficulties associated with the transition or departure of our executive officers and key employees, or if we are unsuccessful in recruiting new personnel or in retaining and motivating existing personnel, our operations may be disrupted, which could harm our business. We are dependent on the continued service of our senior technical and management personnel because of the complexity of our products. Our senior management and key employees are employed on an at-will basis. We cannot ensure you that we will be able to retain the services of our senior management team or other key employees, or that we will be able to timely replace such employees. The loss of one or more of our senior management or other key employees could harm our business.
Labor is subject to external factors that are beyond our control, including our industry’s highly competitive market for skilled workers and leaders, cost inflation, and workforce participation rates. As we build our brand and become more well known and grow globally, there is increased risk that competitors or other companies will seek to hire our personnel. While some of our employees are bound by non-competition agreements, these may prove to be unenforceable. The failure to attract, integrate, train, motivate and retain these personnel could seriously harm our business and prospects.
If we are unable to maintain effective internal control over financial reporting in the future, or implement or integrate effective internal control over financial reporting with respect to any acquired entities or subsidiaries, investors may lose confidence in the accuracy and completeness of our financial reports, and the market price of our common stock may be materially adversely affected.

In the past, we and our independent registered public accounting firm identified two material weaknesses in our internal control over financial reporting, all of which have since been remediated. We did not identify any material weakness for 
the fiscal years 2023 and 2024.
 With respect to any future acquisition, we may encounter unexpected integration challenges, and such integration process may take longer than anticipated, which may have a negative impact on our ability to report effectively on our internal controls. If we are unable to successfully integrate any future acquisition into our existing internal control over financial reporting processes in a timely manner, our ability to accurately report our financial results could be negatively impacted. 
Furthermore, if, in the future, we have a material weakness in our internal controls over financial reporting, we may not detect errors on a timely basis and our financial statements may be materially misstated. We or our independent registered public accounting firm may not be able to conclude on an ongoing basis that we have effective internal control over financial reporting, which could harm our operating results, cause investors to lose confidence in our reported financial information and cause the trading price of our stock to fall. In addition, as a public company, we are required to file accurate and timely quarterly and annual reports with the SEC under the Exchange Act. Any failure to report our financial results on an accurate and timely basis could result in sanctions, lawsuits, delisting of our shares from the Nasdaq Global Select Market or other adverse consequences that would materially harm our business. In addition, we could become subject to investigations by the stock exchange on which our securities are listed, the SEC and other regulatory authorities and litigation from investors and stockholders, which could harm our reputation and our financial condition, and/or divert financial and management resources from our core business. 
We have incurred and will continue to incur significant increased expenses and administrative burdens as a public company, which could negatively impact our business, financial condition and results of operations.
We face increased legal, accounting, administrative and other costs and expenses as a public company that we would not incur as a private company. The Sarbanes-Oxley Act of 2002, including the requirements of Section 404, as well as rules and regulations subsequently implemented by the SEC, the Dodd-Frank Wall Street Reform and Consumer 
56
Table of Contents
Protection Act of 2010 and the rules and regulations promulgated and to be promulgated thereunder, the PCAOB and the securities exchanges, impose additional reporting and other obligations on public companies. Compliance with public company requirements will increase costs and make certain activities more time consuming. A number of those requirements require us to carry out activities that we had not done previously as a private company. For example, we created new board committees and adopted new internal controls and disclosure controls and procedures.
Furthermore, if any issues in complying with those requirements are identified (for example, if we identify a material weakness or significant deficiency in the internal control over financial reporting), we could incur additional costs rectifying those issues, and the existence of those issues could adversely affect our reputation or investor perceptions of us. It may also be more expensive to obtain director and officer liability insurance. Risks associated with our status as a public company may make it more difficult to attract and retain qualified persons to serve on our Board of Directors or as executive officers. As a public company, we have additional reporting and other obligations, which lead to higher legal, accounting and administrative costs for supporting regulatory compliance requirements. These increased costs require us to divert a significant amount of money that could otherwise be used to expand the business and achieve strategic objectives. Advocacy efforts by stockholders and third parties may also prompt additional changes in governance and reporting practices, which could further increase our compliance costs. 
In addition, we implemented an enterprise resource planning (“ERP”), system for our company. An ERP system is intended to combine and streamline the management of our financial, accounting, human resources, sales and marketing and other functions, enabling us to manage operations and track performance more effectively. However, an ERP system will likely require us to complete many processes and procedures for the effective use of the system or to run our business using the system, which may result in substantial costs. If a major system upgrade to our ERP system is required in the future, we will incur additional system implementation costs. Additionally, any disruptions or difficulties in using an ERP system could adversely affect our controls and harm our business, including our ability to forecast or make sales and collect our receivables. Moreover, such disruption or difficulties could result in unanticipated costs and diversion of management attention. 
We have expended significant resources as a public company to comply with Section 404(a)of the Sarbanes-Oxley Act of 2002, which compliance costs may increase as our operations expand. Any failure to maintain effective controls and procedures could negatively impact our business.
We are subject to Section 404 of the Sarbanes-Oxley Act of 2002. The standards required for a public company under Section 404(a) of the Sarbanes-Oxley Act of 2002 are significantly more stringent than those that were required of us as a privately held company. Management may not be able to maintain effective controls and procedures that adequately respond to these increased regulatory compliance and reporting requirements. Further, we need to incorporate any future acquired acquisitions into our existing system of internal controls and procedures, which will further increase our compliance costs, may require additional staff, and will likely divert the attention of management in the transition and integration period. If we are not able to maintain the requirements of Section 404(a) in a timely manner or with adequate compliance, we may not be able to assess whether our internal controls over financial reporting are effective, which may subject us to adverse regulatory consequences and could harm investor confidence and the market price of our securities.
We are required, pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, to furnish a report by management on, among other things, the effectiveness of our internal control over financial reporting. This assessment includes disclosure of any material weaknesses identified by our management in our internal control over financial reporting. In addition, our independent registered public accounting firm is required to attest to the effectiveness of our internal control over financial reporting. Our compliance with Section 404 requires that we incur substantial expenses and expend significant management efforts. As we continue to expand our operations, including into international locations, we use a combination of our in-house Internal Audit team and third party service providers to assess and improve effectiveness of our internal controls over financial reporting, and we will likely expend more resources to hire additional accounting and finance staff with appropriate public company experience, technical accounting knowledge, and local knowledge, to update and refine the process documentation and internal controls for Section 404 compliance at each of our operational locations.
57
Table of Contents
We have previously been, currently are, and may in the future be involved in class-action lawsuits and other litigation matters that are expensive and time-consuming. If resolved adversely, lawsuits and other litigation matters could seriously harm our business.
We have previously been, currently are, and may in the future be subject to litigation such as putative class action and shareholder derivative lawsuits brought by stockholders. We may be a target for additional lawsuits in the future. Please refer to Note 
9

to the condensed consolidated financial statements in Part I, Item 1 of this Quarterly Report on Form 10-Q for a discussion of pending litigation.
Any litigation to which we are a party may result in an onerous or unfavorable judgment that may not be reversed on appeal, or we may decide to settle lawsuits on similarly unfavorable terms. Any such negative outcome could result in payments of substantial monetary damages, which would negatively impact our business and stock price, and to the extent such damages are paid in stock rather than cash, would result in dilution to our current stockholders. The results of lawsuits and claims cannot be predicted with certainty. Regardless of the final outcome, defending litigation is costly and can impose a significant burden on management and employees. We have in the past, and may in the future, receive unfavorable preliminary, interim, or final rulings in pending matters, which could damage our reputation and seriously harm our business.
Risks Related to Our Capital Needs and Capital Strategy
We may not have adequate funds to finance our operating needs and our growth, and may need to raise additional capital, which we may not be able to do.*
The design, manufacture and sale of batteries is a capital-intensive business. As a result of the capital-intensive nature of our business, we can be expected to continue to sustain substantial operating expenses without generating sufficient revenue to cover expenditures. We may need to raise additional capital to expand our current production capabilities or to acquire additional manufacturing lines and facilities in the jurisdictions in which we operate. Adequate additional funding may not be available to us on acceptable terms or at all, and if the financial markets become difficult or costly to access, including due to rising interest rates, fluctuations in foreign currency exchange rates or other changes in economic conditions, our ability to raise additional capital may be negatively impacted. Our failure to raise capital in the future would have a negative impact on our ability to expand our existing manufacturing facilities for additional production lines or improve the production line capability, which would in turn negatively impact our ability to pursue our business strategies. The amount of capital that we will be required to raise, and our ability to raise substantial additional capital, will depend on many factors, including, but not limited to:
•
our ability and the cost to develop our new and complex manufacturing process that will produce lithium-ion batteries in a cost-effective manner;
•
our ability to continue to scale our Malaysia manufacturing facility in a timely and cost-effective manner;
•
our ability to locate and acquire new, larger manufacturing facilities on commercially reasonable terms;
•
our ability to build out our new, larger manufacturing facilities in a cost-effective manner;
•
the cost of preparing to manufacture lithium-ion batteries on a larger scale;
•
the costs of commercialization activities including product sales, marketing, manufacturing and distribution;
•
our ability to hire additional personnel;
•
the demand for our lithium-ion batteries and the prices for which we will be able to sell our lithium-ion batteries, including as may be affected by the recent imposition of new and increased tariffs and global trade disruptions;
•
the emergence of competing technologies or other adverse market developments; and
•
volatility in the equity markets, including as a result of global trade disruptions, the imposition of new and increased tariffs, rising interest rates, inflation or war or other armed conflict.
Our long-term financial model assumes we expand both on our own and by partnering with other battery companies. Should we not be able to achieve these partnering goals we would have to expand purely on our own. This would require 
58
Table of Contents
additional capital and could impact how fast we can ramp revenue and achieve profitability. It could also impact our ability to service some customers that require second sources for supply. Additionally, if we can achieve these partnerships but not on the financial terms we are assuming, it could impact our financial performance.

Further, we cannot guarantee that our business will generate sufficient cash flow from operations to fund our capital expenditures or other liquidity needs. Over time, we expect that we will need to raise additional funds through the issuance of equity, equity-related or debt securities or through obtaining credit from financial institutions to fund, together with our principal sources of liquidity, ongoing costs such as research and development relating to our batteries, any significant unplanned or accelerated expenses and new strategic investments.
As discussed in

the consolidated financial statements, in Part II, Item 8 of this Annual Report on Form 10-K, we are not profitable and have incurred losses in each year since our inception. 
We incurred a n
et loss attributable to Enovix 
of $121.8 million and $184.8 million, respectively, for the fiscal years-to-date
 ended 
September 28, 2025
 and September 29, 2024.
 As of September 28, 2025, we had an accumulated deficit of $942.8 million.
 We anticipate these losses will increase as we continue our manufacturing scale up, add additional manufacturing capacity, continue commercialization and continue to operate as a public company and comply with legal, accounting and other regulatory requirements. We currently expect to continue to incur losses in fiscal year 2025 until we achieve scale in the near future. We cannot be certain that additional capital will be available on attractive terms, if at all, when needed, which could be dilutive to stockholders, and our financial condition, results of operations, business and prospects could be materially and adversely affected.
Raising additional funds may cause dilution to existing stockholders and/or may restrict our operations or require us to relinquish proprietary rights.
To the extent that we raise additional capital by issuing equity or convertible debt securities, our existing stockholders may experience substantial dilution, and the terms of these issued securities may include liquidation or other preferences that adversely affect the rights of our existing common stockholders. For example, we may issue debt or equity securities under our shelf registration statement filed with the SEC in August 2023, including in an at-the-market (“ATM”) offering under our ATM facility, or we may issue debt or equity securities in private transactions.
During the third quarter of 2025, we declared the Warrant and raised gross proceeds of $232.1 million from the exercise of Warrants (see Note 10 “Treasury Stock, Warrant Dividend and Warrants” for further details), and we issued 26,526,344 shares of our common stock in connection with the exercise of the Warrants. 
In September 2025, we issued $360.0 million of our 2030 Convertible Senior Notes, which are convertible into shares of our common stock (see Note 8 “Borrowings” for further details). 
Any agreements for future debt or preferred equity financings, if available, may involve covenants limiting or restricting our ability to take specific actions, such as raising additional capital, incurring additional debt, making capital expenditures or declaring dividends. In addition, if we raise additional funds through collaborations, strategic alliances or marketing, distribution or licensing arrangements with third parties, we may be required to relinquish valuable rights to our technologies or future revenue streams. 
If we incur additional debt, the debt holders, together with holders of our outstanding Convertible Senior Notes, would have rights senior to holders of common stock to make claims on our assets, and the terms of any future debt could restrict our operations, including our ability to pay dividends on our common stock.
Risks Related to Our Convertible Senior Notes
Servicing our debt requires a significant amount of cash, and we may not have sufficient cash flow from our business to pay our substantial debt.
Our ability to make scheduled payments of the principal of, to pay interest on or to refinance our indebtedness, including the Convertible Senior Notes, depends on our future performance, which is subject to economic, financial, competitive and other factors beyond our control. Our business may not continue to generate cash flow from operations in the future sufficient to service our debt and make necessary capital expenditures. If we are unable to generate such cash flow, we may be required to adopt one or more alternatives, such as selling assets, restructuring debt or obtaining additional equity capital on terms that may be onerous or highly dilutive. Our ability to refinance our indebtedness will depend on the capital markets and our financial condition at such time. We may not be able to engage in any of these activities or engage in these activities on desirable terms, which could result in a default on our debt obligations, including the Convertible Senior Notes.
59
Table of Contents
The conditional conversion feature of the Convertible Senior Notes, if triggered, may adversely affect our financial condition and operating results.
In the event the conditional conversion features of the Convertible Senior Notes are triggered, holders of the applicable series of Convertible Senior Notes will be entitled to convert their notes at any time during specified periods at their option. If one or more holders elect to convert their notes, unless we elect to satisfy our conversion obligation by delivering solely shares of our common stock (other than paying cash in lieu of delivering any fractional share), we would be required to settle a portion or all of our conversion obligation through the payment of cash, which could adversely affect our liquidity. In addition, even if holders do not elect to convert their notes, we could be required under applicable accounting rules to reclassify all or a portion of the outstanding principal of the Convertible Senior Notes as a current rather than long-term liability, which would result in a material reduction of our net working capital.
Certain provisions in the indentures governing the Convertible Senior Notes may delay or prevent an otherwise beneficial takeover attempt of us.
Certain provisions in the indentures governing the Convertible Senior Notes may make it more difficult or expensive for a third party to acquire us. For example, the indenture governing the Convertible Senior Notes will require us to repurchase the Convertible Senior Notes for cash upon the occurrence of a fundamental change and, in certain circumstances, to increase the conversion rate for a holder that converts its notes in connection with a make-whole fundamental change. A takeover of us may trigger the requirement that we repurchase the Convertible Senior Notes and/or increase the conversion rate, which could make it costlier for a potential acquirer to engage in such takeover. Such additional costs associated with these and other provisions of the indenture governing our Convertible Senior Notes may have the effect of delaying or preventing a takeover of us that would otherwise be beneficial to investors.
Conversion of the Convertible Senior Notes may dilute the ownership interest of our stockholders or may otherwise depress the price of our common stock.
The conversion of some or all of the Convertible Senior Notes may dilute the ownership interests of our stockholders. Upon conversion of the Convertible Senior Notes, we have the option to pay or deliver, as the case may be, cash, shares of our common stock, or a combination of cash and shares of our common stock. If we elect to settle our conversion obligation in shares of our common stock or a combination of cash and shares of our common stock, any sales in the public market of our common stock issuable upon such conversion could adversely affect prevailing market prices of our common stock. In addition, the existence of the Convertible Senior Notes may encourage short selling by market participants because the conversion of the Convertible Senior Notes could be used to satisfy short positions, or anticipated conversion of the Convertible Senior Notes into shares of our common stock could depress the price of our common stock.
The accounting method for the Convertible Senior Notes could adversely affect our reported financial condition and results.
The accounting method for reflecting the Convertible Senior Notes, including our Affiliate Notes (each as defined in Note 8 “Borrowings” in the notes to our condensed consolidated financial statements in Part I, Item 1 of this Quarterly Report on Form 10-Q) on our Condensed Consolidated Balance Sheet, accruing interest expense for the Convertible Senior Notes and reflecting the underlying shares of our common stock in our reported diluted earnings per share may adversely affect our reported earnings and financial condition.
In August 2020, the Financial Accounting Standards Board published Accounting Standards Update 2020-06 (“ASU 2020-06”), which simplified certain of the accounting standards that apply to convertible notes. ASU 2020-06 eliminated the cash conversion and beneficial conversion feature modes used to separately account for embedded conversion features as a component of equity. Instead, an entity would account for convertible debt or convertible preferred stock securities as a single unit of account, unless the conversion feature requires bifurcation and recognition as derivatives. Additionally, the guidance requires entities to use the “if-converted” method for all convertible instruments in the diluted earnings per share calculation and to include the effect of potential share settlement for instruments that may be settled in cash or shares. ASU 2020-06 became effective for us beginning on January 1, 2022.
In accordance with ASU 2020-06, we recorded the Convertible Senior Notes as liabilities on our Condensed Consolidated Balance Sheets, with the initial carrying amount equal to the principal amount of the Convertible Senior Notes, net of issuance costs. The issuance costs are treated as a debt discount for accounting purposes, which are amortized into interest expense over the term of the Convertible Senior Notes. As a result of this amortization, the 
60
Table of Contents
interest expense that we recognize for the Convertible Senior Notes for accounting purposes is greater than the cash interest payments we will pay on the Convertible Senior Notes, which will result in lower reported income.
In addition, the shares of common stock underlying the Convertible Senior Notes are reflected in our diluted earnings per share using the “if converted” method, if dilutive, in accordance with ASU 2020-06. Under that method, diluted earnings per share are generally calculated assuming that all the Convertible Senior Notes were converted solely into shares of common stock at the beginning of the reporting period, unless the result would be anti-dilutive. The application of the if-converted method may reduce our reported diluted earnings per share to the extent we are profitable in the future, and accounting standards may change in the future in a manner that may adversely affect our diluted earnings per share.
Furthermore, if any of the conditions to the convertibility of the Convertible Senior Notes is satisfied, then we may be required under applicable accounting standards to reclassify the liability carrying value of the Convertible Senior Notes as a current, rather than a long-term, liability. This reclassification could be required even if no noteholders or holders of Affiliate Notes convert their Convertible Senior Notes or Affiliate Notes, respectively, following the satisfaction of those conditions and could materially reduce our reported working capital.
The capped call transactions may affect the value of the Convertible Senior Notes and our common stock.
In connection with the issuance of both the 2028 Convertible Senior Notes and the 2030 Convertible Senior Notes, we entered into capped call transactions (the “Capped Call Transactions”) with certain of the purchasers or affiliates thereof and/or other financial institutions (the “Option Counterparties”). The Capped Call Transactions will cover, subject to customary adjustments, the number of shares of our common stock initially underlying the Convertible Senior Notes. The Capped Call Transactions are expected generally to reduce the potential dilution to our common stock upon any conversion of notes and/or offset any cash payments we are required to make in excess of the principal amount of converted notes, as the case may be, with such reduction and/or offset subject to a cap. However, because the capped call transactions entered into in connection with the 2030 Convertible Senior Notes do not match the maturity of the 2030 Convertible Senior Notes, the capped call transactions will not offset the actual dilutive impact of the 2030 Convertible Senior Notes to our common stock and/or the actual cash payments we are required to make upon conversion of the 2030 Convertible Senior Notes.
In connection with establishing their initial hedges of the Capped Call Transactions, the Option Counterparties or their respective affiliates likely entered into various derivative transactions with respect to our common stock and/or purchased shares of our common stock concurrently with or shortly after the pricing of the Convertible Senior Notes, including with, or from, as the case may be, certain investors in the Convertible Senior Notes.
In addition, the Option Counterparties and/or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to our common stock and/or purchasing or selling our common stock or other securities of ours in secondary market transactions prior to the maturity of the Convertible Senior Notes (and are likely to do so on each exercise date of the Capped Call Transactions, or, to the extent we exercise the relevant election under the Capped Call Transactions, following any repurchase, redemption, or conversion of the Convertible Senior Notes). 
We cannot make any prediction as to the direction or magnitude of any potential effect that the transactions described above may have on the price of the Convertible Senior Notes or the shares of our common stock. Any of these activities could adversely affect the value of the Convertible Senior Notes and our common stock.
We are subject to counterparty risk with respect to the Capped Call Transactions.
The Option Counterparties are financial institutions, and we will be subject to the risk that any or all of them might default under the Capped Call Transactions. Our exposure to the credit risk of the Option Counterparties will not be secured by any collateral. 
If an Option Counterparty becomes subject to insolvency proceedings, we will become an unsecured creditor in those proceedings with a claim equal to our exposure at that time under the capped call transaction with such Option Counterparty. Our exposure will depend on many factors but, generally, an increase in our exposure will be correlated to an increase in the market price and in the volatility of our common stock. In addition, upon a default by an Option Counterparty, we may suffer more dilution than we currently anticipate with respect to our common stock. We can provide no assurances as to the financial stability or viability of the Option Counterparties.
61
Table of Contents
Risks Related to Our Intellectual Property
We rely heavily on our intellectual property portfolio. If we are unable to protect our intellectual property rights, our business and competitive position would be harmed.

We may not be able to prevent unauthorized use of our intellectual property, which could harm our business and competitive position. We rely upon a combination of the intellectual property protections afforded by patent, copyright, trademark and trade secret laws in the U.S. and other jurisdictions, as well as license agreements and other contractual protections, to establish, maintain and enforce rights in our proprietary technologies. In addition, we seek to protect our intellectual property rights through nondisclosure and invention assignment agreements with our employees and consultants and through non-disclosure agreements with business partners and other third parties. Despite our efforts to protect our proprietary rights, third parties may attempt to copy or otherwise obtain and use our intellectual property or be able to design around our intellectual property. Monitoring unauthorized use of our intellectual property is difficult and costly, and the steps we have taken or will take to prevent misappropriation may not be sufficient. Any enforcement efforts we undertake, including litigation, could be time-consuming and expensive and could divert management’s attention, which could harm our business, results of operations and financial condition. Moreover, our intellectual property is stored on computer systems that could be penetrated by intruders and potentially misappropriated. There is no guarantee that our efforts to protect our computer systems will be effective. In addition, existing intellectual property laws and contractual remedies may afford less protection than needed to safeguard our intellectual property portfolio. 
Patent, copyright, trademark and trade secret laws vary significantly throughout the world. A number of foreign countries do not protect intellectual property rights to the same extent as do U.S. laws. Therefore, our intellectual property rights may not be as strong or as easily enforced outside the U.S., and efforts to protect against the unauthorized use of our intellectual property rights, technology and other proprietary rights may be more expensive and difficult outside the U.S. Further, we have not established our intellectual property rights in all countries in the world, and competitors may copy our designs and technology and operate in countries in which we have not prosecuted our intellectual property. Failure to adequately protect our intellectual property rights could result in our competitors using our intellectual property to offer products, and competitors’ ability to design around our intellectual property would enable competitors to offer similar or better batteries, in each case potentially resulting in the loss of some of our competitive advantage and a decrease in our revenue, which would adversely affect our business, prospects, financial condition and operating results.
We may need to defend ourselves against intellectual property infringement claims, which may be time-consuming and could cause us to incur substantial costs.

Companies, organizations or individuals, including our current and future competitors, may hold or obtain patents, trademarks or other proprietary rights that would prevent, limit or interfere with our ability to make, use, develop or sell our products, which could make it more difficult for us to operate our business. From time to time, we may receive inquiries from holders of patents or trademarks inquiring whether we are infringing their proprietary rights and/or seek court declarations that they do not infringe upon our intellectual property rights. Companies holding patents or other intellectual property rights relating to batteries, electric motors or electronic power management systems may bring suits alleging infringement of such rights or otherwise asserting their rights and seeking licenses. In addition, if we are determined to have infringed upon a third party’s intellectual property rights, we may be required to do one or more of the following:
•
cease selling, incorporating or using products that incorporate the challenged intellectual property;
•
pay substantial damages;
•
obtain a license from the holder of the infringed intellectual property right, which license may not be available on reasonable terms or at all; or
•
redesign our batteries.

In the event of a successful claim of infringement against us and our failure or inability to obtain a license to the infringed technology, our business, prospects, operating results and financial condition could be materially adversely affected. In addition, any litigation or claims, whether or not valid, could result in substantial costs and diversion of resources and management’s attention. 
62
Table of Contents
We may also license patents and other intellectual property from third parties, and we may face claims that our use of this intellectual property infringes the rights of others. In such cases, we may seek indemnification from our licensors under our license contracts with them. However, our rights to indemnification may be unavailable or insufficient to cover our costs and losses, depending on our use of the technology, whether we choose to retain control over conduct of the litigation and other factors. 
Our patent applications may not result in issued patents or our patent rights may be contested, circumvented, invalidated or limited in scope, any of which could have a material adverse effect on our ability to prevent others from interfering with our commercialization of our products.

Our patent applications may not result in issued patents, which may have a material adverse effect on our ability to prevent others from commercially exploiting products similar to ours. The status of patents involves complex legal and factual questions and the breadth of claims allowed is uncertain. As a result, we cannot be certain that the patent applications that we file will result in patents being issued or that our patents and any patents that may be issued to us will afford protection against competitors with similar technology. Numerous patents and pending patent applications owned by others exist in the fields in which we have developed and are developing our technology. In addition to those who may claim priority, any of our existing or pending patents may also be challenged by others on the basis that they are otherwise invalid or unenforceable. Furthermore, patent applications filed in foreign countries are subject to laws, rules and procedures that differ from those in the U.S., and thus we cannot be certain that foreign patent applications related to issued U.S. patents will be issued.
Even if our patent applications succeed and we are issued patents in accordance with them, it is still uncertain whether these patents will be contested, circumvented, invalidated or limited in scope in the future. The rights granted under any issued patents may not provide us with meaningful protection or competitive advantages, and some foreign countries provide significantly less effective patent enforcement than in the U.S. In addition, the claims under any patents that issue from our patent applications may not be broad enough to prevent others from developing technologies that are similar or that achieve results similar to ours. The intellectual property rights of others could also bar us from licensing and exploiting any patents that issue from our pending applications. In addition, patents issued to us may be infringed upon or designed around by others, and others may obtain patents that we need to license or design around, either of which would increase costs and may adversely affect our business, prospects, financial condition and operating results.
Risks Related to Our Regulatory Compliance
We may encounter regulatory approval difficulties which could delay our ability to launch our lithium-ion battery cells, and compliance with regulatory laws may limit their usefulness.

Any delay in the development and manufacturing scale-up of our lithium-ion battery cells would negatively impact our business as it will delay time to revenue and negatively impact our customer relationships. For example, although we plan to successfully pass all required regulatory abuse testing, because our design is new and has very high energy density, there may be unanticipated failure modes that occur in the field which could delay or prevent us from launching our batteries. Further, there are current limits on the amount of energy that can be transported using different delivery methods, particularly air travel. These limits on battery transportation have historically been based on the energy of batteries currently on the market. If battery transportation regulations remain static or the energy capacity of new batteries is deemed unsafe at certain levels, our transportation options may be limited, which could increase the costs and duration of shipping of our finished product and reduce customer use of our batteries in certain locations. This could increase our inventory costs and limit sales of our batteries in some markets.
We are subject to substantial regulation, and unfavorable changes to, or our failure to comply with, these regulations could substantially harm our business and operating results.

Our batteries are subject to substantial regulation under international, federal, state and local laws, including export control laws. We expect to incur significant costs in complying with these regulations. Regulations related to the battery and alternative energy are currently evolving, and we face risks associated with changes to these regulations. 
To the extent the laws change, our products may not comply with applicable international, federal, state or local laws, which would have an adverse effect on our business. Compliance with changing regulations could be burdensome, time consuming and expensive. To the extent compliance with new regulations is cost prohibitive, our business, prospects, financial condition and operating results would be adversely affected. 
63
Table of Contents
Internationally, there may be laws in jurisdictions we have not yet entered or laws we are unaware of in jurisdictions we have entered that may restrict our sales or other business practices. The laws in this area can be complex, difficult to interpret and may change over time. Continued regulatory limitations and other obstacles that may interfere with our ability to commercialize our products could have a negative and material impact on our business, prospects, financial condition and results of operations.
We are subject to a variety of laws and regulations related to the safety and transportation of our batteries. Our failure to comply with these laws and regulations may have a material adverse effect on our business and results of operations.

Many federal, state and local authorities require certification by Underwriters Laboratory, Inc., an independent, not-for-profit corporation engaged in the testing of products for compliance with certain public safety standards, or other safety regulation certification prior to marketing battery cells. Foreign jurisdictions also have regulatory authorities overseeing the safety of consumer products. Our products may not meet the specifications required by these authorities. A determination that any of our products are not in compliance with these rules and regulations could result in the imposition of fines or an award of damages to private litigants. 
In addition, lithium batteries have been identified as a Class 9 dangerous good during transport. To be safely transported (by air, sea, rail or roadways), they must meet various international, national, state and local authorities, including, for example, the provisions laid out in United Nations standard UN 38.3. This standard applies to batteries transported either on their own or installed in a device. UN 38.3 has been adopted by regulators and competent authorities around the world, thus making it a requirement for global market access. Any failure to fully comply with such international or other transportation safety standards could subject us to increased costs or future liabilities.
We are subject to requirements relating to environmental and safety regulations and environmental remediation matters which could adversely affect our business, results of operations and reputation.

We are subject to numerous federal, state and local environmental laws and regulations governing, among other things, solid and hazardous waste storage, treatment and disposal and remediation of releases of hazardous materials. There are significant capital, operating and other costs associated with compliance with these environmental laws and regulations. Environmental laws and regulations may become more stringent in the future, which could increase costs of compliance or require us to manufacture with alternative technologies and materials. 
Federal, state and local authorities also regulate a variety of matters, including, but not limited to, health, safety and permitting in addition to the environmental matters discussed above. New legislation and regulations may require us to make material changes to our operations, resulting in significant increases to the cost of production. 
Our manufacturing process will have hazards such as, but not limited to, hazardous materials, machines with moving parts and high voltage and/or high current electrical systems typical of large manufacturing equipment and related safety incidents. There may be safety incidents that damage machinery or product, slow or stop production or harm employees. Consequences may include litigation, regulation, fines, increased insurance premiums, mandates to temporarily halt production, workers’ compensation claims or other actions that impact the company brand, finances or ability to operate.
Risks Related to Ownership of Our Securities
The trading price of our common stock may be volatile, and the value of our common stock may decline.*
Historically, our stock price has been volatile and the trading price of our securities could continue to be volatile. The trading price of our common stock is subject to wide fluctuations in response to various factors, many of which are beyond our control. Any of the factors listed below could have a material adverse effect on your investment in our securities and our securities may trade at prices significantly below the price you paid. In such circumstances, the trading price of our securities may not recover and may experience a further decline.

Factors affecting the trading price of our securities:
•
actual or anticipated fluctuations in our quarterly financial results or the quarterly financial results of companies perceived to be similar to us;
•
changes in the market’s expectations about our operating results;
•
market perception and speculation regarding announcements of new product or customer agreements;
64
Table of Contents
•
success of competitors;
•
our operating results failing to meet the expectation of securities analysts or investors in a particular period;
•
changes in financial estimates and recommendations by securities analysts concerning us or the market in general;
•
operating and stock price performance of other companies that investors deem comparable to us;
•
our ability to develop products for our end-user markets;
•
changes in laws and regulations affecting our business;
•
commencement of, or involvement in, litigation involving us;
•
changes in our capital structure, such as future issuances of securities or the incurrence of additional debt;
•
the volume of shares of our securities available for public sale;
•
any major change in our board of directors or management;
•
sales of securities convertible into shares of our capital stock by us;
•
sales of substantial amounts of common stock by our directors, executive officers or significant stockholders or the perception that such sales could occur; and
•
general economic and political conditions such as global trade disruptions, the imposition of increased and retaliatory tariffs by the U.S. and its trading partners, recessions, interest rates, fuel prices, international currency fluctuations and acts of war or other armed conflict or terrorism.

Broad market and industry factors may materially harm the market price of our securities irrespective of our operating performance. The stock market in general and the Nasdaq Global Select Market in particular have experienced price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of the particular companies affected. The trading prices and valuations of these stocks, and of our securities, are not predictable. A loss of investor confidence in the market for battery company stocks or the stocks of other companies which investors perceive to be similar to us could depress our stock price regardless of our business, prospects, financial conditions or results of operations. A decline in the market price of our securities also could adversely affect our ability to issue additional securities and our ability to obtain additional financing in the future.
Furthermore, short sellers may engage in manipulative activity intended to drive down the market price of target company stock. We have in the past been the subject of a short seller report containing certain allegations against us. While we reviewed the allegations in such report and believe them to be unsubstantiated, we may in the future become subject to additional unfavorable reports, which may cause us to expend a significant number of resources to investigate such allegations and may lead to increased volatility in the price of our common stock.
If securities or industry analysts do not publish or cease publishing research or reports about us, our business, or our market, or if they change their recommendations regarding our securities adversely, the price and trading volume of our securities could decline.

The trading market for our securities is influenced by the research and reports that industry or securities analysts may publish about us, our business, our market, or our competitors. If any of the analysts who currently cover us change their recommendation regarding our stock adversely, or provide more favorable relative recommendations about our competitors, the price of our securities would likely decline. If any analyst who currently covers us were to cease coverage of us or fail to regularly publish reports on us, we could lose visibility in the financial markets, which could cause our stock price or trading volume to decline. If we obtain additional coverage and any new analyst issues an adverse or misleading opinion regarding us, our business model, our intellectual property or our stock performance, or if our operating results fail to meet the expectations of analysts, our stock price could decline.
The future sales of shares by existing stockholders may adversely affect the market price of our common stock.
Sales of a substantial number of shares of our common stock in the public market could occur at any time. If our stockholders sell, or the market perceives that our stockholders intend to sell, substantial amounts of our common stock 
65
Table of Contents
in the public market, the market price of our common stock could decline. We have a total of 215,816,004 shares of common stock outstanding as of November 3, 2025. All of our outstanding shares are eligible for sale in the public market, other than shares and options held by directors, executive officers, and other affiliates that are subject to volume limitations under Rule 144 of the Securities Act, various vesting agreements, and restrictive legends that limit sales other than under an effective registration statement. Additionally, the shares of common stock subject to outstanding options and restricted stock unit awards under our equity incentive plans and the shares reserved for future issuance under our equity incentive plans will become eligible for sale in the public market upon issuance, subject to the applicable provisions of our insider trading policy.
Private Placement Warrants are exercisable for our common stock, which would increase the number of shares eligible for future resale in the public market and result in dilution to our stockholders.

In connection with the initial public offering of our predecessor entity, Rodgers Silicon Valley Acquisition Corp. (“RSVAC”), RSVAC issued and sold 6,000,000 private placement warrants (the “Private Placement Warrants”) to Rodgers Capital, LLC, which entity subsequently distributed the Private Placement Warrants to its Series B Unit holders. Each Private Placement Warrant is exercisable for one share of common stock at an adjusted exercise price of $10.66 per share. As of 
September 28, 2025, t
here are 5,500,000 Private Placement Warrants outstanding following the exercise of warrants by one warrant holder in July 2024.
To the extent Private Placement Warrants are exercised, which may be more likely given the exercise price for the Private Placement Warrants will be adjusted downward based on the fair market value of the Warrant Dividend, additional shares of our common stock will be issued, which will result in dilution to our existing common stockholders, and increase the number of our shares eligible for resale in the public market. 
Sales of a substantial number of these shares in the public market, or the perception of such sales, could adversely affect the market price of our common stock. The Private Placement Warrants expire on July 14, 2026, or earlier upon redemption or liquidation, as more fully described in the Warrant Agreement, dated July 31, 2021, filed as an exhibit to our Annual Report on Form 10-K. 
An active trading market for our securities may not continue, which would adversely affect the liquidity and price of our securities.

The price of our securities may fluctuate significantly due to general market and economic conditions and an active trading market for our securities may not be sustained. In addition, the price of our securities can vary due to general economic conditions and forecasts, our general business condition and the release of our financial reports. If our securities are not listed on, or for any reason become delisted from, the Nasdaq Global Select Market and are quoted on the OTC Bulletin Board, an inter-dealer automated quotation system for equity securities that is not a national securities exchange, the liquidity and price of our securities will be adversely affected. Following their expiration, the Warrants will no longer be tradable on Nasdaq. You may be unable to sell your securities if an active trading market for our securities cannot be sustained and/or the securities are no longer listed on the Nasdaq Global Select Market or other national securities exchange.
There can be no assurance that we will be able to comply with the continued listing standards of the Nasdaq Global Select Market.

If the Nasdaq Global Select Market delists our securities from trading on its exchange for failure to meet the listing standards, we and our stockholders could face significant material adverse consequences including:
•
a limited availability of market quotations for our securities;
•
a determination that our common stock is a “penny stock” which will require brokers trading in our common stock to adhere to more stringent rules, possibly resulting in a reduced level of trading activity in the secondary trading market for our common stock;
•
a limited amount of analyst coverage; and
•
a decreased ability to issue additional securities or obtain additional financing in the future. 
Our amended and restated certificate of incorporation provides that the Court of Chancery of the State of Delaware and U.S. federal district courts will be the exclusive forums for certain disputes between us and our stockholders, 
66
Table of Contents
which could limit our stockholders’ ability to choose the judicial forum for disputes with us or our directors, officers or employees.

Our amended and restated certificate of incorporation provides that the Court of Chancery of the State of Delaware (or, if and only if the Court of Chancery of the State of Delaware lacks subject matter jurisdiction, any state court located within the State of Delaware or, if and only if all such state courts lack subject matter jurisdiction, the federal district court for the District of Delaware) is the exclusive forum for:
•
any derivative action or proceeding brought on our behalf;
•
any action asserting a claim of breach of fiduciary duty owed by any of our current or former directors, officers or other employees to us or our stockholders;
•
any action asserting a claim against us by any of our current or former directors, officers or other employees to us or our stockholders arising under the Delaware General Corporation Law, our amended and restated certificate of incorporation or our amended and restated bylaws;
•
any action or proceeding to interpret, apply, enforce or determine the validity of the amended and restated certificate of incorporation or the amended or restated bylaws (including any right, obligation or remedy thereunder);
•
any action or proceeding as to which the General Corporation Law of the State of Delaware confers jurisdiction to the Court of Chancery of the State of Delaware; and
•
any action asserting a claim against us or any of our current or former directors, officers or other employees that is governed by the internal affairs doctrine, in all cases to the fullest extent permitted by law and subject to the court’s having personal jurisdiction over the indispensable parties named as defendants.

This exclusive-forum provision would not apply to suits brought to enforce a duty or liability created by the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction, or the Securities Act. In addition, to prevent having to litigate claims in multiple jurisdictions and the threat of inconsistent or contrary rulings by different courts, among other considerations, our amended and restated certificate of incorporation provides that, unless we consent in writing to the selection of an alternative forum, to the fullest extent permitted by law, U.S. federal district courts will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. However, Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder. Accordingly, both state and federal courts have jurisdiction to entertain such claims. As noted above, our amended and restated certificate of incorporation provides that U.S. federal district courts will be the exclusive forum for the resolution of any complaint asserting a cause of action under the Securities Act. Due to the concurrent jurisdiction for federal and state courts created by Section 22 of the Securities Act over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder, there is uncertainty as to whether a court would enforce the exclusive form provision. Our amended and restated certificate of incorporation further provides that any person or entity holding, owning or otherwise acquiring any interest in any of our securities shall be deemed to have notice of and consented to these provisions. Investors also cannot waive compliance with the federal securities laws and the rules and regulations thereunder. 
These exclusive-forum provisions may limit a stockholder’s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers or other employees. While the Delaware courts have determined that such choice of forum provisions are facially valid, a stockholder may nevertheless seek to bring such a claim arising under the Securities Act against us or our directors, officers or other employees in a venue other than in U.S. federal district courts. In such instance, we would expect to vigorously assert the validity and enforceability of the exclusive forum provisions of our amended and restated certificate of incorporation. This may require significant additional costs associated with resolving such action in other jurisdictions and we cannot assure you that the provisions will be enforced by a court in those other jurisdictions. If a court were to find either exclusive-forum provision in our amended and restated certificate of incorporation to be inapplicable or unenforceable in an action, we may incur further significant additional costs associated with resolving the dispute in other jurisdictions, all of which could harm our business.
67
Table of Contents
General Risk Factors
We have been, and may in the future be, involved in legal proceedings and commercial or contractual disputes, which could have an adverse impact on our profitability and consolidated financial position.

We may be involved in legal proceedings and commercial or contractual disputes that, from time to time, are significant. These are typically claims that arise in the normal course of business including, without limitation, commercial or contractual disputes, including warranty claims and other disputes with potential customers and suppliers, intellectual property matters, personal injury claims, environmental issues, tax matters and employment matters. Please refer to Note 
9
 to the condensed consolidated financial statements in Part I, Item 1 of this Quarterly Report on Form 10-Q for a discussion of pending litigation.
It is difficult to predict the outcome, duration or ultimate financial exposure, if any, represented by these matters, and there can be no assurance that any such exposure will not be material. Such contractual disputes and claims may also divert management’s attention away from our business operations, negatively affect our reputation and/or result in increased compliance costs.
Global conflicts could adversely impact our business, costs, supply chain, sales, financial condition or results of operations.
Recent global conflicts, such as the Russia’s invasion of Ukraine and the war in Yemen, have led the U.S. and certain other countries to impose significant sanctions and trade actions or have slowed down shipping options, and the U.S. and certain other countries could impose further sanctions, trade restrictions and other retaliatory actions, and affect shipment of products. It is not possible to predict the broader consequences of the conflicts, including related geopolitical tensions, and the measures and retaliatory actions taken by the U.S. and other countries in respect thereof, as well as any counter measures or retaliatory actions taken in response, have caused and are likely to continue to cause regional instability and geopolitical shifts. Further, such conflicts have in the past, and will likely continue to, materially adversely affected global trade, currency exchange rates, regional economies and the global economy. While it is difficult to anticipate the impact of any of the foregoing on the Company, such conflicts, and any similar future conflicts, including as a result of rising tensions between China and Taiwan, and actions taken in response to the conflict, could increase our costs, disrupt our supply chain, reduce our sales and earnings, impair our ability to raise additional capital when needed on acceptable terms, if at all, or otherwise adversely affect our business, financial condition and results of operations.
We may become subject to product liability claims, which could harm our financial condition and liquidity if we are not able to successfully defend or insure against such claims.
Highly publicized incidents of laptop computers and cell phones bursting into flames have focused attention on the safety of lithium-ion batteries. If one of our products were to cause personal injury or property damage, including as a result of product malfunctions, defects or improper installation leading to a fire or other hazardous condition, we may become subject to product liability claims, even those without merit, which could harm our business, prospects, operating results and financial condition. We face inherent risk of exposure to claims in the event our batteries do not perform as expected or malfunction resulting in personal injury or death. Our risks in this area are particularly pronounced given our batteries have a limited history of commercial testing and mass production. A successful product liability claim against us could require us to pay a substantial monetary award. Moreover, a product liability claim could generate substantial negative publicity about our batteries and business and inhibit or prevent commercialization of other future battery product candidates, which would have material adverse effect on our brand, business, prospects and operating results. Any insurance coverage might not be sufficient to cover all potential product liability claims. Any lawsuit seeking significant monetary damages either in excess of our coverage, or outside of our coverage, may have a material adverse effect on our reputation, business and financial condition. We may not be able to secure additional product liability insurance coverage on commercially acceptable terms or at reasonable costs when needed, particularly if we do face liability for our products and are forced to make a claim under our policy.
If our batteries, our website, systems or data we maintain are or were compromised we could experience adverse consequences resulting from such compromise, including but not limited to regulatory investigations or actions; litigation; fines and penalties; disruptions of our business operations; reputational harm; loss of revenue or profits; loss of customers or sales; and other adverse consequences. 
68
Table of Contents
In the ordinary course of business, we collect, receive, store, process, generate, use, transfer, disclose, make accessible, protect, secure, dispose of, transmit, and share (collectively, process) personal data and other sensitive information, including proprietary and confidential business data, trade secrets, intellectual property, and sensitive third-party data. cyberattacks, malicious internet-based activity, online and offline fraud, and other similar activities threaten the confidentiality, integrity, and availability of our sensitive information and information technology systems, and those of the third parties upon which we rely. Such threats are prevalent and continue to rise, are increasingly difficult to detect, and come from a variety of sources, including traditional computer “hackers,” threat actors, “hacktivists,” organized criminal threat actors, personnel (such as through theft or misuse), sophisticated nation states, and nation-state-supported actors. Some actors now engage and are expected to continue to engage in cyber-attacks, including without limitation nation-state actors for geopolitical reasons and in conjunction with military conflicts and defense activities. During times of war and other major conflicts, we, the third parties upon which we rely, and our customers may be vulnerable to a heightened risk of these attacks, including retaliatory cyber-attacks, that could materially disrupt our systems and operations, supply chain, and ability to produce, sell and distribute our goods and services.
We and the third parties upon which we rely are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, and phishing attacks), malicious code (such as viruses and worms), malware (including as a result of advanced persistent threat intrusions), denial-of-service attacks, credential stuffing attacks, credential harvesting, personnel misconduct or error, ransomware attacks, supply-chain attacks, software bugs, server malfunctions, software or hardware failures, attacks facilitated or enhanced by artificial intelligence, loss of data or other information technology assets, adware, telecommunications failures, earthquakes, fires, floods, and other similar threats. In particular, severe ransomware attacks are becoming increasingly prevalent – particularly for companies like ours that are engaged in manufacturing – and can lead to significant interruptions in our operations, loss of sensitive data and income, reputational harm, and diversion of funds. Extortion payments may alleviate the negative impact of a ransomware attack, but we may be unwilling or unable to make such payments due to, for example, applicable laws or regulations prohibiting such payments.
Remote work has become more common and has increased risks to our information technology systems and data, as more of our employees utilize network connections, computers and devices outside our premises or network, including working at home, while in transit and in public locations. Additionally, future or past business transactions (such as acquisitions or integrations) could expose us to additional cybersecurity risks and vulnerabilities, as our systems could be negatively affected by vulnerabilities present in acquired or integrated entities’ systems and technologies. Furthermore, we may discover security issues that were not found during due diligence of such acquired or integrated entities, and it may be difficult to integrate any acquired companies into our information technology environment and security program.
We rely on third-party service providers and technologies to operate critical business systems to process sensitive information in a variety of contexts, including, without limitation, cloud-based infrastructure, data center facilities, encryption and authentication technology, employee email, and other functions. Our ability to monitor these third parties’ information security practices is limited, and these third parties may not have adequate information security measures in place. If our third-party service providers experience a security incident or other interruption, we could experience adverse consequences. For example, the Crowdstrike-Microsoft outage in July 2024 caused temporary disruptions to our systems and servers at our U.S., Malaysia and India locations. While we may be entitled to damages if our third-party service providers fail to satisfy their privacy or security-related obligations to us, or we may be entitled to reimbursement under our insurance policies, any award may be insufficient to cover our damages, or we may be unable to recover such award.
Any of the previously identified or similar threats could cause a security incident or other interruption that could result in unauthorized, unlawful, or accidental acquisition, modification, destruction, loss, alteration, encryption, disclosure of, or access to our sensitive information or our information technology systems, or those of the third parties upon whom we rely. A security incident or other interruption could disrupt our ability (and that of third parties upon whom we rely) to provide our products. We may expend significant resources or modify our business activities to try to protect against security incidents. Certain data privacy and security obligations may require us to implement and maintain specific security measures or industry-standard or reasonable security measures to protect our information technology systems and sensitive information.
While we have implemented security measures designed to protect against security incidents, there can be no assurance that these measures will be effective. We take steps to detect, mitigate, and remediate vulnerabilities in our information systems (such as our hardware and/or software, including that of third parties upon which we rely), but we 
69
Table of Contents
may not be able to detect and remediate all vulnerabilities on a timely basis because the threats and techniques used to exploit the vulnerability change frequently and are often sophisticated in nature. Therefore, such vulnerabilities could be exploited but may not be detected until after a security incident has occurred. These vulnerabilities pose material risks to our business. Further, we may experience delays in developing and deploying remedial measures designed to address any such identified vulnerabilities. Vulnerabilities could be exploited and result in a security incident.
Applicable data privacy and security obligations may require us to notify relevant stakeholders, including affected individuals, customers, regulators, and investors, of security incidents. For example, new SEC rules require disclosure on Form 8-K of the nature, scope and timing of any material cybersecurity incident and the reasonably likely impact of such incident. Such disclosures are costly, and the disclosure or the failure to comply with such requirements could lead to adverse consequences. If we (or a third party upon whom we rely) experience a security incident or are perceived to have experienced a security incident, we may experience adverse consequences, such as government enforcement actions (for example, investigations, fines, penalties, audits, and inspections); additional reporting requirements and/or oversight; restrictions on processing sensitive information (including personal data); litigation (including class claims); indemnification obligations; negative publicity; reputational harm; monetary fund diversions; diversion of management attention; interruptions in our operations (including availability of data); financial loss; and other similar harms. Security incidents and attendant consequences may cause customers to stop using our products, deter new customers from using our products, and negatively impact our ability to grow and operate our business.
Our contracts may not contain limitations of liability, and even where they do, there can be no assurance that limitations of liability in our contracts are sufficient to protect us from liabilities, damages, or claims related to our data privacy and security obligations. We cannot be sure that our insurance coverage will be adequate or sufficient to protect us from or to mitigate liabilities arising out of our privacy and security practices, that such coverage will continue to be available on commercially reasonable terms or at all, or that such coverage will pay future claims.
Additionally, sensitive information of the Company or our customers could be leaked, disclosed, or revealed as a result of or in connection with the use by our employees, personnel, or vendors of generative artificial intelligence (“AI”) technologies.
We are subject to stringent and evolving U.S. and foreign laws and other obligations related to data privacy and security. Our actual or perceived failure to comply with such obligations could harm our reputation and expose us to increased liability and other adverse business consequences.
We collect, store, use, transfer and share (collectively, “process”) personal data and other sensitive information.

Our data processing activities may subject us to various laws and contractual requirements. 
A number of U.S. states have enacted comprehensive privacy laws that impose certain obligations on covered businesses. For example, the California Consumer Privacy Act of 2018, as amended by the California Privacy Rights Act of 2020 (collectively, “CCPA”) applies to personal data of California residents and requires businesses to provide specific disclosures in privacy notices and honor requests of such individuals to exercise certain privacy rights. 
Outside the U.S., the U.K. and EU General Data Protection Regulation (“GDPR”) applies to some of our operations in Europe. Our data processing activities in Asia are subject to new and emerging data privacy regimes, including China’s Personal Information Law 2021 (“PIPL”) and in India’s Digital Personal Data Protection Act (“DPDPA”). 
Our employees are instructed by Enovix IT not to use unauthorized generative AI and machine learning (“ML”) technologies to perform their work. Nevertheless, employees’ indirect use of generative AI in unapproved third-party software and services may still occur, risking the inadvertent disclosure of personal data and sensitive company information to third parties. As Governments have passed and are likely to pass additional laws regulating generative AI, our use of this technology could result in additional compliance costs, regulatory investigations and actions, and lawsuits. If we are unable to use generative AI, it could make our business less efficient and result in competitive disadvantages.
Obligations related to data privacy and security are quickly changing, becoming increasingly stringent, and creating regulatory uncertainty. Preparing for and complying with these obligations requires us to devote significant resources, which may necessitate changes to our services, information technologies, systems, and practices, and to those of any third parties that process personal data on our behalf. If we or the third parties on which we rely fail, or are perceived to have failed, to address or comply with applicable data privacy and security obligations, we could face significant consequences, including government enforcement investigations, fines, penalties, audits, and inspections, additional reporting requirements, and litigation. Any of these events could have a material adverse effect on our reputation, business, or financial condition.
70
Table of Contents
Our facilities or operations could be damaged or adversely affected as a result of natural disasters and other catastrophic events. 
Our facilities or operations could be adversely affected by events outside of our control, such as natural disasters, wars or other armed conflicts, health epidemics, pandemics and other outbreaks, the long-term effects of climate change and other calamities. Our headquarters is located in Fremont, California, which is prone to earthquakes. We cannot assure you that any backup systems will be adequate to protect us from the effects of fire, floods, typhoons, earthquakes, power loss, telecommunications failures, break-ins, war, riots, terrorist attacks or similar events. Any of the foregoing events may give rise to interruptions, breakdowns, system failures, technology platform failures or internet failures, which could cause the loss or corruption of data or malfunctions of software or hardware as well as adversely affect our ability to provide services.
Any financial or economic crisis, or perceived threat of such a crisis, including a significant decrease in consumer confidence, may materially and adversely affect our business, financial condition and results of operations.
Global economic conditions have impacted, and will likely continue to impact, businesses around the world, including ours. Inflation and other macroeconomic pressures in the U.S. and global economy such as rising interest rates and recession fears are creating a complex and challenging environment for us and our customers. 
The U.S. and certain foreign governments have taken actions in an attempt to address and rectify these extreme market and economic conditions by providing liquidity and stability to the financial markets. If the actions taken by these governments are not successful, the return of adverse economic conditions may negatively impact the demand for our lithium-ion battery cells and may negatively impact our ability to raise capital, if needed, on a timely basis and on acceptable terms or at all.
Our ability to utilize our net operating losses and certain other tax attributes to offset future taxable income and taxes may be subject to certain limitations. 
Under the Internal Revenue Code of 1986, as amended, (the “Code”), a corporation is generally allowed a deduction for net operating losses (“NOLs”) carried over from a prior taxable year. Under the Code, we can carryforward our NOLs to offset our future taxable income, if any, until such NOLs are used or expire. The same is true of other unused tax attributes, such as tax credits. Under current U.S. federal income tax law, U.S. federal NOLs generated in taxable years beginning after December 31, 2017, may be carried forward indefinitely, but the deductibility of such U.S. federal NOLs is limited to 80 percent of taxable income. Many U.S. states do not conform to current U.S. federal income tax law regarding NOLs carried forward and deductibility, and generally have more restrictive rules which limit the use of NOLs for state income tax purposes. In addition, there may be periods during which states suspend or otherwise limit the use of NOLs for state income tax purposes.
In addition, under Sections 382 and 383 of the Code and corresponding provisions under state law, a corporation that undergoes an “ownership change” is subject to limitations on its ability to use its pre-change NOL carryforwards and other pre-change tax attributes to offset future taxable income and taxes. The limitations apply if a corporation undergoes an “ownership change,” which is generally defined as a greater than 50 percentage point change (by value) in its equity ownership by certain stockholders over a three-year period. We have experienced ownership changes and are subject to limitations on our ability to utilize a portion of our NOLs and other tax attributes to offset taxable income or tax liability. In addition, future changes in our stock ownership, which may be outside of our control, may trigger additional ownership changes and further limitations. Similar provisions of state tax law may also apply to suspend or otherwise limit our use of accumulated state tax attributes. As a result, even if we earn net taxable income in the future, our ability to use our or Legacy Enovix’s NOL carryforwards and other tax attributes to offset such taxable income or tax liability may be subject to limitations, which could potentially result in increased future income tax liability to us.
Changes in tax laws or regulations that are applied adversely to us or our customers may have a material adverse effect on our business, cash flow, financial condition or results of operations.
New income, sales, use or other tax laws, statutes, rules, regulations or ordinances could be enacted at any time, which could adversely affect our business operations and financial performance. Further, existing tax laws, statutes, rules, regulations or ordinances could be interpreted, changed, modified or applied adversely to us. For example, the legislation enacted in Tax Cuts and Jobs Act of 2017, the Coronavirus Aid, Relief, and Economic Security Act of 2020 and the Inflation Reduction Act of 2022 enacted many significant changes to U.S. tax laws. Further guidance from the Internal Revenue Service and other tax authorities with respect to such legislation may affect us, and certain aspects of 
71
Table of Contents
such legislation could be repealed or modified in future legislation. In addition, it is uncertain if and to what extent various states will conform to federal tax laws. Future tax reform legislation could have a material impact on the value of our deferred tax assets and could increase our future U.S. tax expense. 
In addition, effective January 1, 2022, the Tax Cuts and Jobs Act of 2017 requires taxpayers to capitalize and subsequently amortize research and development expenses over five years for research activities conducted in the U.S. and over 15 years for research activities conducted outside the U.S. Unless the U.S. Department of the Treasury issues regulations that narrow the application of this provision to a smaller subset of our research and development expenses or the provision is deferred, modified, or repealed by Congress, it could harm our future operating results by effectively increasing our future tax obligations. The actual impact of this provision will depend on multiple factors, including the amount of research and development expenses we will incur, whether we achieve sufficient income to fully utilize such deductions and whether we conduct our research and development activities inside or outside the U.S.
In 2021, the Organization for Economic Cooperation and Development announced an Inclusive Framework on Base Erosion and Profit Shifting including Pillar Two Model Rules defining the global minimum tax, which calls for the taxation of large multinational corporations at a minimum rate of 15%. Subsequently multiple sets of administrative guidance have been issued. Many non-US tax jurisdictions have either recently enacted legislation to adopt certain components of the Pillar Two Model Rules beginning in 2024 (including the European Union Member States) with the adoption of additional components in later years or announced their plans to enact legislation in future years. We performed an initial assessment of the potential impact from the Pillar Two rules to our income taxes and determined that there is no impact to us as it is below the global revenue threshold.
We are subject to anti-corruption, anti-bribery, anti-money laundering, import and export controls, financial and economic sanctions and similar laws, and non-compliance with such laws can subject us to administrative, civil and criminal fines and penalties, collateral consequences, remedial measures and legal expenses, all of which could adversely affect our business, results of operations, financial condition and reputation.
We are subject to anti-corruption, anti-bribery, anti-money laundering, import and export controls, financial and economic sanctions and similar laws and regulations in various jurisdictions in which we conduct or in the future may conduct activities, including the U.S. Foreign Corrupt Practices Act (“FCPA”), the U.K. Bribery Act 2010 and other anti-corruption laws and regulations. The FCPA and the U.K. Bribery Act 2010 prohibit us and our officers, directors, employees and business partners acting on our behalf, including agents, from directly or indirectly corruptly offering, promising, authorizing or providing anything of value to foreign government officials for the purposes of influencing official decisions or obtaining or retaining business or otherwise obtaining favorable treatment. The FCPA also requires companies to make and keep books, records and accounts that accurately reflect transactions and dispositions of assets and to maintain a system of adequate internal accounting controls. The U.K. Bribery Act also prohibits non-governmental “commercial” bribery and soliciting or accepting bribes. A violation of anti-corruption laws or regulations could adversely affect our business, results of operations, financial condition and reputation. Our policies and procedures designed to ensure compliance with these regulations may not be sufficient and our directors, officers, employees, representatives, consultants, agents and business partners could engage in improper conduct for which we may be held responsible.
We are also subject to import and export control laws and regulations, including the U.S. Export Administration Regulations, U.S. Customs regulations, and various economic and trade sanctions regulations administered by the U.S. Treasury Department’s Office of Foreign Assets Control, and similar laws in other jurisdictions in which we conduct business. Exports of our products must be made in compliance with these laws and regulations. In addition, these laws may restrict or prohibit altogether the provision or supply of certain of our products to certain governments, persons, entities, countries, and territories, including those that are the target of comprehensive sanctions, unless there are license exceptions that apply or specific licenses are obtained. Any changes in import, export control, or sanctions laws and regulations, shift in the enforcement or scope of existing laws and regulations, or change in the countries, governments, persons, or technologies targeted by such laws and regulations, could result in decreased ability to export our products internationally. 
Significant increases in import and excise duties or other taxes on, as well as any tariffs, particularly on our products to China, could materially increase our costs of our products and have an adverse effect on our business, liquidity, financial condition, and/or results of operations.
72
Table of Contents
Non-compliance with anti-corruption, anti-bribery, anti-money laundering, import and export control, or financial and economic sanctions laws could subject us to whistleblower complaints, adverse media coverage, investigations, and severe administrative, civil and criminal sanctions, collateral consequences, remedial measures and legal expenses, all of which could materially and adversely affect our business, results of operations, financial condition and reputation. 
Our insurance coverage may not be adequate to protect us from all business risks.

We may be subject, in the ordinary course of business, to losses resulting from products liability, accidents, acts of God and other claims against us, for which we may have no insurance coverage. As a general matter, the policies that we do have may include significant deductibles or self-insured retentions, and we cannot be certain that our insurance coverage will be sufficient to cover all future losses or claims against us. A loss that is uninsured or which exceeds policy limits may require us to pay substantial amounts, which could adversely affect our financial condition and operating results.
73
Table of Contents
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
Recent sales of unregistered securities; use of proceeds from registered securities
In July 2025, we declared and issued the Warrant Dividend to shareholders of record of our common stock and the holders of 2028 Convertible Senior Notes as of the close of business on July 17, 2025. On July 21, 2025, 29,233,276 Warrants were issued and distributed in connection with the Warrant Dividend, and such issuance was exempt from registration by virtue of Section 2(a)(3) of the Securities Act. The Warrants expired by their terms on August 29, 2025. 26,526,344 shares of common stock were issued upon exercise of the same number of Warrants, and we separately registered the shares of common stock issuable upon exercise of the Warrants. Please see Note 10 “Treasury Stock, Warrant Dividend and Warrants” of the notes to our condensed consolidated financial statements in Part I of this Quarterly Report on Form 10-Q for further information.
Issuer Purchases of Equity Securities
The following table provides information about purchases we made during the quarter ended 
September 28, 2025
 of equity securities that are registered by us pursuant to Section 12 of the Exchange Act:
(a)
(b)
(c)
(d)
Fiscal periods
Total Number of Shares Purchased 
(1)
Average Price Paid Per Share
Shares Purchased as Part of Publicly Announced Plans or Programs 
(2)
Approximate Dollar Value of Shares That May Yet be Purchased Under the Plans or Programs 
(2)
June 30 - July 27, 2025
— 
$
— 
— 
$
60,000,000 
July 28 - August 24, 2025
4,218,320 
10.81 
4,218,320 
14,409,538 
August 25 - September 28, 2025
1,219,236 
10.43 
1,219,236 
1,696,643 
Total
5,437,556 
$
10.72 
5,437,556 
(1)    
We did not have any repurchased shares from former employees for the early exercised stock options, which were unvested on the termination date, at the exercise price.
(2)
     On June 30, 2025, our Board of Directors authorized the repurchase of up to $60.0 million worth of shares of the Company’s common stock, $0.0001 par value per share.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
None.
Item 5. Other Information
Insider Trading Arrangements
During the quarter ended September 28, 2025, none of the Company’s directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) 
adopted
, modified or 
terminated
 a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” as defined in Item 408(a) of Regulation S-K.
74
Table of Contents
Item 6. Exhibits.
The documents listed in the Exhibit Index of this Quarterly Report on Form 10-Q are incorporated by reference or are filed or furnished with this Quarterly Report on Form 10-Q, in each case as indicated therein:
Incorporated by Reference
Exhibit
Number
Description 
Schedule/Form
File No.
Exhibit
Filing Date
Filed Herewith
3.1
Amended and Restated Certificate of Incorporation
8-K
001-39753
3.1
July 19, 2021
3.2
Amended and Restated Bylaws
8-K
001-39753
3.2
July 19, 2021
4.1
Indenture, dated as of April 20, 2023, by and between Enovix Corporation and U.S. Bank Trust Company, National Association, as Trustee
8-K
001-39753
4.1
April 21, 2023
4.2
Form of Global Note, representing Enovix Corporation’s 3.00% Convertible Senior Notes due 2028 (included as Exhibit A to the Indenture filed as Exhibit 4.1)

8-K
001-39753
4.2
April 21, 2023
4.4
Indenture, dated as of September 15, 2025, by and between Enovix Corporation and U.S. Bank Trust Company, National Association, as Trustee
8-K
001-39753
4.1
September 15, 2025
4.5
Form of Global Note, representing Enovix Corporation’s 4.75% Convertible Senior Notes due 2030 (included as Exhibit A to the Indenture filed as Exhibit 4.1)
8-K
001-39753
4.2
September 15, 2025
10.1
Form of Confirmation for Capped Call Transactions
8-K
001-39753
10.1
September 15, 2025
31.1
Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
X
31.2
Certification of Chief Financial Officer and Treasurer (Principal Financial
 Officer
) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
X
32.1*
Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*
Certification of Chief Financial Officer and Treasurer (Principal Financial
 Officer
) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS
Inline XBRL Instance Document
X
75
Table of Contents
Incorporated by Reference
Exhibit
Number
Description 
Schedule/Form
File No.
Exhibit
Filing Date
Filed Herewith
101.SCH
Inline XBRL Taxonomy Extension Schema Document
X
101.CAL
Inline XBRL Taxonomy Extension Calculation Linkbase Document
X
101.DEF
Inline XBRL Taxonomy Extension Definition Linkbase Document
X
101.LAB
Inline XBRL Taxonomy Extension Label Linkbase Document
X
101.PRE
Inline XBRL Taxonomy Extension Presentation Linkbase Document
X
104
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibits 101)
*    The certifications attached as Exhibit 32.1 and Exhibit 32.2 that accompany this Quarterly Report on Form 10-Q are deemed furnished and are not filed with the SEC for purposes of the Exchange Act nor shall they be deemed incorporated by reference into any filing of Enovix Corporation under the Exchange Act or the Securities Act whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing.
76
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: November 5, 2025
Enovix Corporation
By: 
/s/ Raj Talluri
Dr. Raj Talluri
President and Chief Executive Officer 
(Principal Executive Officer)
By: 
/s/ Ryan Benton
Ryan Benton
Chief Financial Officer 
(Principal Financial Officer)
77